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The Road goes ever on and on 
Down from the door where it began. 
Now far ahead the Road has gone, 
And I must follow, if I can, 
Pursuing it with eager feet, 
Until it joins some larger way 
Where many paths and errands meet. 




This thesis is centred upon the design and development of new stimuli responsive 
system, looking at new targets for sensing applications, and the release of new effector 
molecules for responsive catalytic systems.  
Chapter 1 encompasses a comprehensive review of the current range of 
ratiometric electrochemical sensors, exploring the concepts fundamental in the design 
of new biosensors and highlighting strategies that improve selectivity and sensitivity. The 
chapter aims to provide an overview of the field and place in context the research 
undertaken in the thesis. 
Chapter 2 reports the design, synthesis and testing of two ratiometric 
electrochemical chemodosimeters, and covers the development of the assays and their 
application towards point-of-use sensing. The chemodosimeter developed for the 
detection of -galactosidase exhibited a negligible background rate, which allowed for 
accurate detection to 0.1 U mL-1. The second chemodosimeter was selective for 
organophosphorus(III) compounds, sensitive to 13 ppm for triphenylphosphine, and the 
assay was readily compatible with a handheld potentiostat. 
Chapters 3 and 4 introduce the concept of a stimuli responsive asymmetric 
catalytic system, with the aim of combing two ‘switch-on’ catalytic cycles that could be 
selectively triggered, with each cycle affording a different enantiomer product. Chapter 3 
reports the development of pseudo-enantiomeric proligands for the catalytic transfer 
hydrogenation of ketones, covering their initial design, synthesis, and the triggered 
release of the proligands, which was explored via mass spectrometry. Five successful 
proligands are reported for a range of enzyme and small molecule triggers: -
galactosidase, fluoride, hydrogen peroxide, hydrazine, and alkaline phosphatase. 
Chapter 4 focuses on the incorporation of the developed proligands into the 
stimuli responsive catalytic system. Firstly, three proligands are incorporated into a single 
pseudo-enantiomer system, with a brief substrate scope explored. Finally, two different 
dual pseudo-enantiomer systems are formed from the combination of two single pseudo-
enantiomer systems. The selective triggering of each system is tested, and the 
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1 Ratiometric Electrochemistry: Improving the Robustness, 
Reproducibility and Reliability of Biosensors 
1.1 Introduction 
Electrochemical biosensors are becoming an increasingly attractive option when 
considering the development of a novel analyte detection method, especially when 
integration within a point-of-use device is the overall objective. Principally, this is due to 
the ability to obtain good sensitivity at very low cost, the potential for multiplexing1–3 and 
the capability for miniaturisation4 and sample-to-signal requiring little-to-no user 
manipulation. Additionally, accuracy and sensitivity are not compromised when working 
with opaque samples as the electrical readout signal can be directly read by a device 
without the need for any signal transduction. However, electrochemical detection can be 
susceptible to substantial signal drift and increased signal error.  This is most apparent 
when analysing complex mixtures and when using small, single-use, screen-printed 
electrodes. Over recent years, analytical scientists have taken inspiration from self-
referencing ratiometric fluorescence methods to counteract these problems and have 
begun to develop ratiometric electrochemical protocols to improve sensor accuracy and 
reliability. 
Despite their rapid development over the last few years, there has been 
significant confusion in the literature that ratiometric detection offers increased signal 
intensity, and improved assay sensitivity in comparison to traditional ‘switch-on’ detection 
methods.5–7 Improved sensitivity greater than an order of magnitude is typically achieved 
through rigorous assay development and a thorough investigation of the assay 
parameters including: the mechanism of the analyte–probe recognition event; the 
electrode composition and its surface area; the electrochemical experiment employed; 
composition of the buffer, concentration and pH; and if any signal amplification protocols 
are used, among many other factors.8,9 If an identical analyte detection assay is 
maintained with these assay parameters kept identical, but switches the detection 
method from ‘switch-on’ with a single redox-active compound, to a ratiometric detection 
method with two redox active compounds, then the sensitivity of the assay should remain 
similar. Indeed, one of the first published examples of a ratiometric electrochemical 
biosensor reported a limit of detection (LOD) of 1.9 nM for the sum of the current 
difference using two redox-active labels, whereas LODs for the labels individually were 
5.2 and 4.8 nM, respectively.10  
The true benefit of employing a ratiometric detection method is not for sensitivity, 
but rather for improved assay reliability and reproducibility. This overall increase in assay 
accuracy should provide the analyst with greater confidence in the analyte concentration 
determined by the assay. This is something which becomes increasingly important when 
moving analyte testing out of clean laboratories with controlled environments, and into 
the field. Here, a host of external environmental factors can all lead to significant 
disparities in signal intensity, such as: temperature, humidity, sample volume, electrode 
surface area, out-of-calibration instrumentation, and contamination, among others, which 
can all lead to significant disparities in signal intensity. The accumulated errors 
associated with these factors can be minimised by including a redox-active internal 
standard into the design of the electrochemical sensor, in addition to the redox-active 
label responsible for signal generation. In the case of a positive scenario, this allows for 
the signal produced to be referenced against the internal standard, and analyte 
concentration can therefore be accurately determined by the ratio between these two 
signals. Variations in signal intensity caused by any external factors, and not by the 
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concentration of the target, should affect both redox-active labels equally and would 
therefore be cancelled out when calculating the analyte concentration from the ratio of 
the two peaks rather than the signal intensity from just one. As such, dual-signalling 
assays, where both signals are attributed to the same redox-active label, do not offer the 
same unique self-correcting properties, and are therefore not considered ratiometric.11  
This chapter will provide comprehensive coverage of key developments in 
ratiometric electrochemical (bio)sensors, highlighting innovative assay design, and the 
critical experiments performed that challenge assay robustness and reliability. The 
review is divided into three main sections according to the approaches that have been 
typically deployed to date.  Firstly through an internal standard as a secondary redox-
active label bound to a probe or directly to the electrode or unbound in the assay; 
secondly through a ratiometric electrochemical chemodosimeter that undergoes a 
selective shift in electrochemical signal; and finally a dual-channel system that employs 
two working electrodes (Fig. 1-1). 
 
Figure 1-1 – Overview of ratiometric electrochemical biosensors: a) Secondary redox-




1.2 Secondary Redox-active Labelling 
The most common approach to achieving ratiometric electrochemical sensing is 
to use a second redox-active label with a distinct oxidation potential (Eox), in addition to 
the redox-active label used to indicate the presence of the target. Depending on the 
target type, there are three distinct protocols in which to achieve this. For DNA, 
secondary labelling of the probe, or other DNA architecture, which can maintain proximity 
to the electrode to afford an internal reference is often employed. Conversely, for other 
analytes, including metal ions, small molecules, and proteins, direct modification of the 
electrode with a redox-active internal reference is typical. A less prominent strategy 
introduces an unbound electroactive reference into the assay for the detection of 
analytes with unmodified electrodes.  
1.2.1 Secondary labelling of solid-supported DNA structures 
The dual-labelled DNA probe approach to ratiometric electrochemical sensing is 
a general one as many articles based upon this concept have since been published, 
often employing ferrocene (Fc) and methylene blue (MB) as redox labels due to their 
facile and clearly distinguishable oxidation potentials. Some have aimed to improve the 
sensitivity or selectivity of the DNA detection assay, while others have utilised the 
versatility and excellent selectivity of DNA aptamers to extend the method to the 
detection of other analytes of interest. 
 
Figure 1-2 – Schematic representation of a biosensor for target DNA detection.  
Sessler and Ellington were the first to demonstrate the improved robustness and 
reliability that can be achieved when using a ratiometric electrochemical detection 
method (Fig. 1-2).12 Building upon the reagentless ‘switch-off’ electrochemical DNA 
detection protocol developed by Plaxco,13 the groups synthesised a 37-mer DNA probe, 
which was labelled at the 3’ end with a ferrocene (3’-Fc) derivative, and at the 5’ end with 
methylene blue (5’-MB). This was then immobilised onto a gold electrode (Au) via a thiol 
linkage at its 3’ end. In the absence of the target DNA, the probe adopts a looped, or 
molecular beacon conformation, which places both redox-active labels in proximity to the 
electrode. Square wave voltammetry (SWV) curves showed that both electrochemical 
labels have distinct Eox (IFc 440 mV, IMB −265 mV), a crucial criterium for achieving 
ratiometric electrochemical detection. The reproducibility of the ratiometric method was 
then rigorously tested by individually measuring the background current 50 times across 
eight different electrodes over multiple different days. Using this approach, the 
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normalised current ((IMB/IFc)0) obtained with the ratiometric method showed a significantly 
lower variance in comparison to the single-labelled method. Upon hybridisation with the 
target DNA, a T-lymphotropic virus type I gene, the probe undergoes a conformational 
change which results in the MB redox label being moved away from the electrode, while 
the Fc redox label remains in proximity. As such, the current measured for the Fc label 
remains similar to the background, while the current measured for the MB label 
decreases with respect to increasing target concentration. The LOD was calculated to 
be 25 pM, which is comparable to the single-redox label approach. More importantly, the 
ratiometric method was found to be far more reliable with a correlation coefficient 
calculated to be 0.997, in comparison to 0.958 for the ‘switch-off’ approach. However, 
four ferrocene labels were required to obtain a reasonable signal current for the internal 
standard to accommodate for the high scan rate associated with SWV. 
1.2.1.1 Binding Modes 
The utility of DNA-based biosensors has been expanded past direct detection of 
target DNA. Inspired by non-ratiometric example, DNA-based biosensors have been 
developed for the detection of heavy metal ions and the direct detection of enzymes. 
Antibodies and aptamers have become common in biosensors,14–16 and their 
incorporation into ratiometric electrochemical biosensors was a logical conclusion, 
further expanding the scope of the detectable analytes to include proteins and other 
small molecules of interest.  
1.2.1.1.1 Heavy Metals 
Due to the strong binding affinity of DNA to heavy metals, and through an 
emerging technique known as DNA-templated metallisation,17 DNA can also be used as 
an analyte-recognition element in assays for the detection of heavy metals and by 
extension, small molecules. The groups of Zhang and Chen were the first to demonstrate 
that a ratiometric electrochemical endpoint detection method could be applied to such a 
heavy metal detection assay, through exploiting the high binding affinity between 
mercury ions and thymine nucleobases (Fig. 1-3a).18 A thymine-rich hairpin DNA probe 
strand was solid-supported onto a gold electrode via a thiol linkage at its 5’ end and 3’-
MB labelled. In the absence of the target, the hairpin loop remains in its closed conformer 
despite the addition of a 3’-Fc labelled complementary signal DNA strand and current at 
the Eox of MB was observed via differential pulse voltammetry (DPV) due its proximity to 
the electrode. In the presence of Hg2+, mercury-mediated binding between the solid-
supported probe strand and the complementary signal probe occurs, causing a double-
stranded duplex to form. The rigid structure then forces the MB label away from the 
electrode, and the Fc label towards the electrode. A positive assay sees a decrease in 
current at the Eox for MB, and an increase in current at the Eox for Fc. The assay showed 
a dynamic range between 5 μM and 0.5 nM, a correlation coefficient of 0.997, and an 
LOD of 0.08 nM. Despite being selective and reusable, the reproducibility of the assay 
was only demonstrated through five repeated experiments on different electrodes at an 
unreported concentration of Hg2+, which achieved a relative standard deviation (RSD) of 
3.7%. 
In a conceptually similar but opposite assay, the groups of Luo and Li also 
developed a ratiometric electrochemical mercury detection assay (Fig. 1-3b).19 In this 
instance, a Y-shaped probe was formed from the two DNA stands, with a Fc label close 
to the electrode, and an MB label away from the electrode. The probe, in the presence 
of mercury ions, would disassemble to release the Fc labelled strand into solution, and 
allowing the solid-supported DNA to reform the hairpin conformer. Nearly identical 
numbers were obtained for this assay: a dynamic range of between 5 μM and 1 nM, an 
5 
 
LOD of 0.09 nM, a linear regression coefficient of 0.995, and an RSD of 3.6% when 5 
individually prepared electrodes were tested at 1 nM Hg2+. The selectivity of the assay 
was explored against common metal ions.  
  
Figure 1-3 – Schematic representation of two biosensor for the detection of Hg2+ using 
DNA-templated metallisation. 
1.2.1.1.2 Antibodies 
The effective conjugation of DNA to other biomolecules such as antibodies, has 
allowed for the simple construction of DNA-immobilised, sandwich-type immunoassays 
for efficient protein detection. As DNA is the backbone to these assays, ratiometric 
electrochemical detection methods can also be applied to improve assay reliability and 
robustness. Ju et al. in particular have pioneered this approach, utilising ratiometric 
electrochemistry in concert with an immunoassay for the detection of prostate specific 
antigen (PSA) (Fig. 1-4).20 Here, a hairpin support probe was labelled 5’-Fc and 
immobilised at its 3’ end to a gold electrode. The addition of a complementary capture 
probe labelled 5’-MB and its 3’ end with an antibody specific towards PSA. In the absence 
of the target cancer biomarker, this initial double-stranded DNA structure keeps the Fc 
label away from the electrode, while the MB label is in proximity. In the presence of the 
target, an immunoassay-type sandwich structure forms, with the assistance of another 
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single-stranded DNA probe bearing a PSA-specific antibody. This secondary probe, 
complementary to that of the capture probe, displaces the support probe and releases 
the sandwich structure, along with the MB label, into solution. Simultaneously, the 
support probe reverts to its preferred hairpin structure, which places the Fc label close 
to the electrode. Target PSA concentration can then be determined by the ratio between 
the two peak currents observed by alternating current voltammetry (ACV). A successful 
sandwich immunoassay structure is a prerequisite for strand displacement, as without 
the target, no change in current is observed for either redox label. Again, the excellent 
robustness of the ratiometric detection method was exemplified with a correlation 
coefficient of 0.999 over a target concentration range of 0.05–100 ng mL−1, along with 
an LOD of 16 pg mL−1. The same group also demonstrated that the assay can be 
performed in reverse, such that the hairpin support probe could be opened by the 
presence of an analyte-initialised secondary DNA structure, which greatly reduced total 
assay time.21 PSA could be detected over a similar concentration range, between 0.01–
200 nM, with a correlation coefficient of 0.997, and an LOD of 4.3 pg mL-1 after just a 30-
minute incubation. 
 
Figure 1-4 – Schematic representation of an antibody-based biosensor for the 
detection of protein specific antigen (PSA). 
1.2.1.1.3 Aptamers 
DNA aptamers have recently emerged as a tuneable, synthetic alternative to 
antibodies as a way to selectively bind to a target analyte other than DNA.22–24 Coupled 
with their versatility and robustness when applied to solid-supported electrochemical 
biosensors, DNA aptamers have been inevitably utilised in combination with ratiometric 
electrochemistry to achieve selective and accurate analyte detection. This extends the 
use of DNA within such biosensors from solely DNA detection, to other biomolecules 
such as proteins and liposaccharides, as well as small molecules such as plastic 
contaminants and illicit drugs. 
For the electrochemical detection of tumour biomarkers, Xiang et al. showed that 
a DNA aptamer, selective for mucin-1, could be combined with a ‘switch-off’ ratiometric 
method for improved robustness and reliability (Fig. 1-5).25 To achieve this, a hairpin 
reference probe labelled 3’-MB was anchored to a gold nanoparticle-coated glassy 
carbon electrode (AuNPs/GCE), through a thiol linkage at its 5’ end. Close to the 5’ end, 
but within the loop itself, an eleven base-pair link sequence complementary to that of a 
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target-binding aptamer was designed into the probe, with the aptamer itself labelled 3’-
Fc. In the absence of the target, hybridisation between the solid-supported reference 
probe and the aptamer results in both redox-active labels being placed in proximity to 
the electrode, with two current peaks being observed at their expected Eox using SWV. 
In the presence of mucin-1, competitive binding for the aptamer occurs.  This results in 
disassociation from the hairpin reference probe, and a removal of the Fc label away from 
the electrode. Over a concentration range between 1 nM and 1 μM of mucin-1 in 
phosphate buffer solution (PBS), a correlation coefficient of 0.996 was observed and an 
LOD of 0.83 nM could be calculated. More importantly, the excellent reproducibility of 
the ratiometric detection method was also demonstrated with 30 experiments being 
performed over 10 electrodes. The RSD of the background and positive response was 
found to be 4.0% and 5.2% respectively, which compares very favourably with the values 
for the non-ratiometric method of 15.8% and 17.1%. 
  
Figure 1-5 – Schematic representation of an aptamer-based biosensor for the detection 
of mucin-1. 
The specificity of aptamers towards free nucleotides was utilised by Zhang et al. 
for the detection of adenosine.26 They exploited the strong binding affinity of MB-modified 
thymine residues towards alternating AT base sequences, resulting in a ratiometric 
electrochemical ‘switch-on-switch-off’ biosensor (Fig. 1-6). A 5’-thiolated DNA support 
probe, containing the MB-modified thymine residue penultimate to the 3’ end, was 
immobilised onto a gold electrode. The 3’-Fc labelled aptamer formed a stable duplex 
with the support probe, encapsulating the MB-label, and placing the Fc label close to the 
electrode. On addition of adenosine, aptamer binding induces disassociations of the 
duplex, removing the Fc label from the electrode. The immobilised strand brings the MB-
label close to the surface, with a resultant current increase at -280 mV (IMB) and 
concurrent decrease at 390 mV (IFc). Quantification of the ratiometric currents via ACV 
could then be used to determine adenosine concentration over a dynamic range of 
0.1 nM to 10 µM with a correlation coefficient of 0.998, an order of magnitude larger than 
the single label ‘switch-on’ or ‘switch-off’ assays. The biosensor demonstrated good 
reproducibility at 100 nM concentrations, and the regeneration was possible on 
incubation with the labelled aptamer to reform the duplex, with an RSD of 4.8% reported 




Figure 1-6 – Schematic representation of an aptamer-based biosensor for the detection 
of adenosine. 
  
Figure 1-7 – Schematic representation of an aptamer-based biosensor for the detection 
of bisphenol A (BPA) utilising the redox activity of BPA. 
When target compounds themselves have their own facile Eox, one way to avoid 
peak overlap is to choose a reference label and a reporter label with sufficiently different 
Eox to that of the target. The groups of Zhang and Chen performed such a feat for the 
ratiometric electrochemical detection of bisphenol A (BPA), and deliberately incorporated 
the Eox of BPA into the assay (Fig. 1-7).27 In this triple-signalling assay, a double-stranded 
duplex was solid-supported onto a gold electrode containing an immobilised BPA specific 
aptamer labelled 3’-Fc, and hybridised with a complementary strand also labelled 3’-MB. 
In the presence of BPA, displacement of the complementary strand with BPA occurs with 
concurrent removal of the MB label from the electrode, and placement of the Fc label 
close to it. The target is selectively detected by SWV through the reduction of the peak 
at −280 mV (IMB), as well as the concomitant increase of both peaks at 280 mV (IFc) at 
≈575 mV (IBPA). By taking the sum of the current changes for all redox active species 
(ΔIFc + |ΔIMB| + ΔIBPA), the LOD for the assay was calculated to be 0.19 pM. Although 
lower than taking the current from any one of the redox labels individually, this is still 
within the same order of magnitude as a single label assay, and a structurally similar 
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biosensor that utilised a single redox label on the complementary strand.28 This further 
reinforces the notion that increasing the number of redox-active labels does not afford 
great leaps in sensitivity.  
 
Figure 1-8 – Schematic representation of an aptamer-based biosensor for the detection 
of cocaine in whole blood. 
To challenge the ratiometric method further than buffered solutions, Plaxco et al. 
developed an electrochemical DNA aptamer-based sensor for the monitoring of cocaine 
in undiluted whole blood (Fig. 1-8).29 Whole blood is one of the most challenging 
mediums in which electrochemical sensors can be deployed due to the large number of 
potential contaminants present in blood that could cause nonspecific binding and 
electrode fouling, leading to severe drift of the baseline current. To circumvent this issue, 
a DNA aptamer specific towards cocaine, was immobilised onto a gold electrode and 
was labelled at the end proximal to the electrode with anthraquinone (AQ) and labelled 
at the end distal to the electrode with MB. Despite the different redox labels employed, 
both have significantly distinguishable Eox (IAQ −420 mV, IMB −260 mV, vs Ag/AgCl), both 
are stable, and both have similar physical properties, making them ideal for ratiometric 
electrochemical sensing. The current observed for the AQ reference label was shown to 
be largely insensitive to the target, whereas the current observed for the MB signal label 
showed concentration-dependent increases, thus demonstrating the feasibility of the 
method. Continuous monitoring for 15 hours in whole blood in the absence of the target 
was found to significantly reduce baseline drift from as much as 50% to less than 5%. 
This allowed greater biosensor accuracy when reporting target concentrations of 0.2 mM 
and 1 mM, which could easily be determined at any timepoint within several hours of 
continuous blood monitoring. By simply switching the DNA aptamer used, this general 
approach could also be applied to the detection of other small molecule drugs such as 
kanamycin and doxorubicin. However, the latter was found to have a similar Eox to that 
of AQ, exposing an unfortunate limitation of electrochemical sensing. 
1.2.1.1.4 Enzyme Detection 
When the analyte of interest is an enzyme, biosensors can be designed to utilise 
their in-built catalytic activity. For example, telomerase adds repeat units to the 3’ end of 
telomeres and are over expressed in cancer cells. Their chain elongation properties have 
been incorporated into biosensor design for the facile detection of cancer cells. Lei et al. 
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utilised cerium metal organic frameworks (Ce-MOFs), labelled with AuNPs and capture 
DNA to detect telomerase activity (Fig. 1-9a).30 An MB-labelled hairpin was immobilised 
onto a gold electrode, with a hybridised telomer proximal to the electrode, and the hairpin 
conformation bringing the MB label close to the electrode surface. In the presence of 
telomerase and deoxyribonucleotide (dNTPs), chain extension elongates the primer 
disrupting the hairpin conformer, removing the MB label from the surface. The capture 
DNA is complimentary to the elongated strand, which brings the CeMOF structure close 
to the electrode. The MOF catalyses the conversion of hydroquinone (HQ) to 
benzoquinone (BQ), which possess a distinct Eox at 280 mV, allowing for ratiometric 
electrochemical analysis. A dynamic range was reported of 2 × 102 to 2 × 106 HeLa cell 
mL-1 with a calculated LOD of 27 HeLa cell mL-1.   
 
Figure 1-9 – Schematic representation of two biosensor for the detection of telomerase: 
a) a MOF based approach; b) a hybridisation approach.  
A biosensor developed by Miao et al. used a simpler strategy for the detection of 
telomerase (Fig. 1-9b).31 A 5’-MB labelled strand was immobilised onto the gold 
electrode surface and adopted a hairpin conformation. A complimentary telomer labelled 
at 5’ terminus was hybridised to the hairpin conformer which in the presence of 
telomerase and dNTPs extend the primer, hybridising with the hairpin removing the MB 
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label from the surface. The ratiometric sensor had a good dynamic range of 0.2 to 200 
cells µL-1 with and calculated LOD of 0.02 cells µL-1. The correlation coefficient of 0.992 
exhibited the reliability of the biosensor, however its reproducibility was not explored. 
1.2.1.2 Selectivity Strategies 
DNA-based biosensors already boast impressive selectivity towards target DNA, 
with aptamer and antibody-based probes similarly selective. However, when single point 
mutations in the DNA sequence can have a profound biological effect and significant 
biomedical implications, improving selectivity remains a key research goal. Duplex 
stability improves with hybridisation stability; however, this relationship breaks down for 
longer DNA strands. Probing this stability often requires the use of high temperature near 
the duplex melting point or chemical denaturing of the strands,32 making the 
incorporation of either into biosensors unfeasible, and alternative strategies are required 
to discriminate single point mutations. 
 
Figure 1-10 – Schematic representation of a biosensor for the detection of single point 
mutation via DNA branch migration. 
Multiple methodologies have been developed to obtain the selectivity required for 
single point mutation discrimination, and their incorporation with ratiometric 
electrochemical technique has led to reliable, accurate biosensors. Xie et al. 
demonstrated that cascade DNA branch migration could be employed with dual-redox 
labels for selective and robust DNA detection (Fig. 1-10).33 A two-component approach 
was utilised with a 3’-MB label at the end of one signal probe, which was complementary 
to a capture probe immobilised onto a gold electrode, and a second signal probe labelled 
3’-Fc, which was complementary to that of a protection strand. In the absence of target 
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DNA, the protection strand would hybridise with the Fc signal probe, preventing it from 
interacting with the capture probe. This capture probe would be hybridised to the MB 
signal probe, placing the redox label close to the electrode. In the presence of target 
DNA, competitive hybridisation with the Fc signal probe occurs, revealing toeholds, 
overhanging single-stranded DNA complementary to another strand of single-stranded 
DNA. This then initiates spontaneous strand displacement, via a Holliday junction, with 
the hybridised MB signal-probe/capture-probe duplex, which itself has complementary 
toeholds. This displaces the MB signal probe into solution by the Fc labelled strand, 
which in turn places the Fc label in proximity to the electrode. Interestingly, DNA 
concentration was not determined by the ratio between the two peaks but instead used 
the sum of the change in current from both MB and Fc (ΔIFc + |ΔIMB|). Despite this, a 
correlation coefficient was determined to be 0.997 and an LOD was estimated to be 85 
pM. More importantly, the system could easily distinguish between complementary DNA 
and mutant type DNA, which included a base pair mismatch, a base insertion, and a 
base deletion. 
1.2.1.2.1 Locked Nucleic Acids 
 
Figure 1-11 – Schematic representation of a biosensor for the detection of single point 
mutation via locked nucleic acid strand displacement reaction. 
Locked nucleic acids (LNAs), conformational restricted RNA nucleotides, 
improve the thermal stability of base pairings, with a resultant increase in selectivity 
making their incorporation into biosensors favourable.34–36 An amplification free 
methodology for the detection of miRNA was developed by Chen et al. using LNA-
assisted strand displacement reaction (LSDR) (Fig. 1-11).37 A Y-shaped molecular 
beacon was formed from two complimentary DNA strands: a MB-labelled support strand 
immobilised onto a gold electrode and a Fc-labelled probe DNA strand. The Y 
conformation positions the Fc label close to the electrode, with the MB label remaining 
distal. Target miRNA binding to the Fc labelled strand initiates LSDR, destroying the Y-
structure, with the MB-DNA hairpin conformation reforming, resulting in an increase in 
MB signal. The LNAs impart increased stability and improve the rate of strand 
displacement, allowing for single mismatched DNA differentiation. The unamplified 
strategy affords an impressive LOD at 2.3 fM, with a small RSD of 2.15% over eight 
repeats at 50 fM concentration. The variance over 10 samples was small at 0.147, 
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compared to the single signal biosensor with reported variance of 0.401 and 0.262 for 
IMB and IFc respectively. This simple biosensor reported a comparable LOD to amplified 
methodologies, demonstrating the selectivity imparted by LNAs. 
1.2.1.2.2 Triple Helix Molecular Beacons 
An alternative strategy to improve the selectivity of DNA biosensors is the 
construction of triple helix molecular beacons (THMBs).38 In general, an 
electrochemically labelled hairpin strand is immobilised onto the DNA surface, and 
subsequent addition of the capture DNA strand induces formation of the THMB. Two 
short complimentary sequences on the capture probe bind to the hairpin strand, 
removing the initial label from the electrode surface. THMB possess similar stabilities to 
DNA duplexes, however, the increased length of free target sequence confers an 
increased selectivity towards the target DNA. If the capture strand is also labelled, then 
ratiometric electrochemical sensing is possible, combining increased selectivity with 
improved reliability and reproducibility.  
 
Figure 1-12 – Schematic representation of triple helix molecular beacon-based 
biosensor for either target DNA or analyte detection. 
One of the first reported THMB based ratiometric biosensors was by the Zhang 
and Chen groups who used a MB labelled hairpin probe, and a doubly labelled Fc capture 
probe (Fig. 1-12).39 On target DNA binding, hybridisation with the probe strand removes 
the Fc label, and reformation of the hairpin structure results in an increase current arising 
from MB. Ratiometric analysis based upon the two currents (IMB/IFc) was possible over a 
relatively small dynamic range of 0.5–80 pM, with a correlation coefficient of 0.985, and 
a calculated LOD of 0.12 pM, in the same order of magnitude as the single signal LODs. 
However, the more important selectivity of the biosensor was reported, with the ability to 
differentiate between single-base mismatched and triple-base mismatched DNA at a 
concentration of 50 pM, with a 47.9% and 25.5% signal intensity. The selectivity of THMB 
can be further improved with the introduction of signal amplification strategies, with a 
significant increase in selectivity reported by Xiang et al. with single mismatched DNA 
displaying similar currents to the background test.40 Single-base-mismatch 
discrimination factors, the ratio between signal from the perfectly matched DNA to a 
single-base mismatched strand, were reported between 40-58, a significant 
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improvement compared to previous electrochemical biosensors. Triple helix molecular 
beacons are not only limited to DNA biosensors, with Huang et al. reporting an aptamer-
based sensor for adenosine triphosphate (ATP) (Fig. 12).41 The molecular beacon is 
constructed in the same fashion, with the aptamer adopting the beacon conformation 
around the universal MB-labelled DNA strand. The assay offered impressive 
repeatability with an RSD of 2.9% over 20 experiments, with a 2.5% RSD reported from 
5 electrodes. An LOD of 5.2 fM was calculated, in the same order of magnitude compared 
to the ‘switch-off’ assay, however, the improved reliability of the ratiometric system with 
a correlation coefficient of 0.998 compared to 0.989. 
DNA Four-Way Junctions 
 
Figure 1-13 – Schematic representation of a biosensor for the detection of single point 
mutation via DNA four-way junctions. 
Another strategy to improve the selectivity of DNA sensors are DNA four-way 
junctions (DNA-4WJ), where their capability to discriminate at ambient temperatures 
single nucleotide differences is a distinct advantage.42–44 The first group to incorporate 
the DNA-4WJ into a ratiometric electrochemical probe was Zhang et al. who utilised an 
enzyme assisted recycling amplification in a generic DNA sensor (Fig. 1-13).45 A THMB 
was formed from a universal Fc-labelled strand immobilised onto a gold electrode, with 
a complimentary MB-labelled capture probe hybridised. Two unmodified strands,  and 
, which are partially complimentary to the MB hairpin and the target DNA strand, 
remained free in solution. In the presence of the target DNA, DNA-4WJ formation occurs 
with the  and  strand, and the capture probe, removing the redox label from the 
electrode surface. The universal probe then forms a hairpin conformer bringing the Fc 
label close to the surface, and an exonuclease digest the capture probe allowing for the 
formation of a new DNA-4WJ, amplifying the signal. Selectivity studies with single 
mismatched DNA strand exhibited low electrochemical switch on compared to the target 
DNA, demonstrating the benefits of DNA-4WJs. The reproducibility of the ratiometric 
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biosensor was investigated with an RSD of 2.1% calculated (n = 6) at a 1 nM target DNA 
concentration. 
1.2.1.3 Amplification Strategies 
Increasing the sensitivity of an assay can be achieved through employment of a 
compatible amplification protocol.46,47 More recent efforts in electrochemical assay 
development have been towards successfully combining amplification methods with 
ratiometric electrochemical detection. Traditional methods include label amplification, 
where the multivalent nature of nanoparticles increase the number of signal-reporting 
molecules upon a successful analyte recognition event, and target amplification, where 
a target can generate more than one signal-producing molecule through multiple analyte 
recognition events.48–51 
Approaches towards the non-amplified and amplified ratiometric electrochemical 
detection of thrombin, a coagulation protein, can provide the perfect illustration of the 
benefits afforded by amplification. Firstly, the groups of Zhang and Chen used a dual-
aptamer sandwich structure to generate a non-amplified, ratiometric electrochemical 
thrombin aptasensor (Fig. 1-14a).52 In this instance, double-stranded DNA is used as the 
solid-support on a gold electrode to which a thrombin-specific aptamer was appended 
and labelled at its overhanging 5’ end with MB. In the absence of the protein, the aptamer 
would be free to move whilst anchored to its solid support. This allows it to be in proximity 
to the electrode, and a current for its oxidation detected by SWV. In the presence of the 
target the aptamer would bind to it, pulling the redox label away from the electrode, and 
causing a decrease in current. The addition of a secondary DNA aptamer, labelled at 
both ends with Fc, leads to further target-induced binding, placing the second redox-
active labels close to the electrode and causing an increase in current. A dynamic range 
for thrombin concentration was determined to be 1–600 nM, with a linear regression 
coefficient of 0.996, and a LOD of 170 pM, which is in the same order of magnitude as 
that of the single-redox label system. Reproducibility testing of the assay was limited to 
five repeated experiments on different electrodes at an unreported concentration of 
thrombin. The RSD across the five runs was stated to be 3.9%.  
The groups of Ma and Wang were then able to show that the use of AuNPs could provide 
an increase in current signal response through label amplification (Fig. 1-14b).53 Here, 
the AuNPs, multiply labelled with MB through non-participate DNA intercalation (MB-P3-
AuNPs), were bound to a gold electrode via a thrombin-specific aptamer and a support 
probe, 3’-Fc labelled. Despite their increased distance from the electrode compared with 
that of Fc, the label amplification provides a detectable current at the Eox corresponding 
to MB. In the presence of thrombin, competitive binding for the aptamer occurs and the 
solid-supported structure is destabilised leading to removal of the AuNPs from the 
electrode, and a corresponding decrease in MB current. Once released, the anchor 
probe can undergo a conformational change to its preferred hairpin conformer, which in 
turn places the Fc label proximal to the electrode and a concurrent increase in current at 
the Eox for Fc is observed. The dynamic range of the system was determined to be 3 pM 
to 30 nM with a linear regression coefficient of 0.995 and the LOD was estimated to be 
1.1 pM, which is a factor of 100 more sensitive than the non-amplified method. 
Importantly, the ratiometric detection method delivered acceptable reproducibility with 
standard deviations between 2.4% and 4.6% over three repeated assays for three 




Figure 1-14 – Schematic representation of three biosensors for the detection of 
thrombin: a) non-amplified aptasensor; b) label amplification-based aptasensor; c) 
target amplification-based aptasensor. 
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Gao et al. have also demonstrated an amplified ratiometric electrochemical 
method for thrombin detection, but instead utilising target recycling to provide 
amplification (Fig. 1-14c).54 In this instance, two hairpin DNA probes are employed: one 
as a target capture probe containing a thrombin-specific aptamer sequence and labelled 
with Fc, and the other as a support probe which is solid-supported onto a gold electrode. 
The latter contains a sequence specific to that of the target capture probe and is labelled 
with MB. In the absence of the target, signal current is only observed at the Eox of MB 
indicating that both probes remain in their preferred hairpin conformers, as no recognition 
between the strands is observed. In the presence of the target, interaction between the 
capture probe and thrombin occurs, which opens the probe and makes the sequence 
specific to the support probe available. This then initiates the opening of the support 
probe, facilitating strand displacement of the capture probe from the protein to the 
support probe. The resulting solid-supported double-stranded duplex has the MB label 
distal and the Fc label proximal to the electrode, meaning thrombin detection is observed 
through the decrease in MB current and the increase in Fc current. During the strand 
displacement process, thrombin is released back into solution, or recycled, allowing it to 
interact with more capture probes thus causing an amplification in signal. This enabled 
a further improved LOD of just 41 fM over a dynamic range between 0.1 pM and 10 nM, 
and a correlation coefficient of 0.995. When considering only one of the redox labels, 
correlation coefficients of 0.959 and 0.910 were observed with Fc and MB respectively, 
despite the LODs being very similar. This provides further evidence that the dramatic 
increase in accuracy and confidence when moving from a single redox-label method to 
a ratiometric, or dual redox-label method. 
1.2.1.3.1 Enzyme Assisted Amplification 
To improve the sensitivity of the dual-labelled DNA detection assay, classic DNA 
amplification methods have been shown to be compatible with ratiometric 
electrochemical endpoint detection. Enzyme-assisted DNA amplification methodologies 
have been a cornerstone of biosensor developments, where their high activity and facile 
reconfiguration to new specific analytes have been favourable. However, they are often 
limited by their high cost, complexity, and potential issues with contamination, which 
inhibits their incorporation into biomedical and point-of-use devices.  
Exonuclease 
Exonuclease III (Exo III) is a sequence-independent duplex-specific enzyme that 
has limited activity against single strand DNA. The enzyme possesses a high 
exodeoxyribonuclease activity in the 3’ to 5’ direction and has been utilised in biosensors 
to selectively digest duplexes for target recycling amplification strategies. For example, 
Chen et al. demonstrated that an exonuclease-assisted target recycling amplification 
strategy can be used to amplify the signal and therefore improve the sensitivity of the 
biosensor (Fig. 1-15a).55 In this instance, a single-stranded DNA capture probe was 
again employed, but this time labelled at the midpoint with Fc and at the protruding 3’ 
end with MB, and bound to the gold electrode at its 5’ end via a thiol linkage. In the 
absence of the target, the probe adopts a hairpin conformation, placing the MB label 
close to the electrode and the Fc label, as it is in the middle of the loop, away from the 
electrode. In the presence of the target, a double-stranded duplex is formed with the 
capture probe. Exo III then digest the probe strand to the middle, releasing the target 
strand back into solution and allowing it to hybridise with additional probe strands. 
Concomitantly, the terminal MB redox label is also removed, and the remaining probe 
strand forms another hairpin conformer, which places the Fc redox label close to the 
electrode. Target DNA is identified through the decrease of MB current and the increase 
of Fc current, discernible via DPV. The ratiometric detection method gives an improved 
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LOD by an order of magnitude over using the current observed for a single redox label 
and offers a dynamic range between 10–800 fM, with a correlation coefficient of 0.985. 
Importantly, the ratiometric detection method again displayed good reproducibility, by 
affording an RSD of 4% when five individual electrode setups were exposed to 1 pM of 
target DNA. 
 
Figure 1-15 – Schematic representation of two exonuclease-based target recycling 
amplification biosensor: a) a heterogeneous amplification step; b) a homogeneous 
amplification step. 
By binding the DNA probe to the electrode, the enzyme kinetics are inhibited, as 
hydrolysis occurs at the electrode surface where configurational and spatial limitation 
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become apparent. Ma and Wang et al. adopted a similar exonuclease-assisted target 
recycling amplification strategy.56 However, by separating the two redox labels onto 
different strands, a homogeneous system was conceived with an unbound capture probe 
labelled 5’-Fc in solution, and a second support probe complete with 5’-MB label 
immobilised on the gold electrode (Fig. 1-15b). On target DNA hybridisation with the 
capture probe, the duplex is digested by the exonuclease, recycling the target DNA and 
releasing a shortened Fc-labelled probe. The shortened probe hybridises with the bound 
probe, opening the conformer. This moves the MB label away from the electrode surface, 
and moves the Fc label close, with the change in current monitored via ACV. The probe 
offered a significant improvement in dynamic range from 20 fM to 2 nM. This 
improvement is attributed to the advantageous homogenous system over the 
heterogeneous equivalent, with a comparable LOD reported of 12.8 fM. The authors 
report that the ratiometric methodology lowered the LOD by three orders of magnitude 
and exhibited good reproducibility across three repeated detections at target 
concentration across three orders of magnitude with a reported RSD of ~3%. 
Strand Displacement Polymerase Reaction 
Biosensors based upon strand displacement polymerase reaction offer 
significant increase is sensitivity through target amplification. Gao et al. implemented a 
target DNA recycling strategy with a ratiometric electrochemical detection method using 
a two redox-labelled component, molecular beacon-mediated circular strand 
displacement assay (Fig. 1-16a).57 Here, the molecular beacon capture probe was 
labelled 5’-Fc and immobilised onto a gold electrode. An 8-mer polymerase primer 
labelled 5’-MB, complementary to that of the 3’ end of the immobilise capture probe, 
remained in solution distal to the electrode. In the absence of the target, the probe strand 
adopts a hairpin conformer which places the terminal Fc redox label close to the 
electrode. In the presence of the target, opening of the hairpin conformer forms a double-
stranded duplex which moves the Fc label away from, and places the MB label close to 
the electrode. DNA polymerisation from the MB-labelled primer is then initiated through 
the addition of dNTPs and DNA polymerase leading to target displacement, recycling the 
target strand which then interacts with additional probe strands, increasing sensitivity. 
Although various exclusivity studies were disclosed, a crucial background experiment of 
the entire assay, involving the capture probe immobilised on the gold electrode plus the 
MB-labelled primer and the DNA polymerase with dNTPs, but without any target DNA 
present, was absent. Nevertheless, in this DNA detection assay the concentration of 
target DNA could be determined by the ratio between the increasing MB current and 
decreasing Fc current. This allowed for a greatly improved assay reliability with a 
correlation coefficient for the linear regression equation of 0.998 determined over the 
course of five independent assays. This is compared to values of 0.957 and 0.958 when 
measuring the current of only a single redox label, either Fc or MB, respectively. 
Additionally, the assay displayed a large dynamic range (100 fM to 10 nM) and an 
estimated LOD of 28 fM, two orders of magnitude lower than that of the same assay 
performed without amplification from polymerase-catalysed target recycling. 
Zhang et al. showed that an aptamer-based ratiometric electrochemical 
aptasensor for nuclear factor kappa B (NF-B) could be designed along the same 
principles (Fig. 16b).58 A thiol-modified hairpin DNA containing the aptamer was 
immobilised onto the gold electrode, with a complimentary 5’-MB labelled protection 
strand hybridised. The protection DNA strand contains an extended alkyl chain on the 3’ 
end preventing the Fc-labelled polymerase primer from hybridising. In the absence of the 
analyte the MB remains close to the electrode, with the Fc distant. However, on analyte 
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aptamer binding a toehold section of DNA is exposed on the hairpin DNA, and 
displacement of the protection stand by the primer occurs, resulting in an increased 
signal at 280 mV (IFc) and a decrease in signal at -230 mV (IMB). Introduction of a 
polymerase extends the primer, releasing the NF-B in a target recycling amplification. 
The resultant amplification afforded a LOD of 30 fg mL-1, with a correlation coefficient of 
0.987 over a dynamic range of 0.1 pg mL-1 to 15 ng mL-1. The reproducibility of the 
aptasensor was relatively good; with an RSD of 8.8% over five experiments and 9.1% 
over five electrodes. 
 
Figure 1-16 – Schematic representation of two polymerase-base target amplification 
biosensor: a) for target DNA; b) an aptasensor for NF-B. 
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Rolling Circle Amplification 
 
Figure 1-17 – Schematic representation of a rolling circle amplification-based 
biosensor. 
Rolling circle amplification (RCA) is an alternative amplification method used in 
biosensor development.59,60 RCA requires a primer, a circular DNA template, and dNTPs 
in combination with a polymerase to form an elongated single stranded DNA containing 
multiple tandem repeats. The Huang group combined exonuclease-assisted target 
recycling with rolling circle amplification in a strategy for the detection of K-ras gene (Fig. 
1-17).61  A 3’-Fc labelled capture probe was immobilised onto a gold electrode, where it 
adopted a hairpin conformer bringing the Fc close to the electrode surface. Addition of 
the target DNA opens the hairpin conformer, reducing the signal at 420 mV (IFc). The 
exonuclease can then cleave the DNA duplex, removing the Fc label and recycling the 
target DNA. The residual single stranded oligomer can then be elongated via rolling circle 
amplification, where binding of the padlock probe templates the formation of an extended 
structure containing multiple tandem-repeat guanine base sequences. The single 
stranded DNA then forms a stable G-quadruplex which subsequently binds hemin, with 
formation of the G-quadruplex-hemin complex monitored via DPV at -360 mV (Ihemin). 
Determination of target DNA concentration was calculated from the ratio of the current 
between the decreasing Fc and increasing hemin. The assay had a dynamic range of 
0.5 fM to 10 pM, with a LOD of 0.28 fM. This is only slightly lower than when using either 
IFc or Ihemin individually, with a LOD of 0.7 fM and 0.6 fM reported respectively. The 
reproducibility of the assay was highlighted by the authors with an RSD of 1.9% reported 





Figure 1-18 – Schematic representation of a catalytic cascade amplified biosensor. 
For maximum sensitivity within a diagnostic assay, catalytic cascades are 
essential to provide significant signal amplification for a detectable signal at ultralow 
analyte concentrations. The groups of Zhuo and Yuan provide an excellent 
demonstration of such a catalytic cascade whilst still utilising ratiometric electrochemistry 
for signal detection (Fig. 1-18).62 The catalytic cascade involves a target-initiated, target-
recycling protocol which triggers another subsequent catalytic cycle to reveal binding 
sites for a signal-amplifying copper catalyst with an electrochemical signal at a distinct 
Eox. The target, a lipopolysaccharide (LPS), causes a conformational change in solution 
to a hairpin probe DNA strand to reveal a DNA primer sequence. From this primer, 
polymerase-catalysed elongation generates double-stranded DNA, which then acts as a 
signal transducer, and recycles the analyte in the same instance. The output DNA is then 
able to hybridise with a hairpin capture DNA probe bound to a gold electrode through a 
thiol linkage at its 5’ end and labelled 3’-Fc. The resulting DNA superstructure reveals a 
specific cleavage site which is selectively trimmed using a nicking endonuclease, 
releasing the Fc redox label into solution and recycling the output DNA in the same 
process, allowing it to interact with another capture probes. Once trimmed, the remaining 
solid-supported DNA strands act as binding sites for AuNPs-labelled Cu-MOFs. Upon 
the addition of a solution of glucose, signal current is observed using DPV at an Eox of 
−180 mV, generated by Cu-MOF-catalysed glucose oxidation. In the absence of the 
target, the catalytic cascade is not initiated, and the capture DNA probes are not nicked, 
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leaving the Fc redox labels near the electrode with an Eox observed at 160 mV (IFc). The 
signal amplification catalyst cascade enabled a LOD of 0.33 fg mL−1 and using the ratio 
between the two electrochemical signals, a linear dynamic range between 1 fg mL−1 and 
100 ng mL−1 with a regression coefficient of 0.996 was observed. 
1.2.1.3.2 Toehold Mediated Strand Displacement Reaction 
 
Figure 1-19 – Schematic representation of toehold mediated strand displacement 
reaction. 
Toehold mediated strand displacement reaction (TMSDR) utilises an 
overhanging section of DNA, formed when a duplex contains one chain shorter than the 
other, and the increased stability of duplexes containing more complimentary base 
pairs.63 This combination leads to spontaneous strand displacement, initiated in the 
toehold region to the thermodynamically more stable duplex. Xie et al.  developed a 
TMSDR-based biosensor for the detection of target DNA (Fig. 1-19).64 Firstly, a capture 
probe was formed from a support strand hybridised with both a protection strand and the 
Fc-labelled probe. A MB-labelled duplex was immobilised onto a gold electrode, and a 
trigger strand was left unbound. In the presence of target DNA, TMSDR occurs between 
the target DNA and the capture probe, releasing the protection strand and exposing a 
second toehold section.   This exposure allows for the trigger strand to hybridise, 
triggering a second TMSDR, which releases the signal probe and recycles the target 
DNA. The released signal probe undergoes a final TMSDR with the immobilised duplex, 
releasing the MB-labelled strand from the electrode surface and bringing the Fc label 
into close proximity. The TMSDR cascade afforded an improved LOD compared to 
previous methods, with a high correlation coefficient of 0.994. A discrimination factor of 
7.2 was reported for single base pair mismatched DNA. Combined with a low RSD of 
1.59%, this demonstrated the excellent reproducibility and selectivity of the biosensor. 
1.2.1.3.3 Catalytic Hairpin Assembly 
Catalytic hairpin assembly (CHA) offers an alternative approach to miRNA 
sensing. CHA features enzyme-free amplification, overcoming the associated stability 
issues, shortening the number of assay steps required, and simplifying the sensing 
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environment, desirable for inclusion into point-of-use devices. The introduction of 
mismatched nucleotides by Ellington has improved the signal to noise ratio, previously a 
limiting factor for CHA, improving the selectivity of the biosensors.65,66 Work by Xiang et 
al. utilised a gold electrode with an immobilised 3’-MB labelled DNA capture probe (Fig. 
1-20).67 The second probe, labelled 3’-Fc, remained distal to the electrode in the absence 
of target miRNA, with a final unlabelled capture strand adopting a hairpin conformation 
in solution. In the presence of miRNA, hybridisation occurs with the capture strand, 
opening the conformation and exposing a toehold section. TMSDR by the Fc-labelled 
probe affords a duplex and recycles the miRNA. The duplex is then able to hybridise with 
the solid-supported capture probe forming a Y-shaped triplex, with the conformation 
removing the MB label from the electrode and positioning of the Fc label close to the 
surface. The reliability of the biosensor was demonstrated by its high correlation 
coefficient of 0.988, and the LOD of 1.1 fM was comparable with enzyme assisted 
amplification strategies.  
 
Figure 1-20 – Schematic representation of catalytic hairpin assembly-based biosensor. 
1.2.1.3.4 DNA Walkers 
Significant signal amplification can be achieved using DNA walkers, 
nanomachines that are able to ‘walk’ down DNA tracks.68,69 The nanomachines contain 
two strands bound together that can open successive molecular beacons through 
hybridisation. TMSDR with a secondary DNA probe releases one strand of the walker 
that can then hybridise another molecular beacon allowing the walker to ‘walk’ down the 
DNA track.70 Chen et al. developed a DNA walker system for the detection of miRNA 
(Fig. 1-21).71 The assay combined a gold electrode immobilised with proximally MB-
labelled DNA probes that adopted a hairpin conformation, with a magnetic bead 
complete with capture probes that were hybridised with the DNA walker. In the presence 
of the target miRNA, locked-nucleic acid strand displacement of the DNA walker occurs, 
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and the unbound walker then ‘walks’ down the DNA track. The opened hairpin then 
hybridises with a complimentary Fc labelled DNA probe via TMSDR, and the DNA walker 
is then able to open another hairpin. The signal at -200 mV (IMB) remained constant, with 
an increase at 360 mV (IFc) observed via DPV. The reproducibility of the assay was 
explored, with an inter-assay RSD of 4.47% and an intra-assay RSD of 3.21% from five 
repeats. The advantages of the ratiometric system was demonstrated with a high 
correlation coefficient of 0.993, a four order of magnitude dynamic range from 0.1 fM to 
100 fM, and an attomolar LOD of 67 aM.  
 
Figure 1-21 – Schematic representation of a DNA walker-based biosensor 
The Xie group constructed a DNA walker with an endonuclease enzyme and 
platinum nanocomposite for target analyte detection.72 MB-labelled reference probes 
were immobilised onto a gold electrode and adopted a hairpin conformation. The DNA 
walker was also immobilised and partially hybridised with a specific aptamer, preventing 
the DNA walker from walking. Mesoporous platinum nanoparticles were labelled with a 
capture strand and encapsulated an electroactive reference molecule, doxorubicin 
(DOX), to provide a second signal. On aptamer binding, the DNA walker is released and 
able to hybridise with the reference probes, removing the MB-label from the electrode 
proximity. A nicking endonuclease cuts the reference probe, releasing the walker to open 
a further hairpin. The shortened strand can then hybridise with the capture strand of the 
nanoparticles, bringing the reference molecule closer to the electrode. The increase in 
DOX signal along with the decrease in MB signal allowed for highly reliable analysis over 
a large dynamic range, 10 pM to 1 µM, with a calculated LOD of 3 pM. The biosensor 
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was readily adaptable to different aptamers, with each assay displaying good 
reproducibility.  
A similar approach was taken by Chen and Zhang et al., however, they 
incorporated an exonuclease to improve the sensitivity of the assay for thrombin.73 To 
an AuNP modified GCE an MB-labelled DNA support probe was immobilised, with a 
complimentary Fc-labelled probe hybridised. In the duplex, the Fc is proximal to the 
electrode and the MB distal, with a toehold region exposed on the Fc probe. The DNA 
walker was also immobilised onto the electrode, with a thrombin aptamer hybridised 
which prevented initiation of the DNA walker. On addition of thrombin, the aptamer binds 
releasing the DNA walker, and the walker hybridises with the toehold region of the 
duplex. The triplex can then be targeted by the exonuclease digesting the Fc probe. In 
the presence of Mg2+ the solid-supported probe hairpin can reform, increasing the MB 
signal. The ratio between the increasing MB and decreasing Fc signal was followed via 
SWV; with a dynamic range of 0.1–10 pM reported. The LOD of 56 fM is similar to 
previously reported values, and the reliability of the ratiometric assay is shown by the 
correlation coefficient of 0.999. The reproducibility was demonstrated over five 
electrodes with a 3.04% RSD. Further progression has seen the incorporation of three-
dimensional DNA walker which imparts greater mobility, overcoming the conventional 
shortcomings of two-dimensional walkers and resulting in improved sensitivity of the 
biosensors.74 
1.2.1.3.5 Metal Nanoparticles 
 
Figure 1-22 – Schematic representation of a nanoparticles-assisted label amplification 
biosensor. 
The introduction of gold nanoparticles (AuNPs) into biosensors has become a 
popular choice, especially in the design of new modified electrodes, but their 
incorporation into DNA-based biosensor remains less common. Their inclusion offers 
two key advantages. Firstly, the addition of AuNPs to the electrode structure improves 
the electrical conductivity of the electrode, improving sensitivity. Secondly, the AuNPs 
create anchor points for DNA attachment for non-gold electrode surfaces. AuNPs have 
already demonstrated their utility as amplification agents for the detection of thrombin. A 
further example of the amplification properties of AuNPs can be seen in the sandwich-
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type immunoassay utilised by Wang et al. to improve the sensitivity for the detection of 
mucin-1 (Fig. 1-22).75 An AuNP-reduced graphene oxide (rGO) composite was 
electrodeposited onto a GCE, creating a large surface area. A 5’-thiolated aptamer was 
immobilised onto the electrode, with a 3’-Fc label, and separately, AuNPs were labelled 
with 3’-MB labelled aptamers. In the absence of mucin-1, the Fc remains close to the 
electrode surface with the MB signal minimal. However, on analyte-aptamer binding, the 
Fc label is removed from the surface with a decrease in signal observed. Binding of the 
AuNP-aptamer in a sandwich-type assay brings the MB labels closer to the electrode. 
Repeatability studies showed an RSD of 5.7% (n = 6) at 1 nM, and the assay displayed 
an improved sensitivity compared to non-amplified biosensors, producing a calculated 
LOD of 0.25 pM, with a large dynamic range of 1 pM to 1 µM.  
1.2.1.3.6 Multiple Label Intercalation 
 
Figure 1-23 – Schematic representation of multiple label intercalation-mediated 
amplification aptasensor for the detection of Ochratoxin A (OTA). 
The difference in intercalating properties of label molecules into single stranded 
DNA compared to double stranded DNA can be used to incorporate multiple label 
molecules into duplexes in a label amplification biosensor.76 MB is more readily 
intercalated into double stranded DNA than single stranded DNA, and You et al. used 
this property for the detection of Ochratoxin A (OTA) (Fig. 1-23).77 A 3’-Fc labelled DNA 
support probe, complimentary to the aptamer for OTA, was immobilised onto a gold 
electrode adopting a hairpin configuration. Hybridisation with the unbound aptamer and 
a helper strand of DNA elongate the double stranded DNA. Intercalation of MB into the 
duplex afforded a reference peak, and on introduction of the analyte the aptamer binds, 
allowing the hairpin to reform returning the Fc label close to the electrode surface. As 
28 
 
MB intercalates better into double stranded DNA, the MB signal decreases on aptamer 
binding, allowing for ratiometric analysis between the Fc and MB signals. The reliability 
of the assay was demonstrated with a correlation coefficient of 0.995 reported. The 
ratiometric assay offered an increased dynamic range (10 pg mL-1 to 10 ng mL-1), and 
an LOD of 3.3 pg mL-1, in the same order of magnitude compared to the single signal 
equivalent. The reproducibility of the assay was demonstrated with an RSD of 1.9% over 
six electrodes.  
1.2.1.3.7 Hybridisation Chain Reaction 
 
Figure 1-24 – Schematic representation of a hybridisation chain reaction-based 
biosensor with nanoparticle-assisted label amplification. 
The hybridisation chain reaction (HCR) is an enzyme-free strategy for improving 
sensitivity through label amplification.78–80 HCR is the hybridisation of two strands of DNA 
that is triggered in the presence of a target DNA strand, polymerising in an alternating 
end-over-end fashion. The extended duplex can then intercalate multiple labels, giving 
significant label amplification. Liang and Qiu et al. reported a dual-amplification strategy 
for the detection of miRNA; combining a duplex specific nuclease and an HCR to obtain 
unparalleled amplification (Fig. 1-24).81 The Fc-labelled capture probe was attached to 
the gold electrode and adopted a hairpin conformation with a peak at 470 mV (IFc) 
observable by DPV. On target hybridisation the hairpin opens, removing the Fc away 
from the electrode surface. A duplex specific nuclease cleaves the DNA duplex leading 
to the recycling of the miRNA. The residual DNA acts as a primer to initiate the HCR, 
forming an extended duplex from polymerisation of the two helper DNA strands. The 
duplex contains multiple overhanging section that an AuNP-bound capture DNA strand 
hybridises with. The AuNPs contain multiple thionine (Thi) redox labels that, on 
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hybridisation, are brought close to the electrode surface, increasing in the signal at -230 
mV (IThi). The dual-amplification strategy afforded impressive sensitivity with a LOD of 11 
aM and a dynamic range of 100 aM to 100 pM. The reproducibility of the biosensor was 
explored at 10 pM concentrations, with an RSD of 2.7% reported across six batches.  
DNA-templated metallisation was discussed previously as a popular technique 
for the formation of well-defined metal nanoparticles, but the resulting structures can 
destroy the recognition properties of the DNA.82 This can be restored through the addition 
of thiols, a mechanism which has been utilised to full effect by Qu et al. for the ratiometric 
electrochemical detection of glutathione (GSH), a thiol-containing small molecule 
important to biological processes (Fig. 1-25).83 Here, single-stranded capture DNA probe 
strands were first attached to a modified GCE, which served as a template for the 
formation of silver nanoparticles (AgNPs). In the absence of a thiol target, the AgNPs 
prevent the initialisation of a hybridisation chain reaction (HCR) and a sole Ag/Ag+ 
oxidation peak is observed at 150 mV. In the presence of GSH, the high binding affinity 
of the thiol for silver results in the removal of the AgNPs from the probe DNA strand, and 
HCR is initiated. The DNA superstructure is then electrochemically detected using MB 
as a DNA intercalator which has an Eox of −290 mV (IMB), sufficiently different to that of 
AgNPs, and thus distinguishable via DPV. An increase in current at the Eox of MB with a 
concomitant decrease in current for the AgNPs is observed under a positive assay 
scenario. The assay displayed a linear dynamic range between 10–1000 nM with a 
correlation coefficient of 0.997 and a LOD of 0.10 nM but was unselective when 
subjected to additional thiol-containing compounds. It was stated that the use of the 
ratiometric method reduced the relative standard deviation in comparison to a single-
labelled system, though no quantification was given. 
 
Figure 1-25 – Schematic representation of a hybridisation chain reaction-based 
biosensor with intercalation-assisted label amplification. 
HCR can also be used for the detection of enzymes. In a conceptually similar 
assay, a biosensor reported by Miao et al. was developed for the detection of human 8-
oxoguannine DNA glycolase 1, which utilised HCR in combination with a ruthenium redox 
label.84 A DNA support strand was bound to the gold electrode and hybridised with a 
complementary probe labelled 3’-Fc, which contained an enzyme recognition specific 
site. The duplex structure brings the Fc into proximity with the electrode, and in the 
presence of the enzyme the Fc probe is cleaved, with an HCR-primer strand hybridising 
to the support strand triggering the HCR with two further helper strands. The extended 
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duplex adsorbs multiple [Ru(NH3)6]3+ complexes, resulting in an increase in current 
observed via DPV. The ratiometric assay offered an improved dynamic range than the 
single signal system with a range of 0.002 U mL-1 to 10 U mL-1, compared to 0.01 U mL-
1 to 10 U mL-1. Unfortunately, the reproducibility of the assay was not investigated. 
1.2.1.4 Summary 
It is clear to see that DNA is by far the most utilised and versatile structure when 
developing ratiometric electrochemical biosensors. This is not surprising, due to the ease 
in which custom sequences with specific redox-active labels can be acquired. The 
emergence of DNA aptamers as analyte-recognition molecules has extended their 
application to not just DNA, but also to other important analytes of interest. These range 
from small molecules, such as drugs, to heavy metals, like mercury. In the majority of 
articles discussed, the deployment of ratiometric detection methods that use two redox-
active species has clearly provided an increase in reliability and reproducibility, in 
comparison to their singly labelled counterparts. However, in some assays, more 
rigorous testing is needed to demonstrate the robustness of the biosensor prior to its 
potential adoption within an applied setting. Ratiometric electrochemical detection 
methods have also shown to be compatible with numerous different amplification 
strategies, which enables the development of highly sensitive biosensors whilst ensuring 
reliable electrochemical endpoint detection. 
1.2.2 Modified Electrodes 
A second popular way of introducing an electrochemical internal reference label, 
as opposed to secondary labelling of DNA analyte-recognition architectures, is to directly 
modify or label the electrode itself. Typically, this is achieved through one of three 
different ways: direct labelling of the electrode with a redox-active material or tag that 
has a distinct electrochemical signal from that of the analyte recognition signal; 
modification of the electrode with macromolecular analyte-recognition structures for 
host/guest-enabled displacement assays using two different redox-active labels; and 
modification of the electrode surface with oxidation catalysts which serve to produce 
distinct electrochemical signals in the presence of specific small molecules. 
1.2.2.1 Direct Labelling of Electrodes 
One approach towards modifying the electrode with an internal reference is to 
use an electrochemically active material as the electrode surface. The groups of Weng 
and Lin were one of the first to demonstrate this technique by employing a polythionine- 
and gold-modified electrode material to develop an electrochemical immunoassay for 
tumour biomarker detection (Fig. 1-26).85 To achieve this, a GCE was first modified with 
a pre-prepared polythionine-gold (PThi-Au) composite prior to the subsequent addition 
of AuNPs and an antibody specific for carcinoembryonic antigen (CEA). Before the 
addition of the analyte, the electrodes were tested with potassium ferricyanide solution 
using DPV and two peaks were observed: one for the polythionine-modified electrode, 
and one for ferricyanide. Upon addition of the target, the ferricyanide peak decreases 
due to both steric and electrostatic effects preventing the ion from reaching the electrode. 
In contrast, the current observed for the polythionine remains identical, showing its 
excellent potential as an electrochemical internal reference electrode material. The ratio 
between the two peaks could then be used to accurately determine analyte 
concentration. The ratiometric electrochemical method was then extensively tested with 
30 experiments conducted on 10 electrodes over multiple days.  This resulted in a vastly 
improved average standard deviation and variance of 0.044 and 0.002, respectively, in 
comparison to non-ratiometric method, which afforded 2.81 and 7.86, respectively. The 
ratiometric method also exhibited a higher correlation coefficient of 0.997, in comparison 
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to 0.995, over a linear range between 5–40 pg mL−1 of CEA and a LOD of 1.7 pg mL−1. 
However, the current response of the internal reference electrode material was found to 
be less desirable, especially in comparison to the ferricyanide ion, and its Eox was also 
found to shift in different pH buffers, potentially limiting any future application. 
 
Figure 1-26 – Schematic representation of a modified electrode for the detection of 
carcinoembryonic antigen (CEA). 
 
Figure 1-27 – Schematic representation of a modified electrode for the detection of 
Cd2+. 
To improve the signal of the internal reference, Tian et al. utilised the facile 
electrochemical properties of Fc for the ratiometric electrochemical detection of heavy 
metals (Fig. 1-27).  An AuNP-modified GCE was labelled with both ferrocene hexanethiol 
(FcHT) as the internal reference and a ligand with a high binding affinity for the analyte 
of interest. Initially, protoporphyrin IX was chosen as the ligand, due to its high binding 
affinity for cadmium.86 In the presence of increasing concentrations of the target, DPVs 
displayed steadily increasing cadmium peaks while the peak corresponding to Fc 
remained identical, demonstrating that a ratiometric electrochemical method had been 
successfully developed. A linear working range was found between 0.1–10 μM, and an 
LOD of 10 nM achieved. Reproducibility experiments were conducted over six different 
electrodes and delivered an RSD of 3.2%. The approach was found to be general, as 
the porphyrin ligand could be changed to a pyridine-containing tetramine ligand.  This 
enabled the ratiometric electrochemical detection of copper, which found application for 




Nanoparticles provide anchor points for DNA immobilisation and function as 
amplifiers for the electrochemical label in DNA-based biosensors, and they have served 
the same purpose in the development of new modified electrodes. The catalytic activity 
of analytes can be improved by the inclusion of metallic nanoparticles, allowing for the 
direct detection of electroactive molecules.88–90 When combined with an internal 
reference, ratiometric electrochemical analysis is possible, which significantly improves 
the reliability of the biosensors. The prevalent use of nanoparticles has become a 
recurring theme in the development of new electrodes. For example, a bimetallic 
approach was adopted by Gui and Wang, who functionalised a GCE with gold and silver 
nanoparticles (Fig. 1-28).91 These nanoparticles enhanced the oxidation of uric acid (UA) 
at the electrode surface, with an increase in current at 460 mV observed by SWV. 
Electrostatic adsorption of a graphene oxide-thionine composite (GO-Thi) via π-π 
stacking provided an internal reference at -280 mV (IThi).  This allowed reliable 
electrochemical analysis, with a correlation coefficient of 0.993 over a dynamic range of 
1–100 µM. The LOD calculated was comparable to previously reported single signal 
sensors, however, the reproducibility was demonstrated with an RSD of 2.6% obtained 
from six separate electrodes. A similar approach adopted by Wang et al. involved using 
the specific analyte binding affinity of creatine for copper nanoparticles (CuNPs) in their 
sensor.92 A polydopamine-reduced GO composite was used to adsorb the reference 
molecule, Nile blue (NB) which has an oxidation peak at -325 mV. The CuNPs had a 
specific current at -50 mV by SWV, which was reduced on creatine binding. The 
ratiometric method exhibited two dynamic ranges, 0.01–0 µM and 10–100 µM, with a 
calculated LOD of 2 nM, and good reproducibility of 1.9% RSD. Structurally similar 
biosensors have been developed for phenol with molybdenum or manganese,93,94 for 
neurotransmitters with manganese,95 and organic dyes with titanium.96   
 
Figure 1-28 – Schematic representation of a metal nanoparticles-based modified 
electrode for the detection of uric acid. 
The stability of nanoparticle modified electrodes is an important consideration 
when designing them; where aggregation and detachment of nanoparticles greatly 
hinders the stability of the electrodes, preventing their facile incorporation into point-of-
use devices. Therefore, several strategies have been explored to improve their long-term 
stability, repeatability, and reproducibility. Luo and Yang embedded AuNP into a 
carbonised resin as an internal reference for the detection of Cu2+ (Fig. 1-29).97 15 
measurements were conducted over five days, with 92% of the original signal 
maintained. Furthermore, across 10 repeat experiments, an RSD of 3.8% was recorded 
and inter-assay RSD of 3.4% across five electrodes. By comparison, the RSD without 
the internal reference was 13.2%, displaying the improved reliability of ratiometric 
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sensing. A superhydrophobic electrode approach was the cornerstone of the approach 
by Li et al., where a zeolite-imidazole framework was formed creating a 
superhydrophobic surface.98 The increased hydrophobicity prevented non-specific 
absorption, an important factor in complex sample testing and in electrode longevity. The 
long-term stability was demonstrated, with >94% maintenance of the original signal after 
30 days, along with good intra- and inter-assay reproducibility (RSD of 3.5% and 1.7-
3.1% respectively) for the detection of multiple analytes including adrenaline, serotonin 
and tryptophan. 
 
Figure 1-29 – Schematic representation of a resin-supported nanoparticle-based 
modified electrode for the detection of Cu2+. 
1.2.2.1.2 Metal Organic Frameworks  
 
Figure 1-30 – Schematic representation of a MOF-based modified electrode for the 
detection of echinacoside. 
An alternative method developed for encapsulating reference molecules was to 
functionalise the electrode surface with metal-organic frameworks (MOFs) and utilise 
their porous morphology to encapsulate multiple redox labels. Ye et al. formed a 
nanocomposite consisting of nickel nanoparticles (NiNPs), graphene oxide (GO), and 
poly (diallyldimethylammonium chloride) (PDDA), with MOF-5 self-assembled in situ to 
form the nanocomplex that was then immobilised onto a GCE (Fig. 1-30).99 MB was 
encapsulated into the structure to act as an internal reference with a constant signal at 
30 mV. The authors report excellent reliability, with a correlation coefficient of 0.991 for 
the ratiometric detection of echinacoside (Ech) compared with 0.977 from the single 
‘switch-on’ assay. Reproducibility studies demonstrated good stability with an inter-assay 
RSD of 3.52% over five electrodes and intra-assay across six repeats of 4.46%. The 
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LOD reported was similar to the ‘switch-on’ assay, but with an increased dynamic range 
and reliability demonstrating the benefits of ratiometric assays. 
1.2.2.1.3 Graphene Oxide 
The introduction of graphene oxide (GO) onto the glassy carbon electrode (GCE) 
has allowed for the incorporation of an internal reference through electrostatic 
interactions. Guo et al. drop-coated a Fc-GO-Nafion complex onto a GCE for the 
detection of paracetamol (Fig. 1-31).100 The addition of Nafion improved the stability of 
the complex, which formed the reference signal with an Eox at 230 mV. Paracetamol (PA) 
had a distinct oxidation peak at 560 mV which was observed via linear sweep 
voltammetry (LSV), and the two peaks produced were then used to calculate the analyte 
concentration. The electrodes afforded a good dynamic range between 1–100 µM and 
an LOD of 0.2 µM. The reproducibility of the assay was not explored, with no exploration 
into the variance across multiple electrodes. The simplicity of fabrication was also 
paramount in work by Gu et al., who constructed a GO-GCE labelled electrostatically 
with MB.101 The resultant electrode was utilised in the measurement of cerebral ascorbic 
acid in in brain microdialysate, displaying excellent selectivity compared to other 
electroactive chemicals present in cerebral fluid. An RSD of <1% was recorded for six 
electrodes for the online repetitive determination of ascorbic acid concentration, 
displaying the high reproducibility of the assay. 
 
Figure 1-31 – Schematic representation of graphene oxide-based modified electrode 
for the detection of paracetamol. 
1.2.2.1.4 Carbon Nanotubes 
Functionalised carbon nanotubes (CNTs) are a prevalent strategy facilitating the 
construction of new electrodes. CNTs enhance electron transfer, improve the surface 
area, and can encapsulate an internal reference for the system.102,103 Prior to 
functionalisation, CNTs are limited by the number of binding sites preventing sufficient 
incorporation of support materials, which can reduce their catalytic activity and stability. 
However, CNT-containing nanocomposites can overcome these limitations, though often 
a decrease in conductivity is observed. Yin et al., building upon their previous work in 
copper sensing with poly(ionic liquid),104 constructed a nanocomposite material from 
CNTs, PDDA, and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulphonate) (ABTS) which 
was electrodeposited onto a GCE to provide a constant reference peak (Fig. 1-32).105 
Embedding of a Cu2+ recognition element, neurokinin B, into the composite allowed for 
the ratiometric detection of Cu2+.  The peak at 580 mV (IABTS) remained constant, with a 
Cu2+ peak at -120 mV increasing over a dynamic range of 0.1-10 µM. This produced an 
excellent correlation of 0.991, and an LOD of 0.04 µM. The electrode was further utilised 
in the detection of −amyloid peptides, which bind to the copper ion reducing the peak 
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intensity at -120 mV in the DPV. Experiments into the electrode reproducibility 
demonstrated low RSD for Cu2+ at 4.9%, increasing to 7.1% for −amyloid peptides. 
Wang et al. harnessed the electroactivity of multi-walled carbon nanotubes as an internal 
reference at 170 mV, for the accurate detection of dopamine (DA) at 400 mV.106 This led 
to a calculated LOD of 0.23 µM, with a correlation coefficient of 0.998 over a relatively 
small dynamic range of 1–20 µM. However, the reproducibility of the electrode was 
demonstrated with an intra-electrode RSD of 0.7%, and an inter-electrode RSD of 5.0%, 
over five electrodes. Other modified CNTs include Fc labelling for the detection of 
nitrophenols,107 and phytohormones,108 and nitrogen doped nanosheets for the detection 
of metal ions.109 
 
Figure 1-32 – Schematic representation of a carbon nanotube-based modified 
electrode for the detection of Cu2+. 
 
Figure 1-33 – Schematic representation of Bi(III)-assisted modified electrode for the 
detection of Pb2+. 
Carbon nanotubes were also integral to the detection of heavy metal ions by 
Shen et al.110 They utilised differential pulse stripping anodic voltammetry (DPSAV) for 
the multiplex detection of four heavy metal ions: Cd2+, Hg2+, Pb2+, and Zn2+. A conductive 
film was synthesised from poly(2-amino terephthalic acid) doped with CNTs and 
mercaptosuccinic acid. A bismuth(III) film formed in situ provided an internal reference 
for the sensor, with the Bi3+ ions forming multicomponent alloys with the metal ions. The 
sensor exhibited a dynamic range of 0.5–50 µg L-1 and showed impressive multiplex 
reliability, reporting correlation coefficients of 0.998 for Pb2+ and 0.999 for the remaining 
three metals. The calculated LODs ranged from 0.089 µg L-1 for Zn2+ and 0.49 µg L-1 for 
Hg2+. Importantly, the sensor could be readily converted for the detection of cancer 
biomarkers, where metal sulfide nanoparticles were utilised as distinguishable signal 
tags in sandwich-type assays. Following recognition, dissolving the metal sulfides 
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released the metal ions which were then detected with a high reliability. Reproducibility 
studies showed that from five repeats RSDs ranged from 4.7% to 5.8% for the cancer 
biomarkers.  Yu et al. built upon the same principles, instead using porous silica 
nanoparticles to support the Bi(III) coating (Fig. 1-33). The ratiometric detection of Pb2+ 
was improved, with an LOD of 0.09 µg L-1 across a larger dynamic range of 0.2–100 µg 
L-1. The sensor was thoroughly tested with 40 experiments conducted on eight electrodes 
over five days affording an RSD of 3.6%, compared to 9.1% for the comparative single 
‘switch on’ signal.  
1.2.2.1.5 Biocompatible Electrodes 
In vivo sensing necessitates the use of biocompatible materials for the 
construction of electrodes without which toxicology and stability are compromised, 
inhibiting the development of biomedical point-of-use devices. Carbon fibre 
microelectrodes (CFME) have become a prevalent strategy, where the electrodes are 
stable in vivo and possess minimal toxicity.  Tian et al. have pioneered the field, with 
their research on CFME for modified electrodes and in dual-channel systems. 
Electrodeposition of gold nanoleaves (AuNLs) onto a CFME created a large surface area 
nanostructure onto which a refence MB-labelled DNA strand was immobilised (Fig. 1-
34).111 Cu2+ recognition elements were also bound with a distinct Eox at 195 mV, from the 
MB peak at -290 mV. The dynamic range of the electrode was relatively small at 1–12 
µM, with a calculated LOD of 480 nM, with the inclusion of Au nanoleaves was 
highlighted by the authors with a 4.5-fold selectivity improvement. The electrode 
exploited the specific binding affinity of cysteine for Cu2+ to develop a compatible ‘switch 
off’ assay for thiols. Tian et al. further reported a CFME spun from multiwalled carbon 
nanotubes (MWCNTs) for the detection of oxygen and pH in brain ischemia.112 A hemin-
Fc biosensor was attached via π-π stacking to the CNF, where the Fc signal remained 
constant independent of oxygen concentration and pH, with the signal intensity of hemin 
increasing at higher oxygen concentration. In addition, the Eox shifts to a more positive 
potential at reduced pH, allowing for the dual sensing of both variables ratiometrically. 
The sensor was tested in vivo displaying excellent selectivities against other neurological 
compounds. Further work  looked at the introduction of polyethylene glycol to prevent 
electrode fouling, and its utilisation for the detection of furin activity in the cell.113 
 
Figure 1-34 – Schematic representation of a carbon fibre microelectrode for in vivo 
detection of Cu2+ and cysteine. 
1.2.2.1.6 Selectivity Strategies 
Selectivity in modified electrode-based assays remains a detriment to their 
incorporation into point-of-use applications, with a challenging transition from a clean to 
an uncontrolled environment. With most electrodes utilising the electroactivity of the 
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analyte, false positives, cross contamination, and electrode fouling remain challenges to 
overcome in complex environments. Compared to DNA-based biosensors, where a 
change in the DNA code can create a novel selective biosensor, modified electrodes 
require different strategies to tailor the assay for a single target. Many strategies take 
their inspiration from DNA biosensors, incorporating aptamers and antibodies utilising 
their inherent selectivity to improve the assays. Alternative routes look at introducing 
recognition sites to distinguish between analytes to improve selectivity. 
DNA 
 
Figure 1-35 – Schematic representation of a graphene-based modified electrode. 
A ‘switch-off’ assay was developed by Qu et al. for the detection of target DNA, 
removing the requirement to label the DNA with an electroactive label, reducing the cost 
of the proposed biosensor and allowing for facile regeneration.114 In this approach, 
graphene was modified with mesoporous silica nanomaterials before being mounted 
onto GCEs.  This allowed molecules to be encapsulated within the silica while facilitating 
electron transfer (Fig. 1-35). Ferrocene carboxylic acid was covalently bound to the 
sandwich structure through an amide linkage, serving as the internal reference, before 
the nanomaterials were loaded with MB and sealed with duplex DNA probes. Once 
constructed, strand displacement of the duplex DNA probes would only occur in the 
presence of complementary target DNA, which would unblock the mesoporous silica 
channels and release MB into solution. The presence of target DNA would therefore be 
attributed to a decrease in current at the Eox of MB, while the current at the Eox of Fc 
remained the same. A linear dynamic range of the assay spanned six orders of 
magnitude between 10 nM and 10 fM, with an LOD of 10 fM. More importantly, the 
ratiometric method improved the accuracy and reproducibility of the assay, with a 
correlation coefficient of 0.989 compared with a correlation coefficient of 0.981 when just 
measuring MB peak current. Li et al. constructed a biosensor upon similar principles, 
using [Ru(NH3)6]3+ loaded positively charged mesoporous silica nanoparticles sealed 
with single stranded capture DNA, and [Fe(CN)6]3- in solution acting as a reference 
signal.115 In the presence of target DNA, hybridisation occurs with the capture probe, 
unblocking the pores and releasing the encapsulated Ru(III). This results in an increase 
in signal at 160 mV (IRu) and decrease in signal at 220 mV (IFe), allowing for ratiometric 
electrochemical analysis. This produced a dynamic range of 100 aM to 1.5 pM, a 
calculated LOD of 33 aM, and an excellent correlation coefficient of 0.992. 
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An alternative approach combined the high selectivity of DNA and the diffusivity 
of single strand DNA for the detection of target DNA. Li et al. modified indium titanium 
oxide (ITO) with naphthalene sulfonate, creating an electrode that has a high selectivity 
for single stranded DNA over double stranded DNA, through strong π-π stacking 
interactions between the nucleotide bases and the planar naphthalene.116 The biosensor 
was constructed from an MB-labelled capture probe that adopted a hairpin conformation, 
and an unbound Fc-labelled duplex reporter probe. In the absence of target DNA, the 
capture probe remains proximal to the electrode resulting in a high MB signal and the 
reporter probe remains distal, with a low Fc signal. On target DNA addition, hybridisation 
occurs with the capture probe, and initiates exonuclease digestion recycling the target 
DNA. The released shortened strand then undergoes TMSDR with the reporter probe to 
release the Fc-labelled single stranded DNA, which diffuses to the electrode surface. 
The duplex formed is then digested by the enzyme to recycle the shortened strand, 
amplifying the signal output. The assay displayed good reproducibility with a correlation 
coefficient of 0.997 over a dynamic range of 80 aM to 300 fM.   
Antibodies 
 
Figure 1-36 – Schematic representation of an antibody-based modified electrode for 
the detection of immunoglobulin G (IgG). 
Metal NP sandwich-style sensors can improve selectivity combining the 
selectivity of antibodies, with the transducing properties of NPs. Tang and Ma 
constructed a sandwich assay for the detection of immunoglobulin G (IgG) using two 
functionalised AuNPs (Fig. 1-36).117 Firstly, a GCE was functionalised with a 
carboxymethyl cellulose-Au-Pb2+ nanocomposite, then labelled with the recognition 
antibody 1 (Ab1). Secondly, carbon nanoparticle (CNPs) were functionalised with AuNPs 
labelled with the other recognition antibody (Ab2). Cu2+ ions were incorporated into the 
CNPs as a reporter signal, with a Pb2+ oxidation peak used as a reference. In the 
presence of the analyte, antibody binding brings the Cu2+ labelled nanoparticles closer 
to the electrode, increasing their signal intensity, with the reference peak reducing. The 
assay was reliable from 1 fg mL-1 to 100 ng mL-1 with a correlation coefficient of 0.994, 
and a calculated LOD of 0.26 fg mL-1. The selectivity of the assay against common 
interference molecules demonstrated that even in large excess of the interferents, 
reliable ratiometric analysis was possible. Other similar metallic NP-based sandwich 
assays included a biosensor for carcinoembryonic antigen detection,118 and Li et al. 
showed that metal labelled synthetic melanin nanospheres (SMNPs) could be used in 
the construction of biosensor for nuclear matrix protein 22.119 A GCE was labelled with 
SMNPs/Pb2+ nanocomposites and the first antibody. The second antibody was fixed to 
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SMNPs/Cu2+, and analyte binding reduced the Pb2+ peak with a corresponding increase 
in Cu2+. When tested against common interferents, the selectivity of assay was 
demonstrated with negligible changes in current observed. 
Aptamer 
Aptamer binding offers another strategy to expand and improve the selectivity of 
sensors toward novel targets. Combining a modified electrode containing an internal 
reference with a bound aptamer, new sensors have been developed for electroactive 
analytes. Gui and Wang et al. used a NB internal standard with a DA specific aptamer, 
producing a highly selective biosensor (Fig. 1-37).120 Aptamer binding brings the 
electroactive analyte close to the electrode surface, whilst inhibiting the diffusion of other 
molecules to the surface. The biosensor displayed excellent reproducibility. After 15 
days, six experiments afforded an RSD of 3.5%, with a correlation coefficient of 0.992 
across a dynamic range of 10 nM to 0.2 mM. The selectivity towards DA was explored 
against other neurotransmitters, which at 10-fold excesses still had minimal current 
changes compared to DA, confirming the selectivity expected for aptamer binding. A 
similar strategy was used by Deng et al. who developed an aptamer-based biosensor for 
17-estradiol using a Thi internal reference.121 The reusability of the assay was 
thoroughly explored with an RSD of 10.3% recorded after 30 experiments. 
 
Figure 1-37 – Schematic representation of an aptamer-based modified electrode for the 
detection of dopamine (DA). 
Recognition Sites 
 
Figure 1-38 – Schematic representation of -cyclodextrin-based modified electrode for 
the detection of imidacloprid (IMI). 
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Addition of non-DNA recognition sites to electrodes have greatly reduced the 
complexity and cost of modified electrodes, whilst maintaining the selectivity desired for 
complex sampling. The incorporation of -cyclodextrin (-CD), which contains a 
hydrophobic internal cavity that undergoes host-guest cavity interaction, has allowed for 
specific analyte detection. This strategy was utilised by Li and Kan, who 
electropolymerized -CD and Thi onto a GCE (Fig. 1-38).122 Thi provided a constant 
internal reference at -250 mV (IThi), with host-guest interaction of the imidacloprid (IMI), 
an insecticide analyte, with the -CD affording a peak at -950 mV, allowing for ratiometric 
analysis via DPV. The size-selective interaction was integral to the selectivity displayed 
against other insecticides and the assay demonstrated excellent reliability across four 
orders of magnitude, with a correlation coefficient of 0.999 and a calculated LOD of 17 
nM.  
Molecular Imprinted Polymers 
Molecular imprinted polymers (MIPs) restrict non-specific binding, offering a cost-
effective alternative to other strategies to improve assay sensitivity. The templated 
polymerisation forms analyte-specific sites, significantly improving the selectivity and 
stability of the electrode. Kan et al. developed a ratiometric electrochemical sensor for 
PA by forming a MIP from poly(pyrrole) (PPy) templated with PA onto a Prussian Blue 
(PB)-modified GCE (Fig. 1-39).123 PB served as an internal reference at 180 mV, with 
PA binding affording an Eox peak at 420 mV. Reproducibility studies showed an RSD 
1.2% over ten experiments. A good dynamic range of 1 nM to 0.1 mM was observed, 
and an LOD of 0.53 nM was calculated. Alternative MIP based biosensors have been 
formed from poly(thionine), for propyl gallate and DA.124 The poly(thionine) served a dual 
purpose by forming specific binding sites and acting as an internal reference. 
  
Figure 1-39 – Schematic representation of a molecular imprinted polymer-based 
modified electrode for the detection of Paracetamol (PA). 
1.2.2.2 Host-Guest Displacement Assays 
Host-guest displacement assays utilise the difference binding strengths of 
analytes towards specific host recognition sites such as -cyclodextrin (-CD). By 
loading the hydrophobic inner cavity of -CD with the electrochemical label rhodamine B 
(RhB), which could be displaced by an electroactive analyte, Zhang and Chen et al. were 
able to utilise the setup for the ratiometric electrochemical detection of BPA (Fig. 1-40).125 
In the absence of the target, an Eox peak at ≈900 mV (IRhB) was initially seen. In the 
presence of the target, this peak decreased in intensity as the RhB was displaced with 
BPA, thus producing an increase in current at the 575 mV (IBPA). The assay displayed a 
linear dynamic range between 1 nM – 6 μM, with a LOD of 52 pM. Additionally, the 
ratiometric method proved reproducible as a standard deviation of only 5.2% was 
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calculated when five individually prepared electrodes were exposed to a 50 nM 
concentration of BPA. The same group then extended the method to electrochemically 
inactive proteins by using DNA aptamers tagged with MB.126 In the presence of prion 
protein, the labelled aptamers bind to the target which seals the MB label inside the β-
CD cavity. In the absence of the target, the aptamer can be displaced by ferrocene 
carboxylic acid leading to a decrease in signal for MB, and an increase in signal for the 
ferrocene compound. However, this method produced a narrow linear range of between 
0.2–2 pM, a correlation coefficient of 0.995 and an LOD of 0.16 pM. At a prion 
concentration of 1 pM, an RSD of 1.4% was calculated when the experiment was 
conducted using five individually prepared electrodes. Similar strategies have been 
developed for mycotoxins,127 and the detection of artificial dyes.128  
 
Figure 1-40 – Schematic representation of a host-guest displacement assay for the 
detection of bisphenol A (BPA). 
 
Figure 1-41 – Schematic representation of a molecular imprinted polymer-based host-
guest displacement assay for the detection of aloe-emodin (AE). 
 Kan et al. used MIPs for the detection of aloe-emodin using a host-guest 
displacement assay strategy (Fig. 1-41).129 The electrode was formed by 
electropolymerisation of pyrrole templated by aloe-emodin onto CNPs. After removal of 
the template models, Thi could weakly bind into the cavities providing a reference signal 
at -130 mV. On addition of aloe-emodin, displacement of Thi occurs, causing a decrease 
in the reference peak.  At the same time, a new analyte peak at -480 mV appears, with 
the change in current followed by DPV. The biosensor displayed good sensitivity with an 
LOD of 75 nM, with an intra-electrode RSD of 4.29% and inter-electrode at 3.35%. The 
selectivity expected with MIPs was confirmed, with minimal interference observed from 





1.2.2.3 Oxidation Catalysts 
To improve both the sensitivity and selectivity of ratiometric electrochemical 
assays, electrodes have been modified with catalysts capable of providing an amplified 
electrochemical signal selectively in the presence of a specific substrate. Examples of 
both biological catalysts, and synthetic catalysts have been described to achieve 
biosensors with favourable characteristics. The inherent amplification of catalyst greatly 
improves the selectivity and sensitivity. When combined with reliable and reproducible 




Figure 1-42 – Schematic representation of a glucose oxidase-based biosensor for the 
detection of glucose. 
Wang et al. demonstrated that glucose oxidase (GOx) could be co-immobilised 
on to a porous carbon electrode with AuNPs and Thi for the ratiometric electrochemical 
detection of glucose (Fig. 1-42).130 In the absence of the target, a peak at −450 mV vs. 
saturated calomel electrode (SCE) was observed, which was corresponded to AuNP-
catalysed reduction of O2.  However, in the presence of glucose, a peak at −250 mV vs. 
SCE was observed and proposed to correspond to the Thi-catalysed reduction of H2O2, 
produced as a by-product of GOx-catalysed oxidation of glucose. The dynamic range 
obtained for the modified electrode covered three orders of magnitude from 35 µM to 15 
mM, with a calculated LOD of 11.7 µM.  A total of 15 biosensors were tested to determine 
their reproducibility with an RSD of 3.54%. In a further development of this strategy, 
incorporation of Cu-MOFs onto macroporous carbon followed by electrodeposition of 
AuNP created a functionalised electrode.131 The AuNPs served a dual purpose, firstly 
catalysing O2 reduction as an internal reference at -500 mV, and secondly immobilising 
GOx. On addition of glucose, GOx catalyses its oxidation removing O2 from the system, 
thus reducing the reduction peak at -500 mV.  The CuMOFs simultaneously catalyse the 
oxidation of glucose to glucuronic acid, with peak formation observed via DPV at -100 
mV. The biosensor was comparable to their original sensor with an LOD of 14.8 µM, and 
an RSD across 15 electrodes of 4.52%. 
 Song et al. have utilised alternative biocompatible material in the pursuit of a 
glucose biosensor (Fig. 1-43).132 Polymerisation of Thi and terephthalaldehyde created 
an electroactive Schiff base polymer (SBP) that had two separate redox peaks at -50 mV 
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and -200 mV. Co-immobilisation of the SBP and GOx onto a GCE created the biosensor, 
with O2 reduction at the electrode with a peak at -375 mV utilised as the reference signal. 
On addition of glucose, the O2 peak decreases as the O2 is used to re-oxidise GOx 
instead of being reduced at the electrode surface. The biosensor displayed a comparable 
dynamic range from 0.82 µM to 4.0 mM and an improved LOD of 0.27 µM. The electrode 
displayed excellent reproducibility with an RSD of 0.51 % across 10 electrodes, and an 
intra-assay RSD of 0.34% (n = 6). The flexibility of SBP was integral to its development 
as a wearable biosensor, which displayed good retention of LOD at 2.4 µM and a 
dynamic range of 7.2 µM to 4 mM. The group further developed a covalent organic 
framework using an ammonia-aldehyde condensation reaction to form a flexible surface 
with two pore sizes.133 Immobilisation of GOx and microperoxidase 11 into the dual pores 
allowed for ratiometric electrochemical detection of glucose.  
 
Figure 1-43 – Schematic representation of a Schiff base polymer-supported biosensor 
for the detection of glucose. 
1.2.2.3.2 Ketjen Black 
 
Figure 1-44 – Schematic representation of Ketjen Black-based biosensor for the 
detection of ascorbic acid (AA). 
Ketjen Black (KB) is a low-cost synthetic catalyst offering high surface area, 
facilitating the oxidation of electroactive compounds. Wei et al. electrodeposited a 
nanocomposite of KB and Thi onto a GCE (Fig. 1-43).134 Thi exhibited a reversible redox 
potential at -220 mV, with KB catalysing the oxidation of ascorbic acid (AA) at -50 mV. 
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The biosensor covered a dynamic range across physiological concentration of AA, with 
a calculated LOD of 25 µM. The authors report no variation across three electrodes.  
Song et al. incorporated an aluminium-based MOF to improve the sensitivity and 
selectivity for AA. Encapsulation of KB and Thi into the MOFs improved the reliability of 
the assay with a correlation coefficient of 0.998 over a dynamic range of 1.41 µM to 5.5 
mM, with a calculated LOD of 4.6 µM. The introduction of the MOF reduced the 
interference from other molecules, vastly improving the reproducibility with an RSD of 
3.9% over five electrodes. KB has also been used in aptasensors, where aptamer 
binding enhances selectivity, and KB amplifies the signal output.135  
1.2.2.4 Summary 
The modification of electrodes offers a different avenue for the detection of 
electroactive analytes, where their facile preparation compared to DNA-modified 
electrodes reduce costs. However, there is a trade-off with a reduction in sensitivity and 
selectivity, and the biosensors are limited to electroactive compounds. Methods to 
improve selectivity, either through biological architecture or specific recognition sites, 
have been developed, however, DNA labelling is still more selective. Oxidation catalysts 
offer a new strategy to improve biosensor sensitivity, but the limited analyte selection 
requires development. In general, more intensive reliability and reproducibility studies 
are necessary to facilitate their incorporation into point-of-use devices. 
1.2.3 Unmodified Electrodes 
 
Figure 1-45 – Schematic representation of an unmodified electrode for the detection of 
doxorubicin (DOX). 
The synthetic processes required in the construction of biosensors remains a 
non-trivial challenge, with the immobilisation of electroactive substrates onto electrode 
surfaces difficult. With each new analyte, a novel strategy is required. This increases 
cost, labour time and requires thorough investigation. Therefore, the use of unmodified 
electrodes is desirable, with the use of an electrolyte solution containing a reference 
molecule. A general strategy was developed by Gui and Wang who used an unmodified 
GCE, in combination with an MB doped electrolyte solution (Fig. 1-45).136 Detection of 
doxorubicin (DOX) via SWV was possible with separate peaks at -270 mV (IMB) and -600 
mV (IDOX). Ratiometric analysis was possible over a dynamic range of 0.01–3 µM with 
reliability demonstrated by the correlation coefficient of 0.991. A calculated LOD of 0.4 
nM was achieved, and the signals demonstrated good thermal stability. The 
reproducibility of the electrodes was explored, with RSD values varying from 1.96% to 
3.86% over six repeats at multiple concentrations. The authors proposed that the 
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substitution of MB with alternative electrochemical references was feasible and went on 
to show that Fc,137 and Thi were also suitable as an internal reference.138 
 
Figure 1-46 – Schematic representation of diffusivity and intercalation-based 
unmodified electrode. 
Li et al. adapted DNA-labelling methodologies in a strategy that exploited the 
difference in diffusivity of dNTPs towards an unmodified indium tin oxide (ITO) electrode, 
compared to single stranded DNA molecules (Fig. 1-46).139 A Fc-labelled capture probe 
in the absence of target DNA remained distal to the electrode, with a low Fc signal 
observed. On target DNA binding, hybridisation forms a duplex that can then be digested 
by an exonuclease, releasing Fc-labelled dNTPs which can then diffuse to the electrode 
surface, and a shortened DNA strand. The shortened strand templates G-quadruplex 
formation with two helper strands in an HCR. A MB-doped electrolytic solution provided 
a secondary signal, which in the negative reaction diffuses to the electrode surface and 
is intercalated into the G-quadruplex in the positive reaction. The increase in Fc signal 
and decrease of MB signal can then be used to monitor target DNA concentration 
ratiometrically. This was observed over a dynamic range of 0.01–10 pM, with a 
calculated LOD of 0.01 pM, comparable to alternative methods. The assay displayed a 
high reliability with a correlation coefficient of 0.994. 
Unmodified electrodes offer a further alternative for the development of new 
biosensors, where their cost-effective construction is a key factor. So far, their adoption 
has been limited, evidenced by the relatively small number of publications on the topic. 





A smaller subsection of ratiometric electrochemical sensing has been the 
development of chemodosimeters, a class of small molecules which offer significant 
differences to previous methodologies. Chemodosimeters utilise the reactivity of the 
target substrates to cause a trigger event, chemically altering the sensors and resulting 
in the irreversible conversion to a second molecule. The signal transduction process can 
be monitored electrochemically, with the substrate having a distinct Eox compared to the 
released molecule. As they do not require modified electrodes and inexpensive synthetic 
routes, chemodosimeters trade-off a reduction in sensitivity with a corresponding cost 
reduction. Their simplified methodology is optimal for incorporation into point-of-use 
devices, making chemodosimeters an attractive target for cost-effective biosensors. 
 
Figure 1-47 – a) Schematic representation of the ferrocene-based chemodosimeters 




The design of chemodosimeters have taken inspiration from classical prodrug 
strategies, where a trigger moiety is separated from the released molecule through a 
linker unit. A concept that has been widely incorporated into fluorescence 
chemodosimeters.140–142 Electrochemical chemodosimeters predominantly utilise 
aminoferrocene 2 as the effector molecule which possesses a lower Eox at -100 mV 
compared to 4-aminophenol at 70 mV, with the lower Eox preferred to prevent the 
oxidation of other species. Initial electrochemical chemodosimeter design built upon the 
work of the Shabat group who pioneered the field with the development of an aldolase 
specific chemodosimeter.143 The Eox of the ferrocene-based carbamate derivative 
(FcCD) occurred at 100 mV a significant separation from the peak of 2 at -100 mV, 
however, ratiometric analysis was not conducted with fixed potential measurement at -30 
mV used instead. Frost et al. were the first group to utilise concurrent decrease in FcCD 
signal, with the increase in FcNH2 signal (Fig. 1-47).144 An alkaline phosphatase (ALP) 
specific FcCD 1 contained a phosphate trigger unit that remained stable in the absence 
of ALP, however, was readily cleaved in its presence to release the effector. Ratiometric 
analysis of the two signals was possible via DPV (IFcCD 70 mV vs I2 -160 mV), using 
disposable screen-printed electrode. The choice of electrode was important for reducing 
costs, and facile incorporation into point-of-use devices. An LOD of 0.4 U mL-1 was 
reported, and the FcCD was compatible with enzyme linked-immunosorbent assays 
(ELISAs), allowing for the potential incorporation of the substrate into multiple sensing 
platforms. This strategy has proved near universal, with further enzyme substrates,145 
small molecules,146–148 and metal ions.149 
A different strategy was developed by Zhao et al., where a single substrate 
contained two separate electroactive units.150 One remained unaffected by the assay, 
supplying an internal reference, and the formation of the second moiety that could be 
followed electrochemically (Fig. 1-48). The nitro- group of 4-nitrophenyl--D-
glucopyranoside remains constant in the assay, with enzymatic cleavage of the sugar by 
-glucosidase affording 4-nitrophenol. The phenol group had an Eox at 50 mV and the 
nitro group reduced to the amine with a peak at -140 mV. The assay displayed good 
reliability with a correlation coefficient of 0.994 and an LOD of 0.0056 mU mL-1. The 
reproducibility of the assay was explored with an RSD of 1.4% across ten experiments. 
 
Figure 1-48 – Schematic representation of a chemodosimeter for the detection of -
glucosidase (-Glu). 
1.3.1 Improving Sensitivity 
The major drawback of chemodosimeters are their reduced sensitivity for target 
analytes. Therefore, to overcome the issue, Frost et al. modified their ratiometric 
electrochemical sensor for ALP to release an amplification agent, that switched on a 
48 
 
catalytic cycle (Fig. 1-49).151 The proligand carbamate derivate contained a tosylated 
diamine ligand, that on releasing enhances the catalytic activity of an iridium precatalyst. 
The active catalyst converts ferrocene carboxaldehyde 12 to ferrocene methanol 13, with 
a change in Eox from 225 mV to -50 mV observed via DPV.  In the absence of ALP, no 
ligand release would occur and there would be minimal reduction of ferrocene 
carboxaldehyde. The amplification strategy improved the LOD to 7.6 pM after 3 mins, 
highly desirable for incorporation into point-of-use devices. However, the inclusion of the 
iridium catalyst significantly increased the background rate, preventing further LOD 
increases. 
  
Figure 1-49 – Schematic representation of a proligand-based label amplification 
chemodosimeter for the detection of alkaline phosphatase (ALP). 
1.3.2 Summary 
The development of electrochemical chemodosimeters has had important 
implications for the biosensor field. Their design has offered feasible alternatives to 
optical based assays, their simplicity is cost effective and favourable for incorporation 
into point-of-use devices. The adaptable design makes configuration to new targets 
facile, however, thorough selectivity studies are required during assay optimisation.  The 
current range of electrochemical chemodosimeters is small in comparison to 
colourimetric and fluorescent equivalents, therefore, there is significant scope to develop 
the field further. Initial work to improve sensitivity has been conducted, though alternative 
strategies are required to expand current methodologies. Taking this into account, 
chemodosimeters are a promising research area for biosensor design.  
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1.4 Dual Channel 
Signal overlap in voltammograms can prevent reliable analysis often leading to 
false positives. Construction of biosensors must therefore consider peak positioning to 
minimise this overlap, which becomes more apparent in complex sampling, where non-
specific interference must be overcome before accurate sensing is feasible. An elegant 
strategy is to separate the two signals to different electrodes preventing peak overlap. 
As both electrodes are subjected to the same conditions, environmental factors are 
accounted for, and the benefits of ratiometric analysis is maintained. One electrode is 
typically labelled with a specific binding moiety, with the second electrode labelled with 
an electrochemical reference. Voltammograms obtained for both electrodes are 
obtained, and then ratiometric analysis conducted to calculate analyte concentration.  
1.4.1 One Reference Electrode 
Dual channel methodology was first proposed by Tian et al. for the detection of 
Cu2+ in vivo.152 Carbon fibre microelectrodes (CFMEs) was modified with cysteamine and 
AuNPs before the reference working electrode was labelled with ferrocene hexanethiol 
(FcHT) (Fig. 1-50). The second working electrode was further functionalised with 3-
mercaptopropionic acid, then nickel nitriloacetic acid. Finally, the recognition element, a 
copper free derivative of bovine erythrocyte, copper-zinc superoxide dismutase 
(E2Zn2SOD) was bound through a metal chelate effect. Cu2+ binding to the recognition 
site results in a reduction peak observable via DPV at 150 mV vs. Ag|AgCl. The reference 
remains constant at 390 mV (IFc), with significant overlap with the Cu2+ reduction peak, 
justifying the use of a dual-channel system. The reproducibility of the sensor was 
explored with 10 electrodes affording an RSD of 5.7%. An LOD of 3 nM was calculated 
with a dynamic range of 10 nM to 35 µM, suitable for testing Cu2+ concentration in live 
rat brains. Tian et al. proved that the methodology could be readily modified to investigate 
pH in vivo.153 Utilising the same reference working electrode, the second working 
electrode was modified with a pH sensitive pyridine-functionalised Fc moiety. The sensor 
had a dynamic range of pH 5.9 to 8.0, with a detection limit of 0.13 pH. The dual-channel 
approach was made suitable for repetitive in vivo measurements by the introduction of 
an ethylenediaminetetraacetic acid wash, regenerating the electrode in situ.154  
 
Figure 1-50 – Schematic representation of a dual channel biosensor for the detection of 
Cu2+. 
1.4.2 Two Working Electrodes 
An alternative dual-channel approach was taken by Zhang et al., who constructed 
two working electrodes labelled with different electrochemical labels, Fc and carbon 
nanofibers (CNFs), for the detection of tetracycline (TET) (Fig. 1-51).155 Two separate 
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aptasensors were constructed, the first started with a SPCE modified with AuNP-
chitosan (CS) composite, to which the Fc-labelled aptamer was immobilised. The second 
aptasensor contained a CNF composite on the SPCE, followed by addition of AuNPs. 
An unlabelled aptamer was immobilised onto the AuNPs. In the presence of tetracycline, 
aptamer binding reduces the current observed for both electrodes. Ratiometric analysis 
utilising the change in currents proved a highly reliable methodology, with a reported 
correlation coefficient of 0.996 across a dynamic range of 10 ng L-1 to 1 µg L-1, and from 
1 µg L-1 to 1 mg L-1 for the detection of tetracycline. The reproducibility of the assay was 
explored with an intra- and inter-aptasensor RSD of 4.62% and 3.4% respectively. 
 
Figure 1-51 – Schematic representation of a dual channel aptasensor for the detection 
of tetracycline (TET). 
1.4.3 Summary 
Dual channel biosensors overcome the constant issue associated with 
electrochemical sensing of signal overlap, however, this comes with the requirement to 
develop two separate electrodes, doubling the research time. The separation of signal 
has distinct advantages in complex sampling situations, including in vivo, making further 





The vast array of biosensors design means that for each analyte, a selection of 
strategies is feasible, with it up to the researcher to determine which route is optimal. 
Several observations remain consistent, ratiometric electrochemistry offers improved 
reliability and reproducibility, however, there is only minimal gain in sensitivity. An 
increase in sensitivity is achieved through other means, including amplification strategies 
or rigorous optimisation. The reproducibility of the biosensors must be explored, 
otherwise their suitability is not fully understood. Secondly, high selectivity is possible 
through the correct choice of recognition element, although stringent screening is 
necessary to confirm the desired selectivity. Finally, stability studies are important, 
without which incorporation into point-of-use devices is difficult. When constructing a 
biosensor, these factors should be at the forefront. It is needless to overengineer an 
assay if a simpler, cheaper equivalent is suitable. In general, DNA-based biosensors 
offer excellent sensitivity and selectivity, though modified electrodes offer a cheaper 
alternative for electroactive analytes, and dual channel biosensors are designed for 
complex sampling. Chemodosimeters are highly desirable for point-of-use incorporation, 
but the sensitivity reduction may not be favourable. Therefore, it is only through sensible 






2 Designing Ratiometric Electrochemical Chemodosimeters for 
Novel Analyte Detection 
2.1 Ratiometric Electrochemical Detection of -Galactosidase 
2.1.1 Introduction and commentary 
Ratiometric chemodosimeters, their design, synthesis and testing has been a 
cornerstone of research within the Frost group for a number of years. Previous work 
undertaken in the group involved the development of electrochemical probes for both 
enzyme,144 and small molecule targets.145,149 The common scaffold 14 shown in Scheme 
2-1 is a readily modified template for different stimuli, with the self-immolative linker a 
standard motif in sensing strategies.156–161 The trigger-linker-effector methodology 
utilised incorporates a selective trigger that on cleavage leaves an unstable anion 
intermediate 15. Collapse of the intermediate through a 1,6–elimination releases quinine 
methide 4, carbon dioxide and aminoferrocene 2. The electrochemical probes utilise the 
oxidation potential of substituted ferrocenes and how the potentials are affected by the 
substituents electron-donating and withdrawing properties.162,163 Aminoferrocene 2 has 
a lower oxidation potential compared to the probe 14, with the change from a weakly 
electron-donating group to a stronger electron-donating group. The difference in 
oxidation potential means that the collapse of the probe can be followed via differential 
pulse voltammetry (DPV) allowing for facile incorporation into point-of-use devices. 
Careful selection of the trigger unit allows for highly selective probes, with the stability of 
the ferrocene derivatives accounting for excellent sensitivities.  
 
 
Scheme 2-1 - General outline for ratiometric electrochemical chemodosimeters. 
Example differential pulse voltammogram showing the two peaks for the probe 14 in 




At the outset of this project, there have been limited examples of enzyme based 
electrochemical ratiometric chemodosimeters, with the field predominantly focussed on 
the detection of small molecules instead (Fig. 2-1).145,146,149 There had been one 
chemodosimeter 1 previously reported example within the group for the detection of 
alkaline phosphatase (ALP) by this methodology,144 based upon seminal work on by 
Shabat et al. on an aldolase sensor 18.143 Further enzyme sensing strategies involved 
their indirect detection through the generation of a small molecule in situ that can then 
be detected.145 For example, the detection of glucose oxidase was achieved by the 
conversion of glucose into hydrogen peroxide, which then cleaved a boronic acid moiety 
of the chemodosimeter 7. Looking to extend this methodology to new enzyme targets, 
we identified the carbohydrase enzyme family as an under explored area. Out of this 
family, -galactosidase (β-Gal) has the widest applicability, as it offers the best selectivity 
when compared to glucosidases, which are known to be promiscuous in hydrolysing 
other sugar moieties.164  
 
Figure 2-1 – Current range of ratiometric electrochemical probes: a) small molecule 
probes: fluoride 5,146 and hydrogen peroxide 7;145 b) metal probes: palladium(II) 17;149 
c) enzyme probe: alkaline phosphatase 1,144 and aldolase 18.143 
-Gal has found use in both industrial processes, in the removal of lactose from 
milk products,165 and in the development of commercial sensing platforms, where the 
detection of -Gal has been used as a biomarker for elevated coliform level in water 
systems.166,167 For example, a commercialised detector by Colifast® is able to test water 
quality at the source within two hours via a fluorescence assay.168 -gal has also found 
prominence as a reporter gene due to its readily measurable signal compared to 
background noise.169–171 In addition, the enzyme has been well characterised and 
demonstrates a high stability, qualities that are important in enzyme-linked 
immunosorbent assays (ELISAs).172 -gal offers several key advantages over ALP and 
horseradish peroxidase (HRP), where the lower rate of background hydrolysis allows for 
a more sensitive assay and the presence of free cysteine residues allow for facile 
conjugation to the crosslinker molecule.173 However, β-Gal exhibits a lower rate of 




Figure 2-2 – a) General method of -gal detection. Current -gal detection assays: b) 
colourimetric assays; c) fluorometric assays; d) NIR fluorometric assays; e) lanthanide-
based fluorometric assay; f) electrochemical assays.  
Current -Gal detection assays span a range of detection modes, including 
colourimetric, fluorometric and electrochemical based substrates (Fig. 2-2). These 
assays are based around the hydrolysis of galactose anomeric bond to release an 
effector molecule 21. Colourimetric probes release highly coloured compounds that can 
be detected either by the naked eye or using a colourimeter (Fig. 2-2b). Ortho-
nitrophenyl -D-galactoside 22 (OPNG) releases o-nitrophenol, a highly coloured yellow 
compound, allowing for the most simplistic qualitative system for the detection of -Gal, 
with quantitative analysis possible at 420 nm.174 Indigogenic substrates follow the same 
principle as OPNG. 5-bromo-4-chloro-3-indoyl-β-D-galactopyranoside 23 (X-Gal) and its 
derivatives release functionalised indoles that are highly coloured.175,176 The substitution 
pattern shifts the absorption wavelength, allowing for incorporation into complex multiple 
analyte assays. Colourimetric assays are limited by their poor sensitivities, and often 
exhibited high background noise. In contrast, fluorometric assays are up to 1000 times 
more sensitive and allow for detection in intracellular systems. Assays include 
fluorescein-di-β-D-galactopyranoside 24 (FDG),177 and 4-methylumbelliferyl β-D-
galactopyranoside 25 (MUGA) (Fig. 2-2c).168 FDG is limited by the requirement for two 
hydrolysis events to occur before signal detection is possible lowering probe sensitivity. 
Luminescent probes for the detection of β-Gal utilise coumarins tethered to lanthanides 
complexes 27.178 The interchangeable cation allows for wavelength tuning for easily 
accessible luminescent probes for multiplex assays. Shifting the wavelength of the 
system lower, led to development of a near infrared (NIR) probe based upon the 
dicyanomethylene-4H pyran chromophore 22.179 The shift to NIR overcame the high 
background rate often associated with fluorescent and chromogenic probes in complex 
mixtures. However, all optical sensors are limited by their use of specialist equipment, 
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the requirement for transparent samples and low signal-to-noise ratios in complex 
samples. 
Electrochemical -Gal substrates overcome some of the limitation observed in 
optical assays. However, the standard substrate for electrochemical assays is 4-
aminophenyl-β-D-galactosidase 28 (PAPG) which exhibits a high background signal.180 
4-methoxyphenyl-β-D-galactosidase 29 (4-mpgal) is a modified PAPG substrate that has 
a negligible background noise, however, the use of modified graphene oxide electrodes 
is required.181 There use is unfavourable due to their high cost and extended 
manufacturing process making them unsuitable for incorporation into point-of-use 
devices. 
With our expertise in small molecule electrochemical sensors, and the current 
requirement for a simple assay for point-of-use device incorporation it was a logical 
process to modified current methodologies to this new trigger unit. The results achieved 
are reported in the paper entitled: “Ratiometric Electrochemical Detection of -
Galactosidase” published as a communication by the RSC journal Organic and 
Biomolecular Chemistry.  
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Ratiometric electrochemical detection of β-galactosidase 
Sam A. Spring,a Sean Goggins,a* and Christopher G. Frost.a 
Department of Chemistry, University of Bath, Bath, BA2 7AY, UK.  
Abstract 
A novel ferrocene-based substrate for the ratiometric electrochemical detection 
of β-galactosidase was designed and synthesised. It was demonstrated to be an 
excellent electrochemical substrate for β-Gal detection with sensitivity as low as 0.1 
UmL-1.  
Concept  
ß-galactosidase (ß-Gal, EC 3.2.1.23) is a prominent enzyme used biologically as 
a reporter gene as it has been well characterised and demonstrates excellent stability.1 
The low level of background substrate hydrolysis and ready availability makes β-Gal an 
attractive enzyme label within enzyme-linked immunosorbent assays (ELISAs).2 It can 
also be used in heavy-metal ion detection,3 and rapid enzyme assays have been used 
in the detection of coliform and E. Coli in waste water treatment.4 β-Gal is typically 
detected either chromogenically, using ortho-nitrophenyl-β-galactoside (ONPG),3 or 5-
bromo-4-chloro-3-indoyl-β-D-galactopyranoside (X-Gal),5 or is detected fluorometrically 
using fluorescein-di-β-D-galactopyranoside (FDG).6 Lanthanide based coumarins have 
also been utilised as a luminescent probe in the detection of β-Gal.7 Optical substrates 
however, are limited by the use of expensive equipment, non-linear fluorescence, and 
potentially high levels of background signal.1 The development of electrochemical 
enzyme substrates allows for the direct conversion of a biochemical recognition event 
into an electrical signal enabling facile biosensor integration within a handheld device.8 
4-aminophenyl-β-D-galactosidase (PAPG) is standardly used as an electrochemical 
substrate for β-Gal, but high background signals prevents accurate analysis at low 
enzyme concentrations.9 A modified PAPG-style substrate, 4-methoxyphenyl-β-D-
galactosidase (4-mpgal) has a negligible background signal, but the unfavourable use of 
modified graphene oxide electrodes is required.10  
Due to its facile oxidation potential and excellent synthetic utility, ferrocene can 
be implemented as the redox-active moiety in electrochemical probes,11-12 with ferrocene 
derivatives widely used in biological systems due to their stability in aerobic and aqueous 
environments.13 The development of ratiometric probes has overcome the issues of 
reproducibility, by the ability to obtain direct conversions, minimising both sampling errors 
and systematic errors from instrument variation.14 Ferrocene-based ratiometric 
chemodosimeters for enzyme detection have previously been reported for alkaline 
phosphatase,15 and glucose oxidase,16 but none currently for β-Gal. 
Ferrocene-based electrochemical sensing is a continuing interest within our 
research group as it enables an inexpensive and convenient way to monitor enzyme 
activity.17 Utilising trigger–linker–effector methodologies,18 we designed 
ferrocenylcarbamoylphenyl-β-D-galactosidase 1 as a ratiometric electrochemical 
substrate for β-Gal. Previously, ferrocenylamine 3 has been shown to be oxidised at a 
lower potential than carbamate derivatives.12 Substrate 1 would have a higher oxidation 
potential than 3 making them electrochemically distinguishable, allowing for the 
ratiometric electrochemical analysis of β-Gal activity. We propose that in the presence 
of β-Gal, hydrolysis at the anomeric position would afford an unstable phenolate 
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intermediate 2. 1,4-elimination would follow releasing ferrocenylamine 3, quinone 
methide and CO2 (Scheme 1).  
 
Scheme 2 - Structure of Substrate 1 and the proposed mechanism of β-Gal catalysed 
breakdown with subsequent release of ferrocenylamine 3. 
Synthesis 
 
Scheme 2 - Synthesis of substrate 1. 
The synthesis of substrate 1 (Scheme 2) started from the commercially available 
D-galactose pentaacetate which was converted to benzyl alcohol 5. Ferrocenoyl azide 6 
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was synthesised according to a literature procedure,19 and then coupled to the benzyl 
alcohol via a Curtius rearrangement. Zemplén deacetylation of 7 afforded the desired 
substrate 1 in a 16 % overall yield. Once synthesised, substrate 1 was found to be a 
bench stable orange solid with no observable degradation over several months at room 
temperature. Substrate 1 was also stable to hydrolysis in tris buffer (pH 7, 50 mM) 
solutions for several weeks at room temperature (Figure 1). 
 




Figure 2 - Differential pulse voltammogram obtained for substrate 1 (0.1 mM) and 
ferrocenylamine 3 (0.1 mM) in 50 mM pH 7 tris buffer 
The electrochemical behaviour of substrate 1 was tested via differential pulse 
voltammetry (DPV) and compared to ferrocenylamine 3. As expected, substrate 1 had a 
higher oxidation potential than ferrocenylamine 3, with the difference between the two 
peaks being approximately 250 mV and were completely resolved which allowed for the 
peaks to be integrated independently (Figure 2). The conversion of substrate 1 was 
calculated using equation (1). 
𝐶𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 (%) =  
(∫ 3)
(∫ 3 + ∫ 1)




Substrate 1 (0.1 mM) was initially subjected to varying concentrations of β-Gal in 
tris buffer (pH 9, 50 mM) at room temperature (21 °C) and subjected to electrochemical 
analysis every 3 minutes for 60 minutes. The voltammogram of each sample was then 
integrated and conversions calculated using equation (1) (Figure 3).  
 
 
Figure 3 - Conversion of the substrate 1 (0.1 mM) to the product after addition of β-Gal 
(X UmL-1) at room temperature in tris buffer (pH 9, 50 mM). Error bars represent the 
standard deviation where n = 3. 
 
Scheme 3 - Proposed formation of 4-hydroxybenzyl alcohol from quinone methide. 
At high β-Gal concentrations, 5 and 10 UmL-1,20 quantitative conversion was 
observed within 18 minutes, and 60 minutes for 1 UmL-1. Pleasingly, no background 
substrate hydrolysis was observed in the absence of β-Gal allowing for a β-Gal 
concentration as low as 0.1 UmL-1 to be detected within 60 minutes. Intriguingly, the 
presence of a third peak was present in the voltammogram at 390 mV (Figure 4). This 
was confirmed to be 4-hydroxybenzyl alcohol 10, formed when quinone methide 8, 
produced as a by-product from the result of self-immolation, reacts with water or 
hydroxide (Scheme 3).21 Despite being produced in an equimolar concentration as 
ferrocenylamine 3, the peak obtained was still significantly smaller than the ferrocene 
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peaks showing the clear benefit of using the organometallic redox label compared with 
other commonly used organic ones. 
 
Figure 4 - Differential pulse voltammogram obtained of substrate 1 (1 mM) after 





Figure 5 - Conversion of the substrate 1 (0.1 mM) to the product after addition of β-Gal 
(1 UmL-1) at room temperature in tris buffer (pH X, 50 mM). Error bars represent the 
standard deviation where n = 3. 
Next, the effect of pH was investigated. A β-Gal concentration of 1 UmL-1 was 
chosen as it allowed for both positive and negative effects due to the pH to be observed 
(Figure 5). At pH 8 there was a significant increase in the rate of conversion, with 
quantitative conversion observed in under 30 minutes. There was a marginal increase in 
rate from pH 8 to pH 7, but importantly, at the lower pH the presence of the third peak 
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was suppressed, presumably due to protonation of the electrochemically active 
phenolate ion 9. The suppression of the peak produced a cleaner voltammogram, 
allowing for more accurate conversion to be calculated and as a result, pH 7 was used 
moving forward. 
Temperature 
According to previous literature, the optimum working temperature for β-Gal is 37 
°C.22 A lower β-Gal concentration was chosen, specifically 0.1 UmL-1 in tris buffer (pH 7, 
50 mM) (Figure 6), to allow for changes in the rate of conversion to be noticeable. 
Interestingly, increasing the temperature from room temperature had minimal effect on 
the rate of conversion, and above 37 °C the rate was retarded. At 57 °C negligible 
conversion was observed due to denaturing of the enzyme. Substrate 1, however, 
remained stable to hydrolysis even at elevated temperatures, exhibiting the high stability 
of the substrate. With no improved rate of conversion, the assays were continued to be 
conducted at room temperature (21 °C). 
 
 
Figure 6 - Conversion of the substrate 1 (0.1 mM) to the product after addition of β-Gal 
(0.1 UmL-1) at varying temperatures (X °C) in tris buffer (pH 7, 50 mM). Error bars 
represent the standard deviation where n = 3. 
Substrate Concentration 
The concentration of substrate 1 in the assay was then screened, utilising a β-
Gal concentration of 1 UmL-1. Increasing the probe concentration to 0.25 mM from 0.1 
mM had minimal effects on the rate of conversion with quantitative conversion still 
observed within 24 minutes (Figure 7). However, increasing the concentration further 
showed no discernible increase in the rate of reaction. When the substrate concentration 
was decreased to 0.05 mM, the reduced current observed was susceptible to artefacts 
on the voltammogram affecting accurate conversion calculations, which were 
unavoidable when using disposable screen-printed carbon graphite electrode cells. At 
concentrations above 0.1 mM, additional sample manipulation, via serial dilutions, was 
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required before analysis, due to overloading of the electrodes, and therefore, an optimal 
substrate concentration of 0.1 mM was chosen.  
 
 
Figure 7 - Conversion of the substrate 1 to the product after addition of β-Gal (1 UmL-1) 
using different concentrations of the substrate at room temperature in tris buffer (pH 7, 
50 mM). Error bars represent the standard deviation where n = 3. 
Buffer System 
The final condition to be optimised was the buffer system used. Other common 
β-Gal buffer systems such as potassium phosphate buffer (50 mM, pH 7),3 and Z-buffer 
(50 mM, pH 7), were tested. Z-buffer exhibited significant background signal, potentially 
due to the thiols present in Z-buffer, that obscured the peaks and prevented accurate 
electrochemical analysis. In phosphate buffer the stability of ferrocenylamine 3 was 
diminished with a second peak forming at a higher oxidation potential, assumed to be an 
electroactive by-product from ferrocenylamine decomposition.23 Tris buffer (pH 7) was 
therefore chosen as this maintained a low background and ensured ferrocenylamine 
stability, and the effect of buffer concentration was investigated using an β-Gal 
concentration of 1 UmL-1 (Figure 8).  
In unbuffered solution, the rate of conversion was significantly improved 
compared to 50 mM tris buffer solution, however, the voltammogram peaks were shifted 
to a lower oxidation potential. At this lower potential, the presence of voltammogramatic 
artefacts prevented accurate detection. At 25 mM tris buffer concentration, a comparable 
rate of conversion to 50 mM tris buffer concentration with quantitative conversion 
observed in 18 minutes. Further analysis showed that β-Gal was unstable at the lower 
buffer concentration, with increases in conversions stopping after 18 minutes. Increasing 
the concentration of the tris buffer above 50 mM prevented accurate ratiometric analysis 
as we suspect the reduced stability of ferrocenylamine 3 resulted in unreliable peak 




































Figure 8 - Conversion of the substrate 1 (0.1 mM) to the product after addition of β-Gal 
(1 UmL-1) at room temperatures (21 °C) in vary concentrations of tris buffer (pH 7, X 
mM). Error bars represent the standard deviation where n = 3. 
Optimal Conditions 
With optimal conditions obtained, the sensitivity of β-Gal was tested. In the 
optimised conditions, there was no background hydrolysis observed, allowing for 
detection of low β-Gal concentration of 0.1 UmL-1 within 60 minutes (Figure 9a). Utilising 
pseudo-first order kinetics (Figure 9b), a rate constant of 2.91  10-3 s-1 was calculated 
for a β-Gal concentration of 1 UmL-1. At higher concentrations of 10 and 5 UmL-1, 
quantitative conversions were exhibited within just 6 minutes, and at a low concentration 
of 0.25 UmL-1, a 73±5 % conversion was achieved within 60 minutes, with an observed 
rate constant of 0.044  10-3 s-1. The small error bars afforded, indicate the good 
reliability showing the benefit of using ratiometric electrochemical analysis.  
Ortho-Analogue 
It has been previously shown that β-Gal has a large tolerance to the aglycon, as 
long as the D-galactose moiety remains untouched.24 To further explore how the sterics 
of the substrate could impact β-Gal activity, substrate 11 was synthesised (Scheme 3), 
and tested utilising the optimal conditions (Figure 10a). Comparatively, substrate 11, was 
significantly slower than substrate 1. At low β-Gal concentration of 0.1 UmL-1 a 
conversion of 12±6 % within 60 minutes (Figure 10b), compared to a conversion of 16±1 
% for substrate 1. The calculated rate constants of 0.04  10-3 s-1 and 0.06  10-3 s-1 for 
substrate 11 and 1 respectively (Figure 10b), show only a small difference in rate 
between the two regioisomers.  This difference in rate of hydrolysis, is more significant 
at 1 UmL-1 concentrations, where the rate constant for substrate 1, 2.91  10-3 s-1, is an 
order of magnitude higher than for substrate 11, 0.14  10-3 s-1. The increased steric bulk 
around the anomeric position in substrate 11 inhibits the rate of hydrolysis, indicating the 






Figure 9 – a) Conversion of the substrate 1 (0.1 mM) to the product after addition of 
varying concentration of β-Gal (X UmL-1) in tris buffer (pH 7, 50 mM) at room 
temperature. Error bars represent the standard deviation where n = 3; b) Kinetic linear 
transformation curves of substrate 1 (0.1 mM) at increasing concentration of β-Gal (X U 
mL-1) at room temperature (21 °C) in tris buffer (pH 7, 50 mM). Pseudo-first order 
equation y = k 𝑥 + C where: for 1 UmL-1 k = 0.1744 min-1 (2.91 x 10-3 s-1), C = -0.3883; 
for 0.5 UmL-1 k = 0.0996 min-1 (1.66 x 10-3 s-1), C = -0.0009; for 0.25 UmL-1 k = 0.0264 
min-1 (0.44 x 10-3 s-1), C = -0.0692; for 0.1 UmL-1 k = 0.0036 min-1 (0.06 x 10-3 s-1), C = -
0.0056. 
Conclusion 
In conclusion, we have developed a new ferrocene-based electrochemical 
substrate for the detection of β-galactosidase activity. The substrate with a D-
galactopyranoside trigger was synthesised and was distinguishable from the product 
electrochemically via differential pulse voltammetry. The substrate was shown to be 
stable to background hydrolysis, was demonstrated to be sensitive to low concentrations 
of β-galactosidase and shown to be both reproducible and reliable which makes β-






































Figure 10 – a) Conversion of the substrate 11 (0.1 mM) to the product after addition of 
varying concentrations of β-Gal (X UmL-1) at room temperatures (21 °C) in tris buffer 
(pH 7, 50 mM). Error bars represent the standard deviation where n = 3; b) Kinetic linear 
transformation curves of substrate 11 (0.1 mM) at increasing concentration of β-Gal (X 
U mL-1) at room temperature (21 °C) in tris buffer (pH 7, 50 mM). Pseudo-first order 
equation y = k 𝑥 + C where: for 1 UmL-1 k = 0.0083 min-1 (0.14 x 10-3 s-1), C = -0.0382; 






Scheme 3 - Synthesis of Substrate 11 
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2.2 An Organophosphorus(III)-Selective Chemodosimeter for the 
Ratiometric Electrochemical Detection of Phosphines  
2.2.1 Introduction and commentary 
Following the successful design and development of the -galactosidase 
electrochemical probe, our thoughts turned to extending the methodology beyond its 
current triggers. In the pursuit of a new target the Staudinger ligation came to our 
attention due to its chemoselectivity and reliability. The ligation forms an amide bond 
chemoselectively between an azide 31 and an ester group 30, through the electrophilic 
trapping of the aza-ylide intermediate 32.182,183 The initial reaction is now referred to as 
the non-traceless azide-phosphine ligand (Fig. 2-3a),182 with a traceless modification 
developed soon after (Fig. 2-3b).184,185 Non-traceless Staudinger ligation results in the 
incorporation of a phosphine oxide group into the final product 35,182 with the traceless 
version excludes this functionality in the amide product 40. The traceless Staudinger 
ligation has found prevalence in biological applications,183,186 including labelling DNA,187 
and peptide conjugation as an alternative to native chemical ligation. It also has found 
use in bioconjugation reaction,183,188,189 in biotin,189 and fluorophore labelling of biological 
molecules without the need to genetic manipulation.190,191 Further examples include 
FLAG-tag labelling,192 and direct conjugation of coumarins and ferrocene moieties to 
nucleosides.193 
 




Scheme 2-2 – Proposed electrochemical probes designed around Staudinger Ligation. 
The traceless Staudinger ligation has been further adapted to use triphenyl 
phosphine as an external reductant with a release of a leaving group from the activated 
ester.193 We conceived that if the leaving group was electrochemically active, the reaction 
could be monitored via DPV and be used to detect triphenylphosphine. Scheme 2-2 
shows the proposed mechanism of two probes that were designed utilising this system, 
firstly, a ferrocene amide derivative 44 from aminoferrocene 2. The second system 46 
would contain a hydroxybenzyl alcohol linker, that on release would self-immolate to 
release aminoferrocene 2. Critical consideration of the two substrates posed several 
limitations. The long reaction times required are unfavourable for incorporation into 
ratiometric probes, with intermolecular aza-ylide formation significantly slower than the 
intramolecular equivalent. Furthermore, the leaving group efficiency needs to be 
assessed. In the first substrate, the amide bond is unactivated with aminoferrocene a 
poor leaving group which would result in slow transamination and poor conversion. In 
contrast, the ester unit in the second substrate would be susceptible to background 
hydrolysis, giving a large false positive reaction thus reducing the potential sensitivity of 
the probe. 
 
Scheme 2-3 – Proposed electrochemical probes designed around Staudinger Reaction 
We therefore turned our attention to the analogous Staudinger reaction, where 
hydrolysis of the aza-ylide intermediate affords a primary amine (Fig. 2-3c).194 This would 
overcome the slow reaction times, with a bimolecular reaction entropically preferable 
compared to a trimolecular reaction. In addition, the azide group is less reactive than the 
ester to background hydrolysis resulting in a lower background rate. Two further 
substrates were considered utilising the Staudinger reaction (Scheme 2-3), 
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azidoferrocene 48 and a substrate based upon trigger-linker-effector methodology 6. 
Azidoferrocene 48 was ruled out due to its non-trivial synthesis, with the final substrate 
6 preferred due to its similarity to previous developed electrochemical substrates. 
The Staudinger reaction is not limited to triphenylphosphine with other 
organophosphorus(III) compounds showing similar activity. We envisioned that by 
utilising the chemoselectivity of P(III) compounds with the azide compared to other 
nucleophiles, we could develop a universal sensor for organophosphorus(III) 
compounds. P(III) compounds are widely used as ligands in cross coupling reactions, 
and they are common precursors in the synthesis of organophosphorus nerve agents. 
With the aim of developing a organophosphorus(III) sensitive system, we designed a 
modified chemodosimeter with the synthesis, results and application discussed in the 
communication titled “An Organophosphorus(III)-Selective Chemodosimeter for the 
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Abstract  
The high toxicity of phosphine and the use of organophosphines as nerve agent 
precursors has provoked the requirement for a rapid and reliable detection methodology 
for their detection. Herein, we demonstrate that a ferrocene-derived molecular probe, 
armed with an azidobenzene trigger, delivers a ratiometric electrochemical signal 
selectively in response to organophosphorus(III) compounds and can be accurately 
measured with an inexpensive, handheld potentiostat. Through an intensive assay 
optimization process, conditions were found that could determine the presence of a 
model organophosphine(III) nerve agent precursor within minutes and achieved a limit 
of detection for triphenylphosphine of just 13 ppm. Due to the portability of the detection 
system and the excellent stability of the probe in solution, we envisaged that this proof-
of-concept of work could easily be taken into the field to enable potentially toxic 
organophosphorus(III) compounds to be detected at the point-of-need.  
Keywords: phosphine detection; ratiometric sensing; electrochemical chemodosimeter; 
point-of-use 
Introduction  
Phosphine, the simplest phosphorus(III) compound, is a volatile toxic gas that is 
utilized in the agricultural industry as a fumigant.1,2 Alkylphosphines and alkylphosphites 
also have acute toxicologies similar to phosphine.3-5 Alkylphosphinites are listed as 
Schedule 1 compounds under the Chemical Warfare Convention as restricted precursors 
for the nerve agent VX, and alkylphosphites are listed as Schedule 3. In addition, 
phosphorus(III) compounds have been widely used in organic synthesis and the 
pharmaceutical industry, where a diverse number of new phosphorus(III) ligands with 
unknown toxicologies have been used in cross-coupling reactions, which remain a 
predominant synthetic tool.6,7 However, though the toxicology of triphenylphosphine has 
been studied, with a permitted daily exposure (PDE) of 250 µg reported recently,5 only a 
few studies have explored the toxicity of less common aryl- and alkylphosphine ligands. 
In the absence of accurate toxicology, there remains a requirement to detect low-level 
concentrations of these potentially toxic analytes.  
The detection of phosphorus(III) compounds can be performed using 
chemiluminescence,8 gas chromatography–mass spectrometry,9 and flame 
photometry.10 However, these methodologies are limited by the requirement for 
sensitive, lab-based equipment, and the transportation of highly toxic samples to them. 
Extending the current methods to organophosphorus(III) species has so far been limited 
to just volatile alkylphosphines until very recently, when nerve-agent mimics were shown 
to be detected via fluorescence.11 However, for their adoption into a point-of-care device, 
the construction of a lightbox is needed.12  
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Electrochemistry has emerged as a popular detection method, due to its rapid 
sample detection rate, and its use of inexpensive equipment, which allows for 
applications within small, portable detection systems.13,14 To combat problems arising 
from miniaturization, ratiometric electrochemical probes have become more widespread, 
with the minimization of errors increasing their reliability and reproducibility.15,16 By 
obtaining direct conversions from the sample, systematic and sampling errors are 
reduced. Ferrocene-based probes are specifically and commonly used, due to their 
synthetic utility,17-19 aerobic and aqueous stability,20 and tuneable oxidation potential.21,22 
Thus, we believe that we could utilize these advantageous properties to synthesize an 
electrochemical probe purposed for the development of a point-of-care solution for the 
detection of potentially highly-toxic organophosphorus(III) compounds. Herein, we 
describe the application of a ferrocene probe to the ratiometric electrochemical detection 
of organophosphorus(III) compounds, including a model nerve agent precursor, using a 
commercial, hand-held portable potentiometer.  
Materials and Methods 
 All reactions were carried out under an atmosphere of nitrogen, in oven-dried 
glassware, unless otherwise stated. Dichloromethane (DCM), and toluene were dried 
and degassed by passing through anhydrous alumina columns, using an Innovative 
Technology Inc. (Carouge, Switzerland) PS-400-7 solvent purification system, and were 
stored under an atmosphere of nitrogen prior to use. 4-Aminobenzyl alcohol was 
purchased from Alfa Aesar (Heysham, UK). Ferrocene carboxaldehyde was purchased 
from Fluorochem (Hadfield, UK). All other chemicals were purchased from Sigma-Aldrich 
(Gillingham, UK). All chemicals were used as received.  
Desktop electrochemical analysis was performed by applying a 20 µL sample to 
a screen-printed electrochemical cell equipped with carbon working and counter 
electrodes, and a silver (pseudo Ag/AgCl) reference electrode. The potential across the 
cell was powered by a Metrohm Autolab PGSTAT30 potentiostat controlled by a laptop 
running General Purpose Electrochemical System (GPES) software in differential pulse 
mode (modulation = 0.04 s, interval = 0.1 s, initial voltage = −400 mV, end voltage = 600 
mV, step potential = 3 mV, modulation amplitude 49.95 mV). Post-scan, a baseline 
correction (moving average: peak width = 0.03) was performed. Peak integrals were 
obtained by using the ‘peak search’ function, and conversions were calculated by using 
the equation:  
Conversion (%) = (R product)/(R probe + R product) × 100 (1) 
Handheld electrochemical analysis was performed by applying a 20 µL sample 
to a screen-printed electrochemical cell equipped with carbon working and counter 
electrodes, and a silver (pseudo Ag/AgCl) reference electrode. The potential across the 
cell was powered by a PalmSens Emstat3 Blue potentiostat controlled by a tablet, using 
PS Touch in differential pulse mode (equilibration time = 0 s, initial voltage = −800 mV, 
end voltage = 200 mV, step potential = 3 mV, pulse potential = 49.95 mV, pulse time = 
0.1 s, scan rate = 0.015 V s−1 ). Currents were obtained using the ‘peak search’ function, 
and by finding the maximum current. The currents were calibrated by using Figure S1 to 
obtain the concentrations, and the conversions were calculated by using the equation:  





Inspired by trigger–linker–effector methodology,23,24 benzyl ferrocenyl 
carbamates have been effectively employed for the ratiometric electrochemical detection 
of both enzymes, such as β-galactosidase and alkaline phosphatase,25,26 and small 
molecules, such as fluoride and hydrogen peroxide.27,28 To achieve our objective of 
developing a molecular probe for organophosphorus(III) species, we designed benzyl 
ferrocenyl carbamate 1 with a 4-azido trigger to allow for the chemoselectivity for the 
target to be attained through a Staudinger reaction. In the presence of the target, we 
proposed that the formation of iminophosphorane 2 would occur, which, under aqueous 
assay conditions, would be hydrolysed to give aniline 3; then, a subsequent 1,6-
elimination would release aminoferrocene 4 (Scheme 1). Indeed, it has since been 
brought to our attention that whilst this project was ongoing, the release of 
aminoferrocene 4 from 4-azidobenzyl ferrocenyl carbamate 1 under reductive conditions 
had been successfully demonstrated.29 Due to the significantly different electronic 
environments surrounding the iron centre, aminoferrocene 4 should have a lower 
oxidation potential (Eox) compared with that of 1; and, thus it should be electrochemically 
distinguishable.  
 
Scheme 1. Molecular structure of probe 1, and its proposed mechanism for the 
phosphine-triggered release of aminoferrocene 4.  
Synthesis, Stability, and Electrochemical Properties of 1  
The synthesis of 1 was successfully achieved with a 77% overall yield via a 
Curtius rearrangement of 4-azidobenzyl alcohol, obtained from 4-aminobenzyl alcohol 
through a Sandmeyer reaction, with ferrocenoyl azide, obtained from ferrocene 
carboxylic acid (see Electronic Supporting Information (ESI)). Once in hand, 
chemodosimeter 1 remained bench-stable for several months, and more importantly, it 
remained stable for a month as a solution in acetonitrile at room temperature, allowing 
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for its storage as a ready-to-use solution (Figure S1). A comparison of the 
electrochemical behaviour of probe 1 to aminoferrocene 4 via differential pulse 
voltammetry (DPV) showed that the oxidation potential of probe 1 was significantly higher 
than the oxidation potential of aminoferrocene 4, by 300 mV (Figure 1). Evidently, the 
two peaks were fully resolved allowing for conversions to be calculated from the 
integration of the two peaks (Figure S2), using Equation 1 (see Section 2 Materials and 
Methods).  
 
Figure 1. Differential pulse voltammogram obtained for probe 1 (0.5 mM) and 
aminoferrocene 4 (0.5 mM) in MeCN:Tris buffer (pH 9, 50 mM).  
Sensitivity and Selectivity of 1 towards Organophosphorus(III) Compounds 
Table 1. Optimization of the reaction assay of 1 (1 mM) with triphenylphosphine (10 
mM).  
 
Exp. Solvent Solvent:Water Ratio Conversion (%)1 
1 DMF 1:1 37 
2 1,4-dioxane 1:1 78 
3 MeCN 1:1 79 
4 MeCN 3:1 79 
52 MeCN 3:1 43 
63 MeCN 3:1 96 
1 Conversion determined by ratiometric electrochemical analysis. 2 Five equivalents of 
PPh3. 3 5 equivalents of PPh3 at 50 °C. 
To test the probe’s response to phosphorous(III) compounds, triphenylphosphine 
(PPh3) was initially selected as a model analyte, as it is an easy-to-handle solid, and it is 
the standard phosphine of choice in the Staudinger reaction (Table 1). Initial conditions 
were inspired by Staudinger ligation conditions, with 10 equivalents of 
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triphenylphosphine in a mixed solvent system of N,N dimethylformamide (DMF)/water. 
While this delivered a 37% conversion efficiency after 60 minutes at room temperature, 
changing the water-miscible co-solvent to acetonitrile (MeCN) or 1,4-dioxane improved 
the conversion efficiency considerably. Probe 1 was found to be insoluble in alcoholic 
solvents, and aminoferrocene 4 was found to be unstable in both dimethyl sulfoxide 
(DMSO) and tetrahydrofuran (THF), thus preventing accurate electrochemical analyses, 
so acetonitrile was selected as the co-solvent moving forward (Table S1). Altering the 
solvent ratio to a 3:1 ratio of acetonitrile to water greatly improved the homogeneity of 
the reaction mixture, allowing for more reproducible sampling, which in turn improved the 
reliability of the method. Further increasing the ratio of acetonitrile to water was found to 
be detrimental to the reaction. Halving the equivalents of triphenylphosphine improved 
the accuracy, as we believed that this limited electrode fouling, though this alteration 
lowered the conversion down to 43%. The conversion could be increased to 80% within 
20 minutes, and near-quantitative conversion within 60 minutes, by warming the assay 
mixture to 50 °C. At temperatures of above 50 °C, solvent loss and inaccuracies in 
sampling led to unreliable results.  
 
Figure 2. Conversion of probe 1 (1 mM) to aminoferrocene 4 after the addition of 
triphenylphosphine in MeCN:H2O (3:1, 1M) at 50 °C. Error bars represent the standard 
deviation where n = 3.  
With the optimized assay conditions in hand, the sensitivity of probe 1 was further 
examined (Figure 2). At superstoichiometric concentrations of triphenylphosphine (2.5 
mM and 5 mM), quantitative conversion was achieved within 60 min. No background 
reactivity was observed in the absence of triphenylphosphine. The negligible background 
rate allowed for the accurate detection, within 60 min, of low concentrations of 
triphenylphosphine, 50 µM, with a 3% conversion observed. This value is within an order 
of magnitude of the limit of detection (LOD) for the fluorescence detection of 
organophosphorus pesticides, using an expensive desktop fluorimeter with highly 
sophisticated DNA-functionalized nanoparticle detection methodology.30 This value also 
corresponds to a LOD of 13 ppm, which is the value of the reported LC50 for rats.2 At 
the stoichiometric equivalents of triphenylphosphine, a 40% conversion was obtained 
within 30 min, with no significant further increase in conversion was observed after this 
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period. This is consistent with precedent from the literature, where it has been reported 
that the Staudinger reaction requires two equivalents of triphenylphosphine to release 
aniline.31  
To explore the selectivity of probe 1, a selection of organophosphorus(III) 
compounds were screened. An analyte concentration of 1 mM was chosen, to allow for 
changes in the rate of reaction to be observed (Figure 3). Expectedly, electron-rich 
arylphosphines showed an increased reaction rate in comparison to that of 
triphenylphosphine (Figure S3). However, the change in electronics also corresponded 
to a decrease in aminoferrocene stability, which resulted in a reduced degree of 
reproducibility over time. Conversely, electron-deficient arylphosphines showed a 
significantly reduced rate of reaction in comparison to triphenylphosphine. In general, 
both alkylphosphines and alkylphosphites also exhibited lower rates of conversion, 
though pleasingly, diethylmethylphosphonite, a precursor in the synthesis of VX nerve 
gas, delivered a positive conversion of 8%, and it could be easily distinguished from the 
background. Oxygen-sensitive phosphines proved to be incompatible with the assay, 
due to their degradation in the assay media. Common phosphorus(V) compounds such 
as phosphate salts, potassium hexafluorophosphate, triphenylphosphine oxide, and 
triethyl phosphonoacetate yielded no conversion or breakdown of 1, highlighting its high 
specificity towards phosphorus(III) species. Other soft nucleophiles such as thiols were 
also tested and of them, only hydrogen sulfide (H2S) was shown to give any positive 
conversion with a 10% measurement after 60 min. Neither glutathione nor cysteine, both 
of which have also been shown to be able to reduce aryl azides,32 afforded any 
conversion. 
 
Figure 3. Conversion of probe 1 (1 mM) to aminoferrocene 4 60 min after the addition 
of phosphine in MeCN:H2O (3:1, 1M) at 50 ◦C. Error bars represent the standard 
deviation, where n = 3. (1) PPh3; (2) P(p-tol)3; (3) P(p-MeOPh)3; (4) P(p-CF3Ph)3; (5) 
P(OiPr)3; (6) MeP(OEt)2; (7) PCy3; (8) P(OPh)3; (9) PCl2Ph; (10) K2HPO4; (11) KPF6; 
(12) Na2O7P2; (13) triphenylphosphine oxide; (14) triethyl phosphonoacetate; (15) 
hydrogen sulfide (H2S); (16) cysteine; (17) glutathione.  
The robustness of the assay was then challenged by exposing compound 1 to a 
series of complex samples. Specifically, crude reaction mixtures from various Suzuki 
cross-coupling reactions were directly injected into the assay (Figure S5). The crude 
reaction mixture, which contained tetrakis(triphenylphosphine)palladium(0) delivered an 
87% conversion rate. This positive result was attributed to the leaching of the 
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organophosphorus(III) ligands, as alternative Pd(0) sources, without phosphine ligands, 
showed minimal conversion. 
Applications towards a Point-of-Use Assay with a Handheld Potentiostat  
To highlight the point-of-use capability of probe 1, the model assay was tested 
using a PalmSens EmStat3 Blue handheld potentiostat (Figure S6). The lower sensitivity 
of the potentiostat required an increase in probe concentration to 10 mM; however, no 
other modifications of the reaction conditions were necessary. Due to the higher sample 
concentration, a corresponding reduction in sample homogeneity was observed, which 
resulted in a reduced reliability of the conversions, as calculated through peak 
integration. Therefore, in this instance, the currents were measured directly at specific 
oxidation potentials, and they were used to calculate the conversions via a calibration 
curve (Figure S7). While this does not take into account the diffusion coefficients for both 
probe 1 and product 4, we believe that they are similar enough to validate this proof-of-
principle experiment. To test their potential use for the detection of nerve agent 
precursors in the field, the modified assay was tested with the model precursor 
diethylmethylphosphinite (Figure 4).  
 
Figure 4. Conversion of probe 1 (10 mM) to aminoferrocene after the addition of 
diethylmethylphosphinite (X mM) in MeCN:H2O (3:1, 1 M) at 50 °C. 
Error bars represent the standard deviation, where n = 3. Interestingly, the 
conversion obtained was significantly higher (19±3%) than that seen previously with a 
benchtop potentiostat (8±2%). A similar increase was also observed when a comparative 
assay was performed while using triphenylphosphine (Figures S8–S10). We believe that 
the improved reactivity could be attributed to the higher concentration of the probe. More 
importantly, the tight error bars exhibited demonstrates the excellent reproducibility and 
reliability of the ratiometric detection assay. This, coupled with the negligible background 
rate, highlights the potential for the direct incorporation of the assay into a future point-
of-use device. 
Conclusions 
In conclusion, we have developed a ferrocene-based probe for the ratiometric 
electrochemical detection of phosphorus(III) compounds, utilizing the chemoselective 
Staudinger reaction. The probe showed excellent specificity for a range of 
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phosphorus(III) compounds, compared against other phosphorus species, creating a 
highly selective and rapid detection methodology. The negligible background reactivity 
allowed for the reliable and reproducible detection of a model phosphine, down to 13 
ppm. The detection method was successfully applied to the detection of an 
organophosphorus(III) nerve agent precursor, using a portable handheld potentiostat, 
demonstrating that the technique could be potentially applied to the rapid detection of 
nerve agents in the field. 
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Figure S1 – Differential pulse voltammogram obtained for substrate 1 (1 mM) in 




Figure S2 – Differential pulse voltammogram (DPV) overlays of individual duplex 
voltammograms using different ratios of probe 1 and aminoferrocene 4. Total ferrocene 
concentration = 1 mM. 
 
 
Figure S3 – Conversion of substrate 1 (1 mM) to aminoferrocene 4 after addition of PR3 
(1 mM) in acetonitrile:water (3:1, 1 mL) at 50 °C. Error bars represent the standard 




Figure S6 – Photograph of handheld potentiostat setup. PalmSens EmStat3 Blue 
potentiostat (right) connected to electrode rig (middle), and via Bluetooth to a tablet 
(left) running PS Touch. 
 
Figure S7 – Calibration curve for substrate 1 and aminoferrocene 4 in MeCN:Tris buffer 
(pH 9, 50 mM) 7.5:92.5 
 
Figure S8 – Conversion of substrate 1 (10 mM) to aminoferrocene after addition of 
triphenylphosphine (X mM) in acetonitrile:water (3:1, 1 mL) at 50 °C. Error bars 




Figure S9 – Conversion of substrate 1 (10 mM) to aminoferrocene after addition of 
diethylmethylphosphinite (1 mM) in acetonitrile:water (3:1, 1 mL) at 50 °C. Error bars 
represent the standard deviation where n = 3. 
 
Figure S10 – Conversion of substrate 1 (10 mM) to aminoferrocene after addition of 
triphenylphosphine (1 mM) in acetonitrile:water (3:1, 1 mL) at 50 °C. Error bars 
represent the standard deviation where n = 3. 
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2.3 Post-Commentary and Future Work 
The aim of this chapter was the design and development of new ratiometric 
electrochemical chemodosimeters for novel analyte targets, which was achieved for the 
detection of -galactosidase and organophosphorus(III) compounds with minimal 
difficulties. Both sensors proved highly reliable allowing for the rapid detection of analytes 
with potential for point-of-use applications. The understanding gained throughout the 
chapter towards synthetic routes, assay optimisation and electrochemical sensing were 
beneficial in the planning of future projects, and the basic principles learnt formed the 
foundation of the following two research chapters. The further work conducted in this 
thesis moves away from ratiometric electrochemical sensing, however, there remains 
plenty of scope in the field for simple chemodosimeters. The current general design is 
readily modifiable, and has significant potential for new targets towards enzyme, small 
targets and other stimuli of interest, with several potential chemodosimeters summarised 
in Fig. 2-4. 
 





3 Design and Synthesis of Pseudo-Enantiomeric Proligands for 
Stimuli Responsive Asymmetric Catalysis 
3.1 Introduction to Stimuli Responsive Processes 
Stimuli responsive processes are an integral function of biological systems, 
where high selectivities and sensitivities are required for the correct interpretation of an 
external stimulus.195 The combination of signal transduction and signal amplification 
strategies are necessary for the conversion of the stimulus into the appropriate biological 
response, and are seen in bio-signalling,196 glucose regulation,197 and platelet 
activation.198,199 In a cellular environment, membrane-bound protein receptors are 
triggered by a specific stimulus, causing activation of a catalytic cascade that amplifies 
the signal by producing multiple secondary messengers that transduce the signal. 
Inspired by nature, successful synthetic analogues utilise the same two fundamental 
processes of transduction and amplification. The broad research field has led to the 
development of a plethora of stimuli responsive smart materials including polymers,46,200–
204 nanoparticles,51,205 supramolecular,206,207 and small molecule systems.157,158,208 These 
materials have found use for targeted therapeutic delivery,200–202 sensing 
applications,46,51,157,158,204,205,208 and in the development of molecular machines.206,207  
3.1.1 Self-Immolative Linkers 
 
Figure 3-1 – Katzenellenbogen’s prodrug strategy. 
Self-immolative linkers were first reported by Katzenellenbogen et al. as a 
proposed prodrug strategy, where the linker can overcome steric limitations imparted by 
direct conjugation of the trigger to the therapeutic (Fig. 3-1).209 A 4-aminobenzyl alcohol 
linker was used to link a reported molecule with an enzyme substrate. From this first 
report, the use of self-immolative linkers has become prominent in the design of small 
molecule smart materials to covalently link the trigger moiety to a functional 
molecule.156,161 Self-immolative linkers have been incorporated into prodrugs,209 
polymers,160 chemosensors,156 and molecular amplifiers.157 Their modular design allows 
for near universal applicability, with a wide array of triggers and effector molecules 
integrated. These simple trigger-linker-effector systems are signal transduction 
processes, where one trigger event results in release of the effector. The ratiometric 
electrochemical probes for -galactosidase (-gal) and organophosphorus(III) 
compounds discussed in Chapter 2 are examples of self-immolative linkers. The linker 
unit used in the -gal probe 4-hydroxybenzyl alcohol 55,210 and 4-aminobenzyl alcohol 
56 seen in the organophosphorus(III) probe,211 are two of the most common linker 
strategies. Both linkers undergo (aza)quinone methide elimination to release the effector 
21 (Fig. 3-2c & 3-2d). A second widely reported strategy used is cyclisation-elimination 
linkers,156,160 where on stimulation the trigger unit is cleaved allowing the linker to cyclise, 
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eliminating the effector. Fig. 3-2e shows a general cyclisation strategy, where on 
stimulation a pendant thiol is able to attack the carbamate in a 5-exo-trig cyclisation, 
eliminating [1,3]oxathiolan-2-one 61 and releasing the free amine 43. 
 
Figure 3-2 – a) Prodrug strategies; b) 4-amino- and 4-hydroxybenzyl alcohol linkers; c) 
mechanism of quinone methide elimination; d) mechanism of azaquinone methide 
elimination; e) mechanism of cyclisation-elimination. 
3.1.1.1 Modification of Self Immolative Linkers 
 
Figure 3-3 – Theragnostic molecule containing a coumarin diagnostic linker and an 
indomethacin therapeutic. 
The modular approach afforded by self-immolative linkers has meant that small 
molecule systems are not limited to the release of a single effector. Changing the 
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structure of the linker means that multiple functional molecules can be released, a 
strategy that has been used in the development of theragnostics. Theragnostics combine 
the release of a diagnostic molecules with the targeted release of a therapeutic, for 
example Fig. 3-3 shows an example of a theragnostic compound 62 that contains a 
coumarin diagnostic molecule with an etoposide therapeutic.212 In the presence of 
reactive oxygen species, the boronate is cleaved, resulting in the release of the 
fluorophore and the drug molecule. 
3.1.2 Dendrimers and the Dendritic Chain Reaction 
  
Figure 3-4 – a) General structures for prodrug, 1st generation dendrimer and 2nd 
generation dendrimer; b) a 1st generation dendrimer 63, dimeric 64, and trimeric 
dendrimer 65; c) 2nd generation dendrimer 66; d) modifications to control the rate of 
elimination. 
One of the first systems to incorporate a signal amplification strategy were the 
dendrimer systems developed by Shabat et al.208 Synthetic analogues to biological signal 
amplification systems, dendrimers contain a single trigger unit connected to multiple 
effectors through a self-immolative linker, allowing for significant amplification from a 
single trigger event. On stimulation the dendritic chain self-immolates resulting in a 
localised release of the effector molecule. The high functional group density achieved by 
the compact molecular structure has been utilised as a mechanism for sensing,208 and 
targeted drug release.213,214 Initial dendrimer design was based upon prodrug strategies, 
with the 1st generation dendrimer 63 containing two effectors giving a double 
amplification (Fig. 3-4a).215 Further generations have incorporated more effectors giving 
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even greater amplification. The rate of elimination can be further controlled by installation 
of ortho-substituents (67),216 or by increasing the length of the conjugated system (68) 
(Fig. 3-4e).214 
Dendrimers have been developed as sensors for specific analytes including 
hydrogen peroxide.217 Incorporation of chromatic effectors, such as the fluorometric 
aminomethylpyrene,215 and the colourimetric p-nitrophenol allowed for the development 
of optical sensors.218 Physiological stable dendrimers containing non-toxic linkers have 
led to the synthesis targeted drug delivery dendrimers, for example a trimeric prodrug 65 
(general structure shown in Fig. 3-4b) for the anticancer drug camptothecin was 
synthesised by Shabat et al.,213 and Groot et al. developed a paclitaxel prodrug.214 
Dendrimers can suffer from high background rates, with single trigger events resulting in 
multiple analyte release. The synthesis of dendrimers is non-trivial requiring multiple 
synthetic steps, and the high molecular weight molecules are often insoluble in biological 
media.  
3.1.2.1 Dendritic Chain Reaction 
  
Scheme 3-1 – a) General structure of a dendritic chain reagent 65; b) dendritic chain 
reaction for the detection of hydrogen peroxide.219 
Seeking to overcome the limitation imposed by dendrimers, further development 
by Sella and Shabat, led to the creation of the dendritic chain reaction.158,220,221 Instead 
of an extended conjugated system like the 2nd generation dendrimers 66, a trimeric 
dendrimer 69 was functionalised with two amplification reagents and a chromophore 
(Scheme 3-1). The boronic acid trigger is cleaved by hydrogen peroxide, leading to 
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collapse of the dendrimer releasing p-nitroaniline derivative 70 and two equivalents of 
methanol. The methanol is then oxidised by the enzyme alcohol oxidase to afford a 
further equivalent of hydrogen peroxide,220 which is then able to trigger a second 
dendrimer 69, repeating the process and causing exponential signal amplification. 
Significantly higher amplification is possible in the dendritic chain reaction compared to 
simple dendrimers,158 with Shabat et al. reporting a 53-fold signal increase in the 
detection of hydrogen peroxide.219 However, high background reactivity remained an 
issue, as any background trigger event was amplified by the dendritic chain reaction. 
3.1.3 Two-Component Systems 
  
Scheme 3-2 – a) General structure of two-component system; b) mechanism of fluoride 
amplified two-component system;222 c) mechanism of piperidine amplified two-
component system.223 
A further modification of the dendritic chain reaction are the two-component 
systems developed by Baker and Phillips.222 By separating the activity-based detector 
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71 from the amplification reagent 73, the sensor could be readily modified to new targets 
(Scheme 3-2). The activity-based detector 71 releases aminobenzaldehyde 74, a 
colourimetric indicator, and two equivalents of fluoride as amplification agents. The 
fluoride is then able to cleave the silyl ether of the amplification reagent 73, causing self-
immolation releasing another indicator molecule 74 and two further equivalents of 
fluoride (Scheme 3-2b). This two-component system exhibit impressive sensitivity for Pd 
down to 0.36 ppm,222 and fluoride to 2.3 ppm.224 The disadvantages of two-component 
strategies are the difficulties in accurate quantification and their slow reaction times, 
where unstable components can collapse resulting high background rates. Further 
developments to incorporate dibenzofulvene 78 and piperidine 76 have allowed for 
accurate quantification via UV/Vis spectroscopy or by pH indicator (Scheme 3-2c).223  
3.1.4 Ligand Release and Accelerated Catalysis 
A common theme in signal amplification strategies is slow reaction rates resulting 
in long reaction times. In addition, high background rates and the use of organic solvents 
have limited their development and commercialisation. Therefore, endeavouring to 
improve the sensitivity of common ELISA, previous work in the Frost group explored a 
dual catalytic amplification methodology, combining the high selectivity of an enzyme 
with the high activity of a transition metal catalyst (Scheme 3-3).151 Termed ligand release 
and accelerated catalysis, the concept is based upon the ligand accelerating properties 
of diamines with transition metal catalysts towards transfer hydrogenation.  
In the resting state of the system, the iridium pre-catalyst has a low activity with 
minimal reduction of the analyte, ferrocene carboxaldehyde 13 to ferrocene methanol 
12, occurring. However, on addition of tosylated diamine ligand, the active catalyst 11 
can form, which exhibits a significant increase in reactivity. The electroactive aldehyde 
13 is reduced in situ and this catalyst switch ‘on’ was monitored via differential pulse 
voltammetry (DPV). The catalytic activity of the diamine ligands was impeded by 
substitution on the free amine,225 and it was further elucidated that protection of the free 
amine through a carbamate linkage had a deleterious effect on the reaction and would 
allow for selective ligand release through quinone methide elimination. By incorporating 
the ligand into a proligand PL0, the catalyst switch ‘on’ could be utilised to detect target 
substrates. The design of the proligand PL0 followed the same trigger-linker-effector 
methodology seen previously. PL0 consisted of a phosphate trigger unit connected to 
the ligand through a 4-hydroxybenzyl alcohol linker. The phosphate trigger unit could be 
cleaved by alkaline phosphatase (ALP), leaving an unstable phenolate 79 which would 
then self-immolate to release the tosylated diamine ligand. The free ligand is then able 
to complex with the pre-catalyst to form the active catalyst 11 accelerating the transfer 
hydrogenation.  
Having successfully proved that the ligand could be released, and the transfer 
hydrogenation monitored, the accurate detection of ALP was achieved within 30 minutes 
with a limit of detection at 7.6 pM. Lower enzyme concentration detection was inhibited 
by significant background reactivity of the iridium precatalyst. This background 
hydrogenation was attributed to iridium hydrate activity, with the stability of the proligand 
PL0 proved through electrospray ionisation-mass spectrometry (ESI-MS). Further 
developments of the system showed that PL0 was compatible with incorporation into 
ELISAs shown by the detection of C-reactive protein (CRP), a model substrate. This 
demonstrated the utility of the system, allowing for a dual amplification strategy for 









3.2 Stimuli Responsive Asymmetric Catalysis Concept 
Building upon the previous work undertaken in the group initially which looked at 
the triggered release of an achiral ligand for the development of a dual catalytic ELISA.151 
We wanted to take the core concept of ligand release and apply it to a conceptually 
challenging process. The ability to control chirality is a fundamental facet of biological 
systems and is a main interest in the development of pharmaceuticals, with an increasing 
number of drugs being administered as a single enantiomer.226  
  
Figure 3-5 – Concept Overview: a) achiral ligand release and accelerated catalysis; b) 
single pseudo-enantiomeric ligand release and accelerated catalysis; c) dual pseudo-
enantiomeric ligand release and accelerated catalysis. 
With the drive towards chirality, we envisioned an asymmetric analogue of the 
achiral system (Fig. 3-5a), where the selective release of a chiral ligand would switch on 
an asymmetric transformation (Fig. 3-5b). Furthermore, if orthogonal triggers could be 
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identified then two proligands with different effector groups could be selectively triggered 
to activate two separate reaction (Fig. 3-5c). If the effector groups were opposite single 
enantiomer ligands then, dependent on the stimulus, the enantioselectivity of the reaction 
could be inverted and controlled by the external stimulus. The proligands would be 
pseudo-enantiomers of each other, differing only in their remote trigger unit. 
  
Figure 3-6 – Structure of vicinal diamine ligands. 
The previous work released an achiral diamine ligand 80. Installation of chiral 
centres on the ethylene backbone create excellent asymmetric ligands, with a wide array 
of chiral vicinal tosylated diamine ligands developed (Fig. 3-6).227–230 A common core is 
the diphenylethylenediamine backbone which has been a staple of asymmetric transfer 
hydrogenation.228 Substituents on the phenyl rings have been used to improve the water 
solubility of ligand,231 as well as subtly changing the electronic and steric properties.232–
234 A small change in the stereoelectronics can have a significant impact on the reaction, 
for example the introduction of a 4-methoxy group on the phenyl rings increased the yield 
to >99% for the reduction of acetophenone compared to the unsubstituted ligand.232 
Other common ligands include 1,2-trans diaminocyclohexane 86 and the proline derived 
ligand 87.  Due to its commercial availability, high yields and the high enantiomeric ratios 
afforded, N-tosyl diphenylethylenediamine (N-TsDPEN) 81 was selected as the chiral 
ligand. Further information about ligand selection can be found in Chapter 4.  
 
Scheme 3-4 – a) Resting state with inactive catalyst; b) selective triggering of PL-RR to 
release ligand RR-81 to prepare one enantiomer; c) selective triggering of PL-SS to 
release ligand SS-81 to prepare the opposite enantiomer. 
95 
 
In the absence of the ligand the catalyst would be inactive, with the two pseudo-
enantiomeric proligands, PL-RR and PL-SS, stable in the reaction mixture (Scheme 3-
4a). However, on selective stimulation, one of the proligands PL-RR would be triggered 
and undergo self-immolation to release the single enantiomer ligand RR-81. The ligand 
would complex with the precatalyst which would accelerate the activity of the metal 
catalyst and switch on an asymmetric transfer hydrogenation of a prochiral ketone 88 to 
give an enantioenriched product 89 (Scheme 3-4b). The second proligand PL-SS would 
remain a bystander in the reaction with no ligand release. Alternatively, the second 
proligand PL-SS could be triggered to release the opposite enantiomer ligand SS-81, 
which would turn on the asymmetric transfer hydrogenation (Scheme 3-4c). By triggering 
the PL-SS an inverse in enantioselectivity could be achieved with an overall change in 
chirality of the enantioenriched product 89.  
3.2.1 Project Aims 
Having identified the core concept of the project, the work was separated into two 
smaller projects. The first project, discussed in this chapter, was the design of the 
pseudo-enantiomer proligands, with the second project exploring the proligands 
integration into the overall stimuli responsive asymmetric catalytic system, which is 
discussed in Chapter 4. The work in this chapter discusses the development of the 






3.3 Pseudo-Enantiomeric Proligand Design 
The pseudo-enantiomeric proligands were designed along the same principle as 
PL0 used in the ligand release and accelerated catalysis (Fig. 3-7a), following the trigger-
linker-effector methodology. Fig. 3-7b shows the general proposed structure of the two 
pseudo-enantiomer proligands, which would differ in the chirality at the two phenyl 
substituents. Upon stimulation, the trigger unit is cleaved to give an unstable anion 
intermediate 92, which can undergo quinone-methide elimination to release the chiral 
tosylated diamine ligand RR-81 (Fig. 3-7c). 
  
Figure 3-7 – a) ALP selective achiral proligand; b) pseudo-enantiomeric proligands; c) 
triggered quinone-methide elimination to release (R,R)-N-TsDPEN RR-81. 
3.3.1 General Synthetic Route 
  
Scheme 3-5 – General route for proligand synthesis. 
With a general design in place, a common synthetic strategy was developed as 
shown in Scheme 3-5. As the chiral ligand would be the most expensive reagent, the 
route aimed to install the ligand as late as possible, minimising the quantities required. 
In addition, a late installation would reduce the possibility of epimerisation at the chiral 
centre. With this in mind, carbamate formation was planned to be the final major synthetic 
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step. The synthesis of the benzyl alcohol trigger-linker unit 96/97 was then considered, 
with 4-amino- or 4-hydroxybenzyl alcohol deemed a suitable linker. For the aniline 
derivative, the trigger group was installed on the amine to directly give the trigger-linker 
unit 96. In the case of the phenol derivative, due to potential cross-reactivity with the 
benzyl alcohol, synthesis started from 4-hydroxybenzaldehyde 94. The trigger unit was 
attached on the hydroxy group to give 95 and then reduction of the aldehyde to the benzyl 
alcohol affording the trigger-linker unit 97. Formation of the carbamate linkage gave the 
protected proligand 98, followed by global deprotection if necessary, to give the final 
proligand SS-PL. 
3.3.2 Proligand Requirements 
The proligands require many of the characteristics required for point-of-use 
sensors defined by Baker and Philip including stability, specificity and limited background 
reactivity.222 To this shortlist we also determined that aqueous solubility, trigger 
orthogonality and a short induction period would be crucial to the success of the project. 
Addressing each requirement in turn, the stability of the proligands in the absence of the 
stimulus is perhaps the most important facet. The attainment of high enantiomeric ratio 
(er) necessitates ambient temperatures resulting in extended reaction times. The 
proligand must therefore be stable in the reaction media until triggered, as any 
unprompted ligand release would be deleterious to the enantioselectivity. In a similar 
vein, a limited background reactivity is required. The proligand must not be able to ligate 
to the metal catalyst as this would increase background reactivity. Furthermore, side 
reactions must be minimised to prevent false positives, with the by-products formed from 
triggered ligand release remaining inert in the reaction mixture. 
The high ‘on’-water reactivity of the iridium catalyst used previously was 
beneficial for use with enzymes, with facile incorporation into an ELISA system offering 
improved utility.151 With a desire to maintain the aqueous conditions of the previous 
reaction, aqueous solubility of the proligands remains important. With four aromatic rings 
present in the general proligand structure, a hydrophilic trigger unit would be preferable 
to improve the aqueous solubility. The specificity of the trigger unit goes hand in hand 
with the orthogonality of the trigger, with both integral to a successful proligand. The 
trigger should selectively cleave the trigger unit of one proligand, leaving the second 
proligand untouched. This orthogonality is required to prevent cross reactivity which 
would release both ligands and have a detrimental effect on the enantioselectivity of the 
transfer hydrogenation. In addition, due to the complex reaction mixture, the trigger unit 
must be specific to the trigger and not be cleaved by any of the other reactants. Finally, 
in the presence of the trigger molecule, the cleavage should be facile to facilitate a short 
induction period. A longer induction period could prevent high enantioselectivities and 
yields from being obtained. With a difficult checklist to fulfil this work looked at the 




The first pseudo-enantiomer proligand designed was based upon the -gal 
electrochemical probe described in Chapter 2. The D-galactose anomeric bond of the 
trigger unit had a high stability with no background hydrolysis observed in the 
electrochemical probe. Furthermore, the sugar unit increases the hydrophilicity of the 
proligand which should improve the water solubility. Enzymatic cleavage of the anomeric 
bond of the proligand PL1 should happens readily, to give the phenolate intermediate 99 
and D-galactose 20. The intermediate then collapses through quinone methide 
elimination to release the ligand 81, quinone methide 4 and carbon dioxide (Scheme 3-
6). The anomeric bond, however, should remain stable in the presence of most other 
potential triggers and the transfer hydrogenation reaction has been shown to be 
compatible with other enzymes.151 Therefore, we envisioned that a -gal based proligand 
PL1 would be a suitable starting point. 
  
Scheme 3-6 – Triggered release concept for -galactosidase, PL1. 
3.4.1 Synthesis of PL1 
Following the general synthetic route, the benzyl alcohol trigger-linker unit 100 
required had been synthesised previously, see Chapter 2, from D-galactose 
pentaacetate in a 35% yield. The important carbamate linkage step was then considered, 
(Scheme 3-7) with a variety of coupling reagents possible. Using literature conditions,151 
initial attempts to form the carbamate linkage used 1,1’-carbonyldiimidazole (CDI) as a 
coupling reagent. Complete formation of the imidazole carbamate intermediate 101 was 
observed via thin layer chromatography (TLC), however, on addition of the amine no 
reaction occurred, resulting in recovery of the 100 and amine starting material 81. It is 
proposed that reaction between the 81 and 101 does not occur due to steric restriction. 
The bulky phenyl groups on the diamine backbone would inhibit reactivity with the 
sterically crowded carbamate. Therefore, a less sterically encumbered and more reactive 
intermediate was required. 
The smaller chloroformate intermediate 102 was next considered. 
Chloroformates are more reactive than imidazole carbamates, with chlorine a better 
leaving group and the chloroformate less sterically encumbered.235 The negative aspect 
of chloroformate formation is the required use of phosgene, either directly or by 
triphosgene which forms phosgene in situ. However, with proper safety procedures in 
place, phosgene is a highly atom economical process to introduce a carbonyl group and 
was therefore used. Using conditions developed within the group using phosgene in 
toluene, chloroformate formation did not occur due to poor solubility of the 101 in the 
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apolar solvent. Addition of anhydrous ethyl acetate overcame the solubility issues, with 
full conversion observed to the chloroformate 102 via TLC. Quenching of 102 with the 
racemic diamine ligand 81 proved facile with the carbamate 103 formation achieved in a 
37% yield. Attempts to further improve the yield through solvent optimisation proved 
unsuccessful, however, recovery of the unreacted 81 was possible. The instability of the 
chloroformate intermediate 102 means that trace amounts of water could react to reform 
the 100 lowering the yield. Requiring only small amounts of ligand to test the triggered 
release, the protected proligand 103 was taken forward and acetyl deprotection under 
Zemplén conditions afforded the desired racemic proligand, PL1, in an 88% yield, and a 
11% yield from commercially available starting materials. 
  
Scheme 3-7 – Synthetic routes to carbamate formation. 
  
Scheme 3-8 – Synthetic route to PL1. 
3.4.2 Triggered Release of PL1 
The release of PL1 was monitored via ESI-MS (Scheme 3-9), where formation of 
the ligand peak at m/z 367.150 was observed. A modification of the electrochemical 
probe conditions was used, with the introduction of a water miscible alcohol solvent. The 
mix solvent system was required for the transfer hydrogenation step, and the activity of 
-gal in mixed aqueous alcohol systems is highest in methanol.236 Therefore, a 1:1 ratio 
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of methanol to tris buffer was used. A large excess of -gal was chosen at 10 U mL-1 as 
at this concentration complete ratiometric probe collapse was observed with 15 minutes.  
 
Scheme 3-9 – a) Triggered release of PL1 with -gal, ESI-MS obtained after 1 h; b) 
control reaction of PL1 without -gal, ESI-MS obtained after 1 h. 
A longer reaction time was required in the stimuli responsive assay at 16 h (more 
detail in Chapter 4), and with an extended induction period detrimental to the assay, the 
triggered ligand release was analysed after one hour to determine qualitatively the extent 
of ligand 81 release. Pleasingly, complete release of 81 was observed within 1 h with the 
appearance of m/z peak at 367.150 (Scheme 3-9a). In contrast, in the control reaction 
run in the absence of -gal the stability of PL1 was demonstrated with no appearance of 
81 peak, with the molecular ion peak at 800.308 observed (Scheme 3-9b). Pleased by 




With the first proligand PL1 successfully synthesised and tested, the 
development of a second proligand was next considered. Seeking to use a small 
molecule trigger orthogonal to -gal, the reactivity of fluoride came to our attention. Silyl 
ethers are common motifs in sensing strategies,237 where their stability in aqueous 
environment is well understood.238 The facile cleavage of silyl ether is achieved with the 
addition of fluoride, leaving the silyl fluoride by-product 104 and the phenolate 
intermediate 99, which undergoes quinone methide elimination to release the ligand 81, 
quinone methide 4 and carbon dioxide (Scheme 3-10). The silyl ether, fluoride and the 
silyl fluoride by-product should remain inactive bystanders in the transfer hydrogenation 
reaction, with the silyl ether stable in the presence of -gal. 
  
Scheme 3-10 – Triggered release concept for fluoride proligand, PL2. 
3.5.1 Synthesis of PL2 
  
Scheme 3-11 – Synthetic route to PL2. 
Scheme 3-11 shows the synthetic route to PL2. The synthesis of the benzyl 
alcohol trigger-linker unit 106 started from 4-hydroxybenzaldehyde 94. The tert-
butyldimethyl silyl ether was selected over other common silyl ether groups due to its 
improved stability.238 tert-Butyldimethyl silyl chloride installed the trigger unit, with sodium 
borohydride reduction of the aldehyde 105 gave the trigger-linker unit 106 in an 80% 
yield over the two steps. Modifying the phosgene conditions trialled in the synthesis of 
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PL1, chloroformate formation readily occurred in toluene, with the silyl ether imparting a 
higher lipophilicity than seen for the galactose benzyl alcohol 100. A large excess of 
phosgene was used to improve chloroformate conversion, however, following quenching 
with the racemic ligand 81 an 18% yield was obtained. Co-elution of PL1 with unreacted 
81 during silica gel column chromatography partially counting for the poor final yield. 
However, with sufficient quantities to trial the proligand, further optimisation was not 
conducted at this stage. The formation of the racemic proligand PL2 was achieved in a 
11% overall yield.  
3.5.2 Triggered Release of PL2 
Utilising the same method developed for PL1, the triggered release of PL2 was 
monitored via ESI-mass spectrometry for the formation of the ligand peak (Scheme 3-
12). Initial exploration used standard deprotection conditions of tetrabutylammonium 
fluoride (TBAF) in THF. TBAF was selected as a fluoride source due to its facile 
administration as a stock 1 M solution in THF with 10 equivalents used to facilitate 
complete silyl ether cleavage. After 1 h full release of the 81 was observed, with complete 
disappearance of the PL2 molecular ion peak at 653.248. Optimisation of the reaction 
conditions required for the asymmetric transfer hydrogenation are discussed in detail in 
Chapter 4, with a 1:1 mixture of pH 9.2 carbonate buffer and iso-propanol (i-PrOH) 
preferred. To confirm the compatibility of the ligand release, PL2 was subjected to the 
optimised condition with partial ligand release observed after 1 h. The control reaction 
run in the absence of fluoride showed minimal formation of the ligand peak, 
demonstrating the stability of PL2 in the reaction conditions. 
 
Scheme 3-12 – a)  Triggered release of PL2 with TBAF, ESI-MS obtained after 1 h; b) 
control reaction of PL2 without TBAF, ESI-MS obtained after 1 h. 
3.5.3 Synthesis of Pseudo-enantiomer Proligand R-PL1 and S-PL2 
Having ascertained that the proligand readily fragments in the presence of 
fluoride, the next step was to synthesise the enantiomeric proligands. With a facile 
synthesis and desiring to test the release of both enantiomers, the enantiomerically pure 
proligands were synthesised from the optically pure ligands. Synthesis of R-PL1 from 
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(R,R)-N-TsDPEN, and its enantiomer S-PL1, from (S,S)-N-TsDPEN, was achieved in 
30% and 33% yields respectively.  
  




3.6 Hydrogen Peroxide and Other Reactive Oxygen Species 
Seeing the success of a small molecule-based trigger in fluoride, our attention 
was turned to boronate esters as another trigger unit. Boronic acids and boronate esters 
are seen widely in in vivo sensing studies where they are cleaved by reactive oxygen 
species predominantly hydrogen peoxide.239,240 Scheme 3-13 shows the proligand 
concept for S-PL3. The boronate of S-PL3 would cleave to give the phenolate 99, which 
then would eliminate as previously described to release the asymmetric ligand SS-81. 
Cleavage of the boronate ester is a fast process, and therefore a short induction time 
would be expected. In addition, the hydrogen peroxide trigger would be orthogonal to 
fluoride trigger unit, with the silyl ether stable to hydrogen peroxide and boronate ester 
stable to fluoride. Fluoride is known to coordinate to boronic acid and esters and has 
been used as a detection mode for fluoride.241 However, as no cleavage of the boronate 
ester occurs, we expect no cross-reactivity issues to arise. A boronate ester was used 
preferentially over the boronic acid equivalent to limit potential side reactions with PL1. 
Previously, phenyl boronic acids have been used as sensor for diols including sugars, 
where the diol 110 reacts with the boronic acid 108 to give the cyclic boronate 111 
(Scheme 3-13).242 Having already developed PL1, which contains a galactose moiety, to 
prevent this potential side reaction, the boronic acid trigger unit was protected as the 
pinacol ester. 
  
Scheme 3-13 – a) Triggered release concept for hydrogen peroxide, S-PL3; b) 
reactions of boronic acids with fluoride and 1,2-diols. 
3.6.1 Synthesis of S-PL3 
Scheme 3-14 outlines the synthetic route to S-PL3. The pinacol ester of 4-
hydroxymethylphenyl boronic acid 112 was formed in a 65% yield to give the trigger-
linker unit 113. The single enantiomer proligand S-PL3 was formed by a modified 




Scheme 3-14 – Synthetic route to S-PL3 
3.6.2 Triggered Release of S-PL3 
The optimised conditions used to test the triggered release of PL2, were used to 
explore the release of S-PL3 (Scheme 3-15). Hydrogen peroxide was administered as a 
30% solution in water, with 10 equivalents added initially. Disappointingly, only a small 
amount of ligand SS-81 release was observed via ESI-MS. Increasing the equivalents to 
100 resulted in complete ligand release with disappearance of the S-PL3 peak at 
649.256. A significantly larger excess of hydrogen peroxide was required than fluoride, 
potentially due to the instability of the peroxide in alcohol solution. The control reaction 
demonstrated the stability of S-PL3 with no ligand release observed. 
  
Scheme 3-15 – a)  Triggered release of S-PL3 with hydrogen peroxide, ESI-MS 
obtained after 1 h; b) control reaction of S-PL3 without hydrogen peroxide,  ESI-MS 




The use of peroxynitrite was also considered as a potential stimulus. Peroxynitrite 
has an improved reactivity compared to other reactive oxygen species (ROS),243 and has 
been shown to hydrolyse stable esters in aqueous conditions. To overcome the potential 
reactivity of S-PL3 with fluoride (Scheme 3-13b), a second ROS triggered proligand was 
designed. S-PL4 contains a phenolic ester that would be cleaved by peroxynitrite leaving 
the phenolate intermediate 99. Immolation of 99 would afford ligand SS-81 release as 
previously discussed. S-PL4 would be orthogonal to the current range of stimuli, 
however, issues may arise from background hydrolysis of the ester.   
Synthesis of the S-PL4 shown in Scheme 3-16 began with ester formation 
between 4-hydroxybenzaldehytde 94 and 4-bromobutyric acid 114 in a 70% yield. 
Sodium borohydride reduction of the aldehyde afforded the benzyl alcohol intermediate 
116 in a yield of 55%. The diamine ligand was coupled to 116 through a phosgene 
coupling in a 77% yield. The solubility of the proligand was improved by quaternary 
ammonium salt formation with trimethylamine to give the proligand S-PL4 in an overall 
yield of 8%. 
 
Scheme 3-16 – Synthetic route to S-PL4. 
3.6.3.1 Triggered Release of S-PL4 
Pleasingly, in the optimised reaction conditions S-PL4 was readily soluble, and 
on addition of peroxynitrite cleavage of the ester occurred with release of the ligand SS-
81 (Scheme 3-17). However, in the control reaction partial release of the ligand was 
observed via ESI-MS. The ester functionality is highly activated with the phenol a good 
leaving group, and in addition, the quaternary ammonium centre is strongly electron 
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withdrawing, drawing electron density away from the ester making the carbonyl carbon 
more electrophilic increasing the rate of background hydrolysis. Due to the instability of 
S-PL4, alternative proligands were considered. 
   
Scheme 3-17 - Triggered release of S-PL4 with peroxynitrite, ESI-MS obtained after 1 




3.7 Alternative Small Molecule Triggers 
In the pursuit of expanding the library of stimuli available, a series of simple amine 
derived trigger units were synthesised and tested. Scheme 3-18 shows two amine 
protection strategies explored, the fluorenylmethoxy carbamate (Fmoc) protecting group 
and the phthalimide protecting group. 
  
Scheme 3-18 – Triggered release concept for small molecule triggers: (a) Nucleophilic 
base; (b) hydrazine. 
3.7.1 Nucleophilic Base 
The first alternative small molecule trigger consider was the Fmoc protecting 
group that is cleaved by nucleophilic bases, which is considered one of the most stable 
protecting groups and would be orthogonal to the triggers previously used.238 Potential 
issues arise from the solubility of the proligand, with the incorporation of the large 
lipophilic fluorene group. To reduce the lipophilicity of the proligand, the protecting group 
was directly conjugated to the diamine SS-81, shortening the structure by removing the 
benzyl alcohol linker. This helped to reduce the molecular weight and simplified the 
synthesis, with S-PL5 synthesised in one step in a 23% yield. The low yield was 
attributed to the requirement of a double recrystallisation to remove the fluorenemethanol 
by-product. 
  
Scheme 3-19 – Synthetic route to S-PL5. 
3.7.1.1 Triggered Release of S-PL5 
The standard Fmoc deprotection conditions of piperidine in DMF were not able 
to be used due to poor compatibility with the transfer hydrogenation reaction. The 
asymmetric reduction was optimised to an aqueous alcohol conditions, where addition 
of DMF resulted in a reduction in homogeneity of the system, see Chapter 4 for further 
109 
 
details. Under the desired conditions in i-PrOH and CO32- buffer with piperidine, no 
release of SS-81 was observed via ESI-MS (Scheme 3-20a). Instead the formation of an 
intermediate 119 was observed. Mass analysis showed the formation of an ion at 
674.305, the proposed structure of the hemiaminal is shown below in Scheme 3-20b. 
Under aqueous condition, the intermediate 119 could be stabilised by hydrogen bonding, 
preventing the standard deprotection mechanism from occurring. 
   
Scheme 3-20 – a) Triggered release of S-PL5; b) Structure of proposed hemiaminal 
intermediate, and general structure of intermediate. 
With unsuccessful release of the ligand, a screen of nucleophilic amines was 
conducted to elucidate a suitable trigger. Analogous cyclic saturated heterocycles such 
as morpholine, piperazine and pyrrolidine afforded the analogous intermediate, with 
general structure 120. Similar intermediates were obtained with aromatic pyridine and 
imidazole, and with ethanolamine. However, minimal cleavage was observed with the 
non-nucleophilic amidine bases, DBN and DBU, resulting in the release of a small 
amount of the diamine ligand SS-81. With only partial release of the ligand achieved, 
further exploration into S-PL5 was discontinued. 
3.7.2 Phthalimide Proligand 
  
Scheme 3-21 – Synthetic route to S-PL6. 
The second alternative trigger utilised the stability of the phthalimide protecting 
group, which is cleaved by hydrazine.238 As a smaller protecting group than Fmoc, we 
hypothesised that it would have a higher solubility in the aqueous conditions. The 
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phthalimide group should remain stable to fluoride, hydrogen peroxide and -gal 
cleavage and would, therefore, be a suitable orthogonal trigger unit to the current 
developed proligands. Similar to S-PL5 the trigger unit was attached directly to the 
diamine SS-81, with the synthesis of the proligand, S-PL6, achieved in a 36% yield. 
3.7.2.1 Triggered Release of S-PL6 
Classical phthalimide deprotection conditions are hydrazine hydrate in alcoholic 
solvents.238 Envisioning minimal issues with incorporation into the desired conditions, the 
triggered release of S-PL6 was investigated (Scheme 3-22). Addition of 10 equivalents 
of hydrazine hydrate afforded partial ligand release within 1 h and complete release 
within 2 h. The formation of the phthalhydrazide by-product was also observed via ESI-
MS. Pleasingly, S-PL6 remained stable in the absence of trigger over the 2 h reaction 
period. Though the induction period was slightly longer than previous proligands, S-PL6 
was taken forward to the stimuli responsive assay. 
 
Scheme 3-22 – Triggered release of S-PL6 with hydrazine, ESI-MS obtained after 1 h; 





With a plethora of small molecule trigger proligands, our attention returned to 
enzyme triggers. We believed that having an extensive array of stimuli and trigger units 
was beneficial, with enzyme targeted proligands offering dual amplification compared to 
single amplification seen for small molecules. With this in mind, -chymotrypsin is a 
proteolytic enzyme that selectively hydrolyses amide bonds where the amino acid N-
terminal to the bonds contains a large hydrophobic side chain.244 There is a hydrophobic 
pocket in the enzyme active site that the side chain binds resulting in a high 
chemoselectivity.  The high activity and specificity of the enzyme was attractive with no 
expected cross-reactivity with the current developed proligands. Furthermore, the 
stability of the amide would reduce background hydrolysis and subsequent ligand 
release. A simple -chymotrypsin assays utilise a N-benzoyl L-tyrosine ethyl ester 124, 
where the hydrolysis is followed spectrophotometrically.245 Further assays monitor the 
release of p-nitroaniline,246 and -chymotrypsin has been considered in targeted prodrug 
strategies (Fig. 3-9).247 Using these substrates as a foundation, proligand S-PL7 was 
designed. 
  
Figure 3-9 – General activity of -chymotrypsin, with spectrophotometric substrates 
124,245 125,246 and the prodrug 126.247 
3.8.1 Synthesis of S-PL7 
The design of S-PL7 followed the same trigger-linker-effector methodology used 
for PL1-4. Retrosynthetic analysis of S-PL7 in Fig. 3-10 identified the key bond formation 
was the installation of the aminobenzyl alcohol linker via amide bond formation. This 
would give the benzyl alcohol unit 128 that can be coupled to the ligand SS-81 through 
carbamate formation to give the protected proligand 127. The tyrosine derivative 129 
could be formed from L-tyrosine methyl ester 132 through a series of functional group 
interconversion and protecting group strategies. 
Scheme 3-23 shows the synthesis of S-PL7. Synthesis of the tyrosine derivative 
129 started from L-tyrosine methyl ester hydrogen chloride, with benzoyl protection of 
the free amine, followed by ester hydrolysis achieved in a two-step telescoped reaction 
in a 95% yield to give 133. Installation of the silyl protecting group gave the intermediate 
134 in a 48% yield, the moderate yield attributed to competitive silylation of the carboxylic 
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acid, and the di-silylation product. Coupling to the 4-aminobenzyl alcohol linker via DCC 
amide bond formation afforded the key intermediate 135 in a 42%, and a 19% overall 
yield. Under the previously developed phosgene coupling conditions in THF, minimal 
chloroformate formation was observed via TLC. Changing the solvent to EtOAc improved 
chloroformate formation with improved solubility of the benzyl alcohol, however, in the 
second step no product formation was observed in THF. 135 and diamine ligand SS-81 
were recovered following silica gel column chromatography. Modifying the conditions to 
an apolar solvent in DCM proved beneficial, with a change in base from TEA to sodium 
carbonate improved the yield to 26%. With only small quantities required to test ligand 
release, further optimisation was not carried out at this point. Fluoride deprotection of the 
silyl group afforded the first chymotrypsin proligand S-PL7 in a 4% overall yield.  
 
Figure 3-10 – Retrosynthetic analysis of -Chymotrypsin proligand – S-PL7. 
3.8.2 Triggered Release of S-PL7 
Initial test of the triggered release of S-PL7 in the desired condition proved 
unsuccessful with no ligand SS-81 release observed via ESI-MS (Scheme 3-24). 
Suspecting that the -chymotrypsin was not stable in the aqueous i-PrOH system, 
calcium chloride was added as it had been shown previously to stabilise the enzyme.248 
With no conversion still observed, a change in the miscible solvent to acetonitrile or 
methanol offered no improvement. To test the compatibility of the enzyme with the 
solvent system, N-benzoyl L-tyrosine methyl ester was tested,245 with complete 
hydrolysis readily observed via TLC after 1 h. Having eliminated the enzyme as the 
source of the error, reassessment of S-PL7 suggested that the multiple aromatic rings 
would impart poor aqueous solubility. In an attempt to overcome the solubility issues 





Scheme 3-23 – Synthetic route to S-PL7. 
  
Scheme 3-24 – Triggered release of S-PL7. 
3.8.3 2nd Generation Proligand S-PL8 
Identifying the large number of aromatic rings as the key issue with solubility, a 
2nd generation proligand S-PL8 was designed with the aim to reduce to number of 
aromatic rings. The aminobenzyl alcohol linker was removed to improve solubility, and 
the tyrosine core was replaced with phenylalanine to reduce the number of synthetic 
steps. The proligand was formed from L-phenylalanine 137 in two steps, firstly, the 
benzoylation of the amine residue to give 138, followed by EDCI amide bond formation 
directly to the diamine ligand in a 4% yield to give S-PL8. Both synthetic steps were low 
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yielding, however, with S-PL8 in hand, the triggered release was explored under the 
optimised conditions. Initial experiments showed small quantities of ligand release 
observed via ESI-MS, however, solubility remained an issue. 
  
Scheme 3-25 – a) Synthetic route to S-PL8; b) Triggered release of S-PL8 with -
chymotrypsin, ESI-MS obtained after 1 h. 
3.8.4 3rd Generation Proligand S-PL9 
  
Figure 3-11 – Potential modification sites for hydrophilic group inclusion. 
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Seeking to improve the solubility further of S-PL8, assessment of the proligand 
showed four possible sites of modification to improve solubility. Inclusion of a hydrophilic 
substitution in a remote location is a common strategy in pharmaceutical development 
to improve solubility.  The first site of substitution was on the phenylalanine benzene ring, 
Fig. 3-11a, which was dismissed as a possible site, due to its integrity in the activity of 
-chymotrypsin. Binding in the enzyme active site requires the bulky hydrophobic group 
to bind in the hydrophobic pocket, therefore inclusion of a large hydrophilic unit would 
interfere with this binding interaction, having a severe impact on enzyme activity. The 
second site of substitution was on the ligand backbone (Fig. 3-11b). It has been shown 
that inclusion of sulfate groups on the phenyl rings improve the water solubility of the 
ligand.231 However, the synthesis of the ligand is non-facile, and would require redesign 
of the previously developed proligands. In a similar vein amendment of the sulfonyl 
aromatic ring was disregarded (Fig. 3-11d), though there have been reported examples 
in the literature of how solubility of the diamine ligand can be improved.249 The final point 
of substitution is on the benzoyl group (Fig. 3-11c), where inclusion of hydrophilic groups 
would improve the solubility of the proligand. As the substitution is on the benzoyl group, 
incorporation would be facile, with amide bond formation between the free amine and 
the substituted benzoic acid derivative to give S-PL9. 
  
Figure 3-12 – Retrosynthetic analysis of proligand S-PL9. 
Having identified the site of modification a new retrosynthetic analysis was 
conducted shown in Fig. 3-12. By incorporating the functionalised benzoyl group in the 
final key bonding formation, it would mean that groups could be screened. The 
phenylalanine-diamine core 143 could be formed through classical amide bond 
formation, with functional group interconversion affording 145. 3,5-dihydroxybenzoic acid 
146 was used initially as a hydrophilic group, where the two hydroxyl group should 
improve the solubility of proligand. The intermediate 144 could be formed from 146 
through protection of the hydroxyl groups followed by activation of the carboxylic acid as 
a N-hydroxysuccinimide ester. A protecting group strategy was used to prevent self-




Scheme 3-26 – Synthetic route to S-PL9. 
Scheme 3-26 shows the synthetic route to S-PL9 The synthesis of intermediate 
150 started with the tri-silyl protection of the benzoic acid 146 with tert-butyldimethylsilyl 
chloride, followed by cleavage of the carboxylic acid protecting group with acetic acid in 
a 47% yield to give 149. The activated NHS ester intermediate 150 was formed via a 
DCC coupling in a 22% overall yield. To form the phenylalanine core 143, the free amine 
of L-phenylalanine was protected with a BOC group and the carboxylic acid group was 
activated as an NHS ester in a 72% yield over the two steps. The key phenylalanine-
diamine intermediate 143 was formed by reaction of the NHS ester 152 with (S,S)-N-
TsDPEN, followed by BOC deprotection in a telescoped reaction to form the intermediate 
in a 48% yield from L-phenylalanine. Reaction between the 143 and 150 afforded the 
protected proligand 154 in a 32% yield. Silyl deprotection gave 3rd generation proligand 
S-PL9 in 72% and in a 9-step process with a 2% overall yield. 
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The solubility of the S-PL9 was significantly improved, with complete solvation in 
the buffer-i-PrOH mixture. Disappointingly, in the optimised condition no triggered 
release of ligand SS-81 was observed via ESI-MS in the presence of -chymotrypsin. 
The poor ligand release could be attributed to two possibilities. Firstly, substitution of the 
benzoyl group may have a detrimental effect of the active site binding, reducing the 
activity of the enzyme. Secondly, without the inclusion of a linker unit, enzyme activity 
may be reduced due to the bulky crowding around of the amide. With a succession of 
strategies failing to develop a suitable proligand for -chymotrypsin, further 
developments of the proligand were stopped. The synthetic difficulties of future 
proligands was an impediment to further study.  
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3.9 Alkaline Phosphatase 
The final proligand S-PL10 built upon previous successful ligand PL0 developed 
within the Frost group.151 S-PL10 utilises a phosphate-based trigger that is selectively 
dephosphorylated by alkaline phosphatase (ALP) giving the phenolate intermediate 99 
and phosphate (Scheme 3-27). Quinine methide elimination would result in the ligand 
SS-81 In the absence of ALP, the dephosphorylation would be very slow, and the activity 
of ALP has been showed previously to be compatible with transfer hydrogenation 
conditions.151 The phosphate group should be orthogonal to enzyme hydrolysis by -gal 
and the small molecule triggers previously developed. In addition, ALP should have no 
cross reactivity with the other proligands.   
  
Scheme 3-27 – Triggered release concept for alkaline phosphatase S-PL10. 
3.9.1 Synthesis of S-PL10 
  
Scheme 3-28 – Synthetic route to S-PL10. 
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The synthesis of the benzyl alcohol trigger unit 157 followed literature precedent 
starting from phosphorus trichloride. Stoichiometric controlled addition of allyl alcohol, 
oxidation to P(V) and reaction with N-chlorosuccinimide afforded the intermediate 156. 
Reaction with 4-hydroxybenzaldehyde 94, then sodium borohydride reduction gave the 
trigger-linker unit 157 in a 19% yield over a five-step telescoped procedure. Phosgene 
coupling with (S,S)-N-TsDPEN in THF gave the protected proligand 158 in a 68% yield. 
The allyl groups were cleaved using palladium tetrakis(triphenylphosphine), with sodium 
borohydride as the reducing agent to give the proligands, S-PL10, as the disodium salt 
in an overall yield of 7%. 
3.9.2 Triggered Release of S-PL10 
  
Scheme 3-29 - Triggered release of S-PL10 with ALP, ESI-MS obtained after 1 h; b) 
control reaction of S-PL10 without ALP, ESI-MS obtained after 1 h. 
To test the triggered release of S-PL10, the proligand was incorporated into the 
optimised conditions. An ALP concentration of 4 U mL-1 was used, a concentration used 
in the achiral assay that afforded complete ligand release.151 The appearance of the 
ligand SS-81 peak was observed via ESI-MS within 1 h, with concurrent disappearance 
of S-PL10 molecular ion peak. In the control reaction, no ligand release was observed, 





The aim of the project was to develop a range of pseudo-enantiomeric proligands 
for integration into a stimuli responsive asymmetric catalytic system. The proligands 
followed classical standard trigger-linker-effector methodology used previously, and over 
the course of the project, seven different stimuli were considered, with chemoselective 
proligands designed for each stimulus following a common proligand strategy. Ten 
proligands were successfully synthesised in moderate yields, and their triggered release 
was investigated. Following the ligand release via electrospray ionisation mass 
spectrometry, five proligands were successfully triggered, with the proligands remaining 
stable in the absence of the stimuli. The proligands encompassed a range of stimuli: 
enzyme specific substrates, PL1 for -galactosidase and S-PL10 for alkaline 
phosphatase; and small molecule specific proligands, PL2 for fluoride, S-PL3 for 
hydrogen peroxide and S-PL6 for hydrazine. The successful proligands were taken 





4 Stimuli Responsive Asymmetric Catalysis 
4.1 Stimuli Responsive Catalysis 
Stimuli responsive catalysis is an integral function in biological systems, where 
the regulation of enzymatic activity controls every process from ATP generation, to 
protein synthesis and the maintenance of osmotic balance. In this sense, enzymes are 
viewed as the gold standard in responsive catalysis, through their use of allosteric 
secondary messenger regulation. Binding of the secondary messenger at an allosteric 
site leads to a conformational change in the enzyme active site. Two allosteric processes 
are present, allosteric activation and allosteric inhibition (Fig. 4-1). Activation occurs 
when secondary messenger binding switches on the enzyme’s catalytic activity, and 
inhibition when the enzyme activity is switched off. The combination of activation and 
inhibition strategies has allowed the development of self-regulating systems necessary 
for complex systems. Allosteric activation of the enzyme through external stimuli results 
in a localised controlled response, for example, in the dephosphorylation activity of 5’-
nucleotidase II, where binding of guanosine monophosphate (GMP) increases the affinity 
for further GMP binding.250 In addition to their stimuli responsive character, enzymes are 
able to perform synthetically challenging transformations, with a high chemoselectivity, 
yield and enantioselectivity. Enzymes are therefore a logical inspiration in the 
development of synthetic stimuli responsive catalysts, which have potential in sensing 
applications,46,51,205 molecular machines,207 and the development of other smart 
materials. 
 
Figure 4-1 – Allosteric enzyme interactions. 
4.1.1 Modification of Enzymes 
Enzyme-linked immunosorbent assays (ELISAs) utilise the efficiency of enzymes 
in a common signal amplification sensing platform.251,252 There are several different types 
of ELISA, however, the sandwich ELISA offer the highest degree of selectivity and are 
the standard ELISA used in medical diagnostics (Fig. 4-2).253,254 A surface immobilised 
antibody selectively binds to the antigen, with a second antibody binding subsequently. 
The second antibody is conjugated to an enzyme which catalyse the formation of an 
effector molecule. ELISAs offer unparalleled detection of specific analytes, whilst offering 
an easily modified general procedure that has allowed for their incorporation into assays 
for example, the detection of HIV antibodies,255 hepatitis B and C markers in blood 
samples.256,257 ELISAs have found prominence in sensing applications, but there is 
minimal exploration into their applicability in smart materials. Bioengineering of enzymes 
remains a broad field of research, where directed evolution of enzymes can be used to 
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change and improve the catalytic activity towards new enzyme functionality.258,259 
However, bioengineering is a non-facile process, with extensive iterations and 
optimisation required. This has resulted in their development for new reactivity, but 
limited investigation into stimuli responsive processes. 
 
Figure 4-2 – Sandwich ELISA general structure. 
4.1.2 Supramolecular Catalysts 
The search for synthetic enzyme mimics has led to a range of bioinspired 
supramolecular systems that create synthetic active sites that are capable of performing 
challenging transformations.260–262 Stimuli responsive supramolecular catalysts utilise the 
binding of small molecule analytes to switch on the catalytic system. This core process 
has been developed into sensing strategies for metal ions. Anslyn et al. designed a lead 
sensor that uses the binding affinity of ethylenediaminetetraacetic acid (EDTA) for 
different metal cations (Scheme 4-1a).262 The resting state of the system has a 
[Cu(II)EDTA]2- core, that on addition of Pb2+ cations partial Cu2+ displacement occurs. A 
sacrificial reductant, L-ascorbic acid, reduces the free Cu(II) cations to Cu(I), driving full 
displacement of the Cu(II). The Cu+ is then able to catalyse a Huisgen cycloaddition 
between 159 and 160 to form 161 which results in a Förster resonance energy transfer 
(FRET) signal. Further analogous systems use a Pd catalysed Heck reaction to form a 
fluorescent indole 163 and have been developed for the detection of Cu2+,263 and Cd3+ 
ions (Scheme 4-1b).264 A weak ligand coordination approach was adopted by Mirkin et 
al. for the detection of chloride and carbon monoxide in a polymerase chain reaction like 
cascade reaction.265 Ligand binding results in a structural change in the macrocycle 
exposing the active zinc centre. The metal catalyses the synthesis of acetic acid which 
can then be detected via a pH indicator. Supramolecular catalysts are successful 
synthetic mimics of enzymes, however, the use of unfavourable conditions, such as 
organic solvents and inert atmospheres, have limited their utility. Furthermore, few 
supramolecular catalysts offer comparable turnover numbers to enzymes with the same 
degree of chemoselectivity. 
4.1.2.1 Asymmetric Supramolecular Catalysts 
Asymmetric variants are a natural progression in the development of 
supramolecular catalysts,260–262 where the desire to control chirality is a cornerstone in 
biological systems. A more difficult proposition is the ability to switch the 
enantioselectivity of a catalytic system by utilising a single chiral source. 
Enantiodivergent asymmetric catalysis is reliant on a change in either the reaction 
conditions or a change in the active catalyst.266–270 Alterations in the reaction conditions 
including temperature, solvent or addition of an additive, can influence the 
enantioselectivity of the reaction. That same switch has also been achieved by 
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modification of the active catalyst through changing the metal centre, its coordination 
state or a change in the ligand stereoelectronics.  
 
Scheme 4-1 – a) Pb(II) sensor using a Huisgen cycloaddition;271 b) Cu(II) sensor using 
a Heck reaction.264 
Dynamic control of enantioselectivity is possible when the chiral supramolecular 
catalyst is able to undergo a stimuli-responsive structural change.272 Currently, the stimuli 
used have been limited to photo-/thermoisomerisations, solvent or redox control. The 
seminal work in this field by Wang and Feringa, controlled the enantioselectivity of a 
sulfa-Michael addition by using a crowded alkene molecular motor (Scheme 4-2).273 The 
alkene 165 was able to undergo a series of photo- and thermoisomerisation to change 
its chiral helicity and switch the enantioselectivity of the reaction. The relatively low 
enantioselectivity reported, 74:26, has since been improved to comparable levels seen 
with conventional ligands.274  
Solvent switchable catalysts have been developed by Suginome et al., where the 
enantioselectivity of the palladium catalysed asymmetric hydrosilylation of styrenes can 
be inverted.275 The phosphorous ligands were incorporated into a random copolymer of 
poly(quinoxaline-2,3-diyl) that underwent helical inversion dependent on the solvent. 
Impressive yields and enantiomeric ratios (er) were reported with the polymer 
demonstrating excellent reusability. Canary et al. designed a switchable asymmetric 
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catalyst around a redox active copper centre.276 Reduction of the Cu(II) to Cu(I) resulted 
in a change in ligand coordination around the metal, which caused an inversion in the 
helicity of the macrocycle. Good enantioselectivities were achieved for the conjugate 
addition of malonates to nitrostyrene, however, only modest yields were reported. 
 





4.2 Project Aims  
The previous chapter focused on the design of a suite of pseudo-enantiomeric 
proligands for the purpose of incorporation into a stimuli responsive asymmetric catalytic 
system. This chapter focuses initially on the optimisation of the asymmetric transfer 
hydrogenation, followed by work incorporating the proligands into a single pseudo-
enantiomer system (Fig. 4-3a), and then finally exploring two proligands in a dual 
pseudo-enantiomer system (Fig. 4-3b). 
 
Figure 4-3 – Concept Overview: a) single pseudo-enantiomeric ligand release and 
accelerated catalysis; b) dual pseudo-enantiomeric ligand release and accelerated 
catalysis. 
4.2.1 Proligand Orthogonality Review 
The key requirement of the proligands developed was the orthogonality of the 
triggers and the trigger units. Evaluating the five successfully triggered proligands from 
chapter 3 (Fig. 4-4), we selected PL2, the fluoride triggered proligand, as the starting 
point to explore its orthogonality. As discussed previously, silyl ethers are used widely in 
protecting group strategies, where they are known to be stable to oxidising and reducing 
conditions. In addition, the silyl ether should be stable to enzymatic cleavage.238 
Therefore, to examine the orthogonality of PL2, the proligand was exposed under the 
optimised reaction conditions to the four triggers: -galactosidase (-gal), hydrogen 
peroxide, hydrazine and alkaline phosphatase (ALP). Pleasingly, analysis via 
electrospray ionisation mass spectrometry (ESI-MS) after 1 h showed no presence of 
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ligand 81 (Scheme 4-3). In addition, no evidence of side reactivity occurred with the 
molecular ion peak for PL2 prominent in the spectra.  
 
Figure 4-4 – Successful proligands developed in Chapter 3. 
 
Scheme 4-3 – Control reactions of PL2 with orthogonal triggers with ESI-MS obtained 
after 1 h. 
Having identified the suitability and compatibility of PL2, the choice of the second 
proligand was considered. Firstly, S-PL6 was ruled out due to the possible side reaction, 
the reduction of the phthalimide under the transfer hydrogenation conditions. 
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Phthalimides have primarily been shown to be reduced under mild conditions with 
sodium borohydride, however, Bergens et al. showed that phthalimides can be reduced 
under asymmetric transfer hydrogenation conditions to the hydroxy lactam 170.277 
Reduction of S-PL6 to the hydroxy lactam 172 or to the alcohol amide 173 would inhibit 
ligand release preventing switch on of the catalytic cycle. 
 
Figure 4-5 – a) Bergens reduction; b) proposed reduction. 
Drawing upon previous research within the group, it was expected that the 
incorporation of enzyme triggers into complex reaction schemes would be non-trivial. 
The optimisation required to balance the transfer hydrogenation reaction with the 
enzymatic cleavage of PL0 in the achiral system was extensive.151 However, based upon 
this understanding, S-PL10 was the next logical choice for facile integration into the 
stimuli responsive system. In contrast, the other enzyme triggered proligand, PL1, would 
require careful control of the reaction conditions to optimise the process. -gal has an 
increased activity in more acidic conditions, which disfavours the elimination from the 
phenolate intermediate, having an overall reduction in ligand release. The silyl ether of 
PL2 has reduced stability in acidic conditions, and therefore, due to the difference in 
expected optimal pH windows, further research with PL1 was halted. The final proligand, 
S-PL3 remained under consideration, where the expedient hydrogen peroxide triggered 
cleavage was favourable. The use of a small molecule trigger compared to an enzyme 
was expected to be significantly easier when attempting to incorporate its use into the 
stimuli responsive system.  
Therefore, the final aspects to explore were the orthogonality of the proligands, 
and to examine the compatibility of the two proligands with PL2 and its fluoride trigger. 
S-PL3 and S-PL10 were tested in the optimised conditions with fluoride with the results 
shown in Scheme 4-4. As can be seen in Scheme 4-4a, S-PL3 exhibited no ligand 
release or degradation on addition of TBAF. The prominent peak in the spectrum was 
from the tetrabutylammonium ion, with the proligand molecular ion peak at 649.25 still 
present after 1 h. With no reactivity observed with either trigger, it was concluded that S-
PL3 and PL2 were orthogonal to each other and they should be further investigated in 
the stimuli responsive system. The suitability of S-PL10 could be seen in the spectrum 
shown in Scheme 4-4b where the proligand molecular ion peak at 649.252 was easily 
observable. The ion peak at 332.281 was attributed to a molecular ion peak for TBAB 
plus two formate ions. With no observed reactivity S-PL10 was considered suitable for 




Scheme 4-4 – a) Control reactions of S-PL3 with TBAF, ESI-MS obtained after 1 h; b)  




4.3 Model Substrate Selection 
Having ascertained the orthogonality of the proposed proligands, the selection of 
a suitable substrate was considered next. The use of an electroactive ketone would allow 
for reaction monitoring and facile reaction optimisation via differential pulse voltammetry 
(DPV). DPV is repeatable and reliable, allowing for direct rapid analysis of the reaction 
mixture. Ferrocene derivatives are a common core for electrochemical substrates due to 
their facile oxidation potential.278–280 In addition, the synthetic utility and stability of 
ferrocenyl ketones means they are ideal candidate for incorporation into complex 
systems, and they have been shown to be amenable to transfer hydrogenations.281–284 
The change in electronics in the alcohol would significantly lower the oxidation potential 
of the iron centre allowing for ratiometric electrochemical analysis.  
The first of two ferrocene derivatives synthesised to be tested was the prochiral 
acetylferrocene. Acetylferrocene 176 was synthesised via standard Friedel-Crafts 
conditions from ferrocene 174 in an 82% yield. The second substrate, 2-
acetylvinylferrocene 178, was synthesised from ferrocene carboxaldehyde 177 in an 
aldol condensation in an 81% yield.  
 
Scheme 4-5 – a) Synthesis of acetylferrocene 176; b) synthesis of 2-
acetylvinylferrocene 178. 
 
Scheme 4-6 – a) Transfer hydrogenation of acetylferrocene 176; b) transfer 
hydrogenation of 2-acetylvinylferrocene 178. 
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Using aqueous transfer hydrogenation conditions developed in the achiral 
system at a 1% catalyst loading,151 176 was unreactive with no formation of ferrocenyl 
ethanol 179 observed via TLC. This is not unexpected, as unactivated ferrocenyl ketones 
often require the use of either polymer supported ligands,285 or more forcing 
conditions.281–284 Wishing to avoid harsh reaction conditions and increased catalyst 
loading, further investigation into acetylferrocene was halted, with attention turning to the 
second substrate 178. Subjecting 178 to the same conditions, the reduced product 180 
was observed. However, the reduction of .-unsaturated systems requires the 
reduction of both the ketone and the alkene,286 with the intermediates observed. The 
predominant pathway observed was reduction of the alkene to give the ketone 181, 
followed by reduction to the alcohol 180, which was isolated in a 69% yield, with 9% of 
the 181 also isolated. The allyl alcohol 182 was observed via NMR, with difficulties in 
separating the allyl alcohol from the desired alcohol. The oxidation potential of the iron 
centre is controlled by its electronic environment. 180 has a significant electrochemical 
shift compared to the starting material; however, the ketone intermediate 181 has a 
similar electronic environment to the alcohol 180 and the allyl alcohol 182. This results 
in a significant overlap of the two signals, preventing accurate electrochemical analysis 
(Fig. 4-6). The shoulder present in the voltammogram for 180 was attributed to presence 
of 182. 
 
Figure 4-6 – Voltammogram obtained for enone 178 (green), ketone 181 (orange) and 
alcohol 180 (blue) at 0.1 mM in tris buffer (pH 9, 50 mM). 
Desiring to maintain the mild reaction conditions, a more activated ketone was 
required. Trifluoroketones exhibit similar reactivities to aldehyde analogues, with a 
comparable rate of reduction.287 The replacement of a methyl group with a 
trifluoromethyl, a strong electron withdrawing group, reduces electron density on the 
carbonyl carbon making it more electrophilic. The installation of a trifluoromethyl group 
proved to be a non-trivial process. Starting from literature precedent,288 the first route 
under Friedel-Crafts conditions of trifluoroacetic anhydride and aluminium chloride was 
low yielding with only 8% of trifluoroacetylferrocene 183 isolated. A second route 
involving quenching of lithiated ferrocene with ethyl trifluoroacetate 184 also proved 
inadequate (Scheme 4-7b). Preformation of the Weinreb amide 187 from ferrocene 
carboxylic acid 186, followed by reaction with trimethyl(trifluoromethyl)silane (TMS-CF3) 
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afforded 183 in a 50% yield (Scheme 4-7c).289 This synthetic route allowed for initial 
exploration of trifluoroacetyl ferrocene in the transfer hydrogenation, however, a higher 
yielding synthesis was desired. Reactions of aldehydes with TMS-CF3 have been used 
to create -trifluoromethyl alcohols.290 Therefore, a new synthetic route (Scheme 4-7d) 
using TMS-CF3 was conceived starting from ferrocene carboxaldehyde 177. 
Deprotection of the silyl protecting group and oxidation to the ketone would give the 
desired substrate 183. 183 was synthesised in three steps from ferrocene 
carboxaldehyde 177 in a 94% yield on a 1 g scale.  
 
Scheme 4-7 – Synthetic routes to trifluoroacetyl ferrocene. 
Under the mild reaction conditions, the reduction of trifluoroacetyl ferrocene 183 
occurred readily with a 94% yield obtained. Having obtained a high conversion, 
electrochemical data was then recorded for the ketone 183 and the alcohol 188. There 
was a significant difference in the oxidation potential of the two compounds of around 
250 mV which allowed for facile ratiometric analysis (Fig. 4-7a). However, 
voltammograms obtained for 183 contained a second smaller peak. It was proposed that 
due to the activated nature of the ketone, hemiacetal formation could occur in 
nucleophilic solvents, accounting for the second smaller peak seen. Comparative 19F 
NMR spectra in a non-nucleophilic solvent (chloroform-d) and in a nucleophilic solvent 
(methanol-d4) showed the formation of a second fluorine peak in methanol-d4 (Fig. 4-7b). 
Furthermore, ESI-MS analysis of the substrate showed a significant product peak at 
300.010, matching the expected peak from hemiacetal formation. 
To account for the formation of the second peak, a calibration curve was 
produced (Fig. 4-8). Starting from stock solution of trifluoroacetyl ferrocene 183 and 1-
ferrocenyl-2,2,2-trifluoroethanol 188, DPV were recorded at known ratios to produce a 
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calibration curve between actual ratios and measured ratios. Trendline analysis afforded 




Figure 4-7 – Voltammogram of trifluoroacetylferrocene 183 (0.1 mM) in 1:1 mix of 
MeOH (0.05 mL) and tris buffer (pH 7, 50 mM, 0.05 mL); (b) top: 19F NMR of 
trifluoroacetylferrocene 183 in CDCl3; bottom: 19F NMR of trifluoroacetylferrocene 183 
in CD3OD. 
  
Figure 4-8 – Calibration curve calculated for trifluoroacetyl ferrocene 183 (125 µM) and 
1-ferrocenyl-2,2,2-trifluoroethanol 188 (125 µM) in 50 mM pH 7.8 tris buffer. Error bars 
represent the standard deviation where n = 3.  Equation: 







4.3.1 Transfer Hydrogenation Optimisation 
To optimise the yield and enantiomeric ratio (er) of the reaction, a small selection 
of commercial metal catalysts and tosylated diamine ligands were screened, results 
tabulated in Table 4-1. Under the initial conditions of [IrCp*Cl2]2 and (N)-tosyl 
ethylenediamine (Ts-EN), a yield of 94 % was obtained. As expected with an achiral 
ligand, no enantioselectivity was observed for the reduction. The introduction of the chiral 
ligand (R,R)-N-Ts-DPEN RR-81 had no effect on the yield and an er of 72:28 was 
recorded via high performance liquid chromatography (HPLC). This was improved by 
changing to the ligand (R,R)-N-Ts-CYDN RR-86 with an er 78:22, but a small erosion of 
yield to 84% was observed. A change in the metal catalyst to a rhodium centre 
maintained the high yield, however it also resulted in a drop in er to 67:33 with RR-81 
and 69:31 with RR-86. With [Ru(p-cymene)Cl2]2 and RR-81, an 84% yield was obtained 
with an 87:13 er, however, the reaction time was extended to 16 h. The er was only 
marginally improved with RR-86, however, near complete inhibition of the reaction 
occurred, with less than 5% yield afforded. This combination of ruthenium and RR-81 
was therefore selected. In the absence of any ligand, a 1% yield was obtained. This small 
background rate can be attributed to ruthenium-hydrate hydrogenation which has been 
reported previously.291 The reaction in the absence of metal catalyst afforded no 
hydrogenation product as expected.  
Table 4-1 – Reaction Optimisation 
 
 Catalyst Ligand Yield (%) er 
1 [IrCl2Cp*]2 Ts-EN 94 - 
2 [IrCl2Cp*]2 (R,R)-N-Ts-DPEN RR-81 94 72:28 
3 [IrCl2Cp*]2 (R,R)- N-Ts-CYDN RR-86 84 78:22 
4 [RhCl2Cp*]2 Ts-EN 91 - 
5 [RhCl2Cp*]2 RR-81 96 67:33 
6 [RhCl2Cp*]2 RR-86 82 69:31 
7 [RuCl2(p-
cymene)]2 
Ts-EN NR - 
8 [RuCl2(p-
cymene)]2 
RR-81 84 87:13 
9 [RuCl2(p-
cymene)]2 
RR-86 <5b 88:12 
10 [RuCl2(p-
cymene)]2 
- 1 - 
11 - RR-81 NR N/A 
Reaction optimisation. Trifluoroacetyl ferrocene 183 (0.5 mmol), [M] (1 mol %), [L] (2 
mol %), NaOOCH (5 eq.), water (1 mL), ethanol (1 mL), 25 °C, air, 3-16h. er 
determined via HPLC.  
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4.4 Single Pseudo-Enantiomer System 
4.4.1 Fluoride Triggered Proligand PL2  
4.4.1.1 Incorporation and Optimisation 
Table 4-2 – Reaction optimisation of PL2 incorporation 
 






1 EtOH Water - 43 30 1.4:1 
2 MeOH Water - 100 15 6.7:1 
3 i-PrOH Water - 48 16 3:1 
4 MeCN Water - 44 - - 
5 THF Water - 21 - - 
6 DMSO Water - 45 - - 
7 DMF Water - 49 42 1.2:1 
8 Dioxane Water - 29 - - 
9 i-PrOH Tris 9 26 13 2:1 
10 i-PrOH Borate 9 100 39 2.6:1 
11 i-PrOH CO32- 9.2 100 7 14:1 
12 i-PrOH CO32- 9.5 40 - - 
13 i-PrOH CO32- 9.8 33 18 1.8:1 
14 i-PrOH CO32- 10.1 100 33 3:1 
15 i-PrOH CO32- 10.4 100 37 2.7:1 
16 i-PrOH CO32- 10.7 24 - - 
Reaction optimisation. Trifluoroacetyl ferrocene 183 (0.125 mmol), [RuCl2(p-cymene]2 
(1 mol %), PL2 (2 mol %), NaOOCH (5 eq.), buffer (50 mM, 0.5 mL), solvent (0.5 mL), 
TBAF in THF (1 M, 20 mol %), 25 °C, air, 16h; (a) determined via DPV. 
Having ascertained that PL2 readily collapses when triggered and that it was 
orthogonal to the other stimuli, the challenge remained to incorporate the pseudo-
enantiomeric proligand into the asymmetric transfer hydrogenation reaction. The 
optimisation results are summarised in Table 4-2. Under the initial conditions in an 
ethanol/water solvent mix, the first results were promising with a 43% conversion to the 
alcohol obtained in 16 h. However, a background reaction run without fluoride gave 30% 
conversion, significantly higher than the desired level with a catalyst on-to-off state ratio 
of just 1.4:1. Seeking to lower the background reactivity, a screen of water miscible 
solvent was conducted. Nonpolar solvents offered reduced conversions, with dioxane 
giving a 29% conversion. Polar aprotic solvents offered higher conversion, however, 
were limited by poor miscibility (MeCN), substrate instability (DMSO), or elevated 
background rates (DMF). Polar protic solvents are more commonly used in transfer 
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hydrogenation reactions with iso-propanol (i-PrOH) most prevalent. The reaction in i-
PrOH gave an improved conversion at 48%, with a significant reduction in the 
background rate to 16%. Methanol offered near quantitative conversions, however, the 
reduced homogeneity of the reaction prevented reliable electrochemical analysis with an 
increase in electrode fouling observed.  
Silyl ethers have improved stability in basic conditions,238 and the rate of quinone 
methide elimination is improved at higher pH,292 therefore, a basic buffer was introduced. 
The reaction in tris buffer had a significantly lower conversion which was unexpected, 
given the higher background rate observed in the achiral system.151 However, tris 
potentially acts as a chelating ligand for the ruthenium (Fig. 4-9), reducing the catalytic 
activity. In borate buffer, complete conversion was achieved, however, a high 
background was observed at 39%. Boric acid is weakly Lewis acid, and could activate 
the ketone, making the substrate more susceptible to hydrogenation, accelerating the 
background rate. In carbonate buffer at pH 9.2, quantitative conversion was maintained 
with the off state significantly reduced to 7%. This gave an on-to-off ratio of 14:1. 
Increasing the pH above 9.2 showed a decrease in stability of the proligand, with a 
corresponding increase in background rate. The background rate at pH 9.2 can be 
attributed to a combination of two effects. Firstly, the ruthenium-hydrate hydrolysis 
discussed earlier and in addition, a small rate of silyl ether hydrolysis would release the 
ligand, accelerating the rate of transfer hydrogenation. The stability of the proligand was 
confirmed by ESI-mass spectrometry, which shows the presence of the [M+Na]+ adduct, 
however, low traces of ligand release were observed after 16 h. This indicates that limited 
degradation of the proligand had occurred, assumed to be from silyl ether hydrolysis. 
 
Figure 4-9 – Proposed tris chelation of ruthenium. 
4.4.1.2 Asymmetric Exploration and Substrate Scope 
The results for the single pseudo-enantiomer system with R-PL2 are summarised 
in Table 4-3. Substituting the chiral proligand R-PL2 into the optimised conditions 
afforded high yields at 83±3%. Pleasingly, the high er observed in the initial catalyst 
screen were maintained at 87:13 ±1, with the presence of fluoride or silyl fluoride having 
no detrimental effect on the er or yield of the reaction. The reaction was run in triplicate 
to understand the reproducibility, and the small error bars observed in yield, ±3, and er, 
±1, demonstrate the reactions reproducibility. An isolated yield of 4% was yielded from 
the catalyst off-state with a lower er of 75:25 ±5. The reduction in enantioselectivity 
supports the two proposed methods of background hydrogenation. Ruthenium hydrate 
catalysis would be achiral. Background hydrolysis of the silyl ether results in release of 
the ligand which would impart enantioselectivity on the hydrogenation. The combination 
of these two processes would result in a lowering of the expected er. Switching the 
proligand to the opposite enantiomer, S-PL2, caused a switch in selectivity. The high 




Table 4-3 – Single Pseudo-Enantiomeric Results for R-PL2 and S-PL2 
 
 Substrate Ligand Trigger Conversiona 
(Isolated Yield) (%)b 
er (R:S)b,c 
1 183 R-PL2 TBAF 100 (83±3) 87:13±1 
2 183 R-PL2 - 7 (4±1) 75:25±5 
3 183 S-PL2 TBAF 100 (88±5) 12:88±0 
4 183 S-PL2 - 4 (6±1) 28:72±0 
5 acetophenoned 
192 
R-PL2 TBAF 84 (54±13) 98:2±0 
6 R-PL2 - 7 (N/A) - 
7 sodium 
pyruvated 193 
R-PL2 TBAF 100 (55) 3:97e 
8 R-PL2 - 35 (7) 35:65e 
Trifluoroacetyl ferrocene 183 (0.125 mmol), [RuCl2(p-cymene)]2 (1 mol %), PL (2 mol %), 
NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 0.5 mL), i-PrOH (0.5 mL), TBAF in THF (1 M, 
20 mol %), 25 °C, air, 16h; Absolute stereochemistry of 188 not assigned, relative 
stereochemistry inferred from a comparable model system293 (a) determined via DPV; 
(b) error bars calculated as the standard deviation from 3 repeats; (c) er determined via 
HPLC, see ESI; (d) substrate (0.5 mmol), [RuCl2(p-cymene)]2  (2 mol %), L (4 mol %), 
NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 2 mL), i-PrOH (2 mL), TBAF in THF (1 M, 40 
mol %), 25 °C, air, 24h; (e) er determined from benzyl 2-hydroxypropanoate 194. 
A brief substrate scope was explored to find the limitations of the reaction. 
Acetophenone 192 had a lower solubility in the reaction media compared to 
trifluoroacetyl ferrocene, and therefore its reduction required a higher catalyst loading at 
2%, with an 84% conversion observed via 1H NMR after 24 h. Difficulties in isolation 
afforded an isolated yield of 54±13%, however, an impressively high er of 98:2 ±0 was 
observed. The reduction of sodium pyruvate 193 was also examined due to the potential 
for in vivo reduction as a medicinal target.294 The reduction to sodium lactate exhibited 
complete conversion via 1H NMR, however, the background rate was higher than seen 
for trifluoroacetyl ferrocene or acetophenone with a catalyst on-to-off state ratio of 3:1. A 
control reaction done in the absence of proligand showed no conversion, therefore, a 
self-catalysed reaction can be ruled out. ESI-MS shows no significant ligand release in 
the reaction mixture, and therefore the increased background rate was attributed to a 
partial proligand association with a carboxylate ligand to form an active catalytic species 
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(Fig. 4-10). Amino carboxylate ligands are known in asymmetric transfer hydrogenation 
reactions.295 
 
Figure 4-10 – Proposed transition state for the background hydrogenation of sodium 
pyruvate. 
With the difficulties present with isolating the aqueous soluble lactic acid 196 
product from the catalyst, excess sodium formate and the buffer salts present, 
derivatisation to an organic soluble analogue was considered. Benzylation of the 
carboxylic acid moiety with benzyl bromide would derivatise the starting material and the 
lactic acid product to the benzoate esters 197 and 194, allowing for organic extraction 
with no epimerisation of the chiral centre (Scheme 4-8). Purification via silica gel flash 
chromatography afforded the isolated derivative 194, before HPLC analysis to determine 
the enantioselectivity. Analysis of 194 demonstrated the excellent enantioselectivity of 
the reaction with an er of 3:97 recorded.  
 
Scheme 4-8 – Derivatisation of reaction mixture. 
4.4.2 Hydrogen Peroxide Triggered Proligand S-PL3 
The hydrogen peroxide proligand, S-PL3, was the next proligand to be tested in 
the transfer hydrogenation reaction. The proligand and trigger system trialled in chapter 
3 were directly substituted into the optimised reaction conditions, with the results 
summarised in Table 4-4. Successful reduction of trifluoroacetyl ferrocene 183 was 
observed on addition of hydrogen peroxide with a 52±7% isolated yield obtained. The 
observed er was 15:85, which showed minimal erosion of the er compared to the original 
reaction. The reduction in yield compared to PL2 was attributed to a combination of 
several factors. Firstly, hydrogen peroxide and formic acid are known to react in situ to 
form performic acid, a strong oxidising agent.296 Even at small concentrations, this would 
reduce the amount of trigger molecule in the reaction, preventing complete ligand 
release. As both hydrogen peroxide and performic acid are oxidising agents, they may 
react with the ferrocene core degrading the substrate, lowering the yield obtained. The 
background reaction in the absence of hydrogen peroxide was around 14±6%, which is 
higher than the reactivity seen with R-PL2. Wanting to understand further if any ligand 
release was occurring in the absence of hydrogen peroxide, the background reaction 
mixture was analysed by ESI-MS with no corresponding ligand peak present. However, 
a peak was observed which corresponded to the protodeboronation by-product S-PL11. 
This was proposed to have been formed by ruthenium catalyst insertion into the C-B 
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bond, which followed by reductive elimination forms the protodeboronated proligand S-
PL11. 
Table 4-4 – Single Pseudo-Enantiomeric Results for S-PL3 and S-PL11 
 
 Substrate Ligand Trigger Conversiona 
(Isolated Yield) (%)b 
er (R:S)b,c 
1 183 S-PL3 H2O2 44 (52±7) 15:85±1 
2 183 S-PL3 - 14 (14±6) 18:82±2 
3 183 S-PL11 H2O2 28 (24) 19:81 
4 183 S-PL11 - 21 (20) 17:83 
5 192d S-PL3 H2O2 N/R - 
6 193d S-PL3 H2O2 83 (21) 95:5 
7 193d S-PL3 - 62 (17) 91:9 
Trifluoroacetyl ferrocene (0.125 mmol), [RuCl2(p-cymene)]2 (1 mol %), L (2 mol %), 
NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 0.5 mL), i-PrOH (0.5 mL), Hydrogen peroxide 
(100 eq.), 25 °C, air, 16h; Absolute stereochemistry of 188 not assigned, relative 
stereochemistry inferred from a comparable model system297 (a) determined via DPV; 
(b) error bars calculated as the standard deviation from 3 repeats; (c) er determined via 
HPLC, see ESI; (d) substrate (0.5 mmol), [RuCl2(p-cymene)]2  (2 mol %), [L] (4 mol %), 
NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 2 mL), i-PrOH (2 mL), TBAF in THF (1 M, 40 
mol %), 25 °C, air, 24h; (e) er determined from benzyl 2-hydroxypropanoate 194. 
To ascertain the potential reactivity of the protodeboronated proligand, S-PL11 
was synthesised in one step in a 41% yield from benzyl alcohol 198 and (S,S)-N-
TsDPEN, SS-81, (Scheme 4-9). The new proligand S-PL11 was tested under the 
optimised conditions, in the presence and the absence of hydrogen peroxide. In both 
cases, a similar level of conversion, and yield were observed, marginally higher than the 
background rate seen for S-PL3. The small difference in conversion was attributed to 
the protodeboronation requirement for S-PL3 to form the active ligand. This results in a 
lower concentration of S-PL11 in situ, compared to its direct addition, with a 
corresponding lower conversion observed. The observed er in the background reaction 
with S-PL3 and the two reactions with S-PL11 was consistent, supporting the proposed 




Scheme 4-9 – Synthetic route to S-PL11. 
Expanding the substrate scope beyond the ferrocene substrate, lower reactivity 
was also observed with sodium pyruvate 193, compared to with R-PL2, with a lower 1H 
NMR conversion of 83% recorded. As expected, the switch in enantioselectivity was 
achieved with a 95:5 er recorded. A significant increase in er was seen in the background 
rate at 91:9. The high er can be attributed to S-PL11 ligand acceleration. The background 
er observed with R-PL2 was significantly lower at 35:65. The reaction with acetophenone 
192 did not proceed, with no reactivity observed via 1H NMR. Considering the reactivity 
of hydrogen peroxide towards ketones, an alternative reactivity was proposed. The 
Baeyer-Villiger reaction converts aryl ketones into aryl esters, which under the basic 
conditions would hydrolyse to release the phenol 200 (Scheme 4-10).  
 
Scheme 4-10 – Proposed reactivity of acetophenone 192 with hydrogen peroxide. 
4.4.3 Alkaline Phosphatase Triggered Proligand S-PL10 
 
Scheme 4-11 – Single Pseudo-Enantiomer system with S-PL10. 
Using the optimised conditions, the incorporation of S-PL10 and ALP into a 
pseudo-enantiomer system was successful with the trifluoroacetyl ferrocene 183 
successfully reduced in an isolated yield of 77±4%. An er of 15:85 ±1 was observed. The 
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substrate exhibited a higher stability, with no ligand release observed in the background 
reaction when monitored via ESI-MS. A smaller background reactivity was observed with 
a conversion of 4% and a 1% isolated yield. With the reduced background reactivity, 
chiral HPLC data was not attainable on the small amount of product. The background 
reactivity is comparable to the metal hydrate hydrogenation discussed previously in 
section 4.3.1. Further exploration into a substrate scope was not conducted at this point, 
with ALP compatibility explored previously in the achiral system.151  
4.4.4 Proligand Orthogonality in the Single Pseudo-Enantiomer System 
The proligand orthogonality has been proven earlier in a simplified system, 
however, the transition to a more complex system necessitates the re-examination of 
their orthogonality in a single proligand system. Two dual pseudo-enantiomer systems 
were proposed. The first system incorporated the fluoride proligand, R-PL2, and the 
hydrogen peroxide proligand, S-PL3. The second system still used R-PL2 in concert with 
the alkaline phosphatase proligand S-PL10. Therefore, to confirm their orthogonality, the 
single pseudo-enantiomer systems were tested with the corresponding orthogonal 
trigger. 
In the first proposed system, the proligand R-PL2 remained stable when 
subjected to hydrogen peroxide as expected, with a reactivity consistent with the 
background reaction at 5% isolated yield (Scheme 4-12a). In contrast, S-PL3 exhibited 
an 18% yield in the presence of fluoride, a small increase on the 14% background 
reactivity. This increase in reactivity was attributed to an increase in the rate of 
protodeboronation. As discussed previously, fluoride is known to interact with boron, 
which would affect the rate of ruthenium insertion into the C-B bond. An increase in this 
insertion, or the corresponding reductive elimination, would lead to a higher 
concentration of S-PL11, which has been shown to have a higher reactivity compared to 
S-PL3. 
 





In the second proposed system, R-PL2 and S-PL10, the orthogonality was 
explored in the same fashion (Scheme 4-13). As expected, R-PL2 remained stable to 
ALP with a background conversion consistent with previous reactions at 5%. S-PL10 
proved orthogonal to fluoride, with negligible conversion observed at 2% and no isolated 
yield possible. The improved stability of S-PL10 compared to S-PL3 was consistent with 
the background rates observed previously.  
 
Scheme 4-13 – Orthogonality of R-PL2 and S-PL10 in the single pseudo-enantiomer 
system. 
4.4.5 Summary 
The successful investigation of the three proligands in the single pseudo-
enantiomer system was accomplished, with high yields and enantiomeric ratio 
maintained from the initial optimisation. R-PL2 and S-PL10 displayed excellent 
properties with low background rates observed. By comparison, S-PL3 had several 
limitations, with the undesired cross reactivity observed between substrate and hydrogen 
peroxide and the observed protodeboronation. However, despite these limitations, S-
PL3 was successfully incorporated. Furthermore, the exploration of the orthogonality of 
the proligands in the complex system displayed the potential for the development of both 
proposed dual pseudo-enantiomer systems: R-PL2 with S-PL3, and R-PL2 with S-PL10. 
Having achieved the desired goal of developing the asymmetric system, the next 





4.5 Dual Pseudo-Enantiomer System 
4.5.1 Fluoride Triggered Proligand R-PL2 and Hydrogen Peroxide Proligand S-
PL3 
Table 4-5 – Dual Pseudo-Enantiomeric Results for R-PL2 and S-PL3 
 




1 183 ✓ ✓ TBAF 99 (82±3) 81:19±1 
2 183 ✓ ✓ H2O2 36 (43±3) 22:78±0 
3 183 ✓ ✓ - 18 (17±9) 34:66±1 
4 193d ✓ ✓ TBAF 100 (51) 19:81e 
5 193d ✓ ✓ H2O2 89 (31) 84:16e 
6 193d ✓ ✓ - 79 (17) 78:22e 
Trifluoroacetyl ferrocene 183 (0.125 mmol), [RuCl2(p-cymene)]2 (1 mol %), L (2 mol %), 
NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 0.5 mL), i-PrOH (0.5 mL), TBAF in THF (1 M, 
20 mol %) and/or hydrogen peroxide (100 eq.), 25 °C, air, 16h; Absolute stereochemistry 
of 188 not assigned, relative stereochemistry inferred from a comparable model 
system293 (a) determined via DPV; (b) error bars calculated as the standard deviation 
from 2 repeats; (c) er determined via HPLC, see ESI; (d) substrate (0.5 mmol), [RuCl2(p-
cymene)]2  (2 mol %), L (4 mol %), NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 2 mL), i-
PrOH (2 mL), TBAF in THF (1 M, 40 mol %) and/or hydrogen peroxide (100 eq.), 25 °C, 
air, 24h; (e) er determined from benzyl 2-hydroxypropanoate 194. 
The first dual pseudo-enantiomer system trialled was the combination of R-PL2 
and S-PL3, with the results tabulated in Table 4-5. Pleasingly, with trifluoroacetyl 
ferrocene 183, the triggered release of R-PL2 was successful, with a high isolated yield 
maintained at 82±3%. A minimal erosion in er was recorded, however, this was expected 
with the side reactivity of S-PL3 towards protodeboronation. Disappointingly, the dual 
system exposes the limitation of S-PL3. A significant decrease in yield was observed on 
addition of hydrogen peroxide with a 43±3% isolated yield, with a similar drop in 
enantioselectivity. Furthermore, the background reactivity remained high, with a level 
consistent with the S-PL3 single system. With a change in substrate to sodium pyruvate, 
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a similar trend in results was observed. In general, a significant decrease in 
enantioselectivity was measured, and the background reactivity remained high as 
observed in the single pseudo-enantiomer system. The reactivity was not explored with 
acetophenone, due to the expected cross reactivity witnessed with hydrogen peroxide. 
Although the results were not optimal, several conclusions could be drawn from 
the first dual pseudo-enantiomer system. Firstly, the stability and consistency of R-PL2 
in the system, justifying the selection of fluoride as the first trigger. Secondly, that 
selective release of the proligands was obtainable, and an enantioselective system could 
be triggered externally. A switch in enantioselectivity was observed, dependent on the 
trigger, and high yields were possible. Encouraged by these observations, our attention 
turned to the second proposed system, R-PL2 and S-PL10. 
4.5.2 Fluoride Triggered Proligand R-PL2 and Alkaline Phosphatase Proligand S-
PL10 
With trifluoroacetyl ferrocene 183, the initial results looked promising (Table 4-6). 
The reduction was successfully triggered on addition of either TBAF or ALP, with 
complete conversion observed by DPV. Furthermore, the isolated yield remained 
consistently high at 80±3 and 83±0 for R-PL2 and S-PL10 respectively. In addition, the 
erosion in enantioselectivity witnessed in the previous dual system was not as severe. 
The er obtained for R-PL2 was 81:19 ±2, reduced from 87:13 ±1, and pleasingly, with S-
PL10 the enantioselectivity was maintained with an er of 14:86 ±2 compared to 15:85 ±2 
in the single pseudo-enantiomer system. The background rate also remained 
comparatively low at 7%, with a very small enantioselectivity observed of 54:46 ±2. 
 
Scheme 4-14 – Trigger compatibility of TBAF with ALP. 
Expanding the substrate scope to the two preferred substrates, acetophenone 
and sodium pyruvate, further demonstrated the compatibility of the two proligands. The 
reduction of acetophenone was achieved with good conversions for the triggered release 
of both R-PL2 and S-PL10 at 84 and 94% respectively. The background rate remained 
low, consistent with rates observed in the single pseudo-enantiomer system. The 
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enantioselectivity of the reduction was high at 95:5 ±1 on addition of TBAF, with a 
complete inversion in enantioselectivity observed on addition of ALP at 4:96 ±1. The 
results obtained for sodium pyruvate followed the same trend, with good conversion and 
excellent ers obtained for both TBAF and ALP. The high background rate remained in 
the sodium pyruvate reduction with a small enantioselectivity observed with an er of 
44:56 ±1 recorded.  
Table 4-6 – Dual Pseudo-Enantiomeric Results for R-PL2 and S-PL10 
 
 Substrate R-PL2 S-PL10 Trigger Conversion (Isolated 
Yield) (%)a,b 
er (R:S)b 
1 183 ✓ ✓ F 100 (80±3) 81:19±2 
2 183 ✓ ✓ ALP 100 (83±0) 14:86±2 
3 183 ✓ ✓ - 8 (7±1) 54:46±2 
4 183 ✓ ✓ F + ALP 100 (80) 19:81 
5 192d ✓ ✓ F 84 (39±6) 95:5±1 
6 192d ✓ ✓ ALP 94 (32±16) 4:96±1 
7 192d ✓ ✓ - 8 (N/A) - 
8 193d ✓ ✓ F 100 (16±3) 8:92±0e 
9 193d ✓ ✓ ALP 100 (11±3) 97:3±0e 
10 193d ✓ ✓ - 75 (32±4) 44:56±1e 
Trifluoroacetyl ferrocene 183 (0.125 mmol), [RuCl2(p-cymene)]2 (1 mol %), L (2 mol %), 
NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 0.5 mL), i-PrOH (0.5 mL), TBAF in THF (1 M, 
20 mol %) and/or ALP (1 mg), 25 °C, air, 16h; Absolute stereochemistry of 2 not 
assigned, relative stereochemistry inferred from a comparable model system293 (a) 
determined via DPV; (b) error bars calculated as the standard deviation from 3 repeats; 
(c) er determined via HPLC, see ESI; (d) substrate (0.5 mmol), [RuCl2(p-cymene)]2  (2 
mol %), L (4 mol %), NaOOCH (5 eq.), CO32- pH 9.2 (50 mM, 2 mL), i-PrOH (2 mL), 
TBAF in THF (1 M, 40 mol %) and/or ALP (1 mg), 25 °C, air, 24h; (e) er determined from 
benzyl 2-hydroxypropanoate 194. 
To help understand the difference in the change in enantioselectivity between 
addition of TBAF and ALP, the addition of both triggers was investigated. As expected, 
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the isolated yield was consistent, however, the er obtained was not, with an er of 19:81 
recorded. Considering the rate of triggered release observed in the previous chapter, S-
PL10 was considerably faster than R-PL2. Further testing of the triggered release 
elucidated that complete release of ligand SS-81 could be observed after 20 minutes for 
S-PL10. The faster release of ligand SS-81 would favour the enantioselectivity initially, 
but this preference would decrease overtime, and would not account fully for the er 
observed. Therefore, to test the compatibility of the two triggers in a single system, two 
control experiments were conducted utilising the single pseudo-enantiomeric system 
(Scheme 4-14). Each single system was subjected to addition of both triggers, and in 
both cases the high enantioselectivities were maintained, with a small erosion in yield 
observed. With the compatibility of the two triggers demonstrated in the single system, 





The aim of this project was to incorporate the pseudo-enantiomer proligands 
designed in the previous chapter into a stimuli responsive transfer hydrogenation system. 
An initial exploration of the developed proligand orthogonality led to the decision to trial 
a fluoride triggered proligand PL2, a hydrogen peroxide triggered proligand S-PL3, and 
an alkaline phosphatase triggered proligand S-PL10. Following a brief substrate screen 
and optimisation, the three proligands were then successfully incorporated into the 
stimuli responsive single pseudo-enantiomer system, with high yields and good 
enantioselectivities observed for trifluoroacetyl ferrocene. A small substrate screen was 
investigated, with R-PL2 and S-PL10 successfully triggered for the reduction of 
acetophenone and sodium pyruvate. Cross-reactivity issues limited the utility of S-PL3. 
The three proligands were then utilised in a stimuli-responsive dual pseudo-
enantiomer system, where the addition of one trigger would initiate one enantioselective 
reaction, and the addition of the second trigger turning on a different reaction with the 
opposite enantioselectivity. Limited success was achieved with R-PL2 and S-PL3, where 
high background and cross reactivity proved detrimental. However, the second system, 
R-PL2 and S-PL10, proved compatible, where high yields and good enantioselectivities 
observed in the equivalent single pseudo-enantiomer system were maintained for 
trifluoroacetyl ferrocene. Excellent enantioselectivity was observed with both sodium 
pyruvate and acetophenone, with moderate yields achieved for acetophenone. High 
background reactivity remained an issue for the reduction of sodium pyruvate. Across 
the three substrates, enantioselective control was feasible by addition of the correct 




4.7 Future Work 
The processes designed and developed throughout this project have potentially 
significant impact, where the understanding of complex artificial reaction systems 
containing multiple different reactivities and outcomes could lead to the development of 
molecular computers, nanomachines and artificial biological systems.  
Molecular computers require the use of logic gates, and each developed trigger 
exists as simple ‘yes/no’ logic gate, allowing for their combination to serve as the basis 
of a computing system. Simple systems that released transduction molecules could be 
used to compute complex problems, and the ability to switch on catalytic systems greatly 
improves the eventual detectable output. The further design of new trigger systems 
would allow for exponential growth in complexity, allowing for the possibility to perform 
multiple tandem processes to solve complex problems (Fig. 4-11). 
  
Figure 4-11 – Proposed logic gate processes: a) yes/no logic gate; b) and logic gate. 
The same progress in new triggers and catalytic cycles preclude the design of 
molecular machines, where having a series of different stimuli responsive systems in 
combination could be used to create new molecules in a controlled process similar to 
3D-printing, allowing for the synthesis of targeted structures in response to specific 
stimulus. This process has potential applications in the biomedical, biosensors and 
materials field. Biomedical molecular machines could be used for targeted drug delivery, 
that is tailored specifically to the patients in vivo conditions. Miniaturisations of the 
processes into an implant could have wide ranging potential to regulate both chronic and 
acute conditions. For example, devices could be implemented for insulin regulation in 
diabetics or platelet activation in haemophiliacs. Alternatively, responsive systems that 
facilitate targeted drug release could help to treat asymptomatic patients during bacterial 
and viral infections. The integrated biosensor-biomedical devices could be used to 
successfully diagnose and treat patients in resource limited environments.  
Having taken inspiration from nature, the stimuli responsive systems developed 
have potential applications in the design of artificial biological processes, such as 
photosynthesis and protein synthesis. The ability to mimic natural processes is of 
significant interest in an array of fields, from carbon dioxide capture, to biomedical 
purposes. As enzyme mimics, the stimuli responsive systems could be used to further 





5.1 General Information 
5.1.1 Instruments 
Proton and carbon nuclear magnetic resonance (NMR) spectra were recorded 
on an Agilent Technologies 500 MHz spectrometer (1H NMR at 500 MHz, 11B NMR at 
160 MHz, 13C NMR at 126 MHz, 19F NMR at 470 MHz and 31P NMR at 202.5 MHz), a 
Bruker 300 MHz spectrometer (1H NMR at 300 MHz and 13C NMR at 75.5 MHz) or a 
Bruker 400 MHz spectrometer (1H NMR at 400 MHz and 13C NMR at 101 MHz). Chemical 
shifts for protons are reported in parts per million downfield from tetramethylsilane and 
are referenced to residual protium in the solvent (1H NMR: CHCl3 at 7.26 ppm, CD2HOD 
at 3.31 ppm, H2O at 4.90 ppm, DMSO at 2.50 ppm and C6H6 at 7.16 ppm). Chemical 
shifts for boron are reported in parts per million downfield from boron trifluoride etherate 
and are uncorrected. Chemical shifts for carbons are reported in parts per million 
downfield from tetramethylsilane and are referenced to the carbon resonances of the 
solvent peak (13C NMR: CDCl3 at 77.0 ppm, CD3OD at 49.1, and C6D6 at 128.14). 
Chemical shifts for fluorine are reported in parts per million downfield from 
trichlorofluoromethane and are uncorrected. Chemical shifts for phosphorus’ are 
reported in parts per million downfield from 85% H3PO4 and are uncorrected. NMR data 
are represented as follows: chemical shift, integration, multiplicity (s = singlet, brs = broad 
singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of doublets, dt = 
doublet of triplets, ddt = doublet of doublets of triplets, dq = doublet of quartets, t = triplet, 
td = triplet of doublets, qd = quartet of doublets, m = multiplet), coupling constants (Hz), 
assignment. IR spectra were recorded on a Perkin-Elmer 1600 FT IR spectrophotometer, 
with absorbencies quoted as ν in cm-1. High resolution mass spectrometry was 
performed on a Bruker MaXis HD electrospray ionisation quadrupole time-of-flight (ESI-
QTOF) mass spectrometer or an Agilent 6545 quadrupole time-of-flight (QTOF) mass 
spectrometer. Melting points were obtained on an OptiMelt MPA100 automated melting 
point system. Electrochemical analysis was performed on a Metrohm Autolab 
PGSTAT30 potentiostat or a PalmSens Emstat3 Blue potentiostat. Analytical high 
performance liquid chromatography was performed on an Agilent 1260 Infinity Binary LC 
using a Chiralcel OJ, OD or OB-H column. Preparative flash chromatography was 
performed on a CombiFlash NextGen 300+ using RediSep® Rf preparative columns. 
5.1.2 Materials 
Analytical thin layer chromatography (TLC) were performed using aluminium-
backed plates coated with Alugram® SIL G/UV254 purchased from Macherey-Nagel and 
visualised by UV light (254 nm), vanillin, ninhydrin or potassium permanganate staining. 
Silica gel column chromatography was carried out using 60 Å, 200-400 mesh particle 
size silica gel purchased from Sigma-Aldrich. 
5.1.3 Chemicals 
All reactions were carried out under an ambient atmosphere, in oven-dried 
glassware unless otherwise stated. All water used was purified through a Merck Millipore 
reverse osmosis purification system prior to use. Anhydrous acetonitrile (MeCN), 
anhydrous dichloromethane (DCM), anhydrous tetrahydrofuran (THF) and anhydrous 
toluene were dried and degassed by passing through anhydrous alumina columns using 
an Innovative Technology Inc. PS-400-7 solvent purification system and stored under an 
atmosphere of nitrogen prior to use. Anhydrous EtOAc (EtOAc) and anhydrous N,N-
dimethylformamide (DMF) were purchased from Sigma-Aldrich and used as received. 
Triethylamine (TEA), purchased from Sigma-Aldrich, was dried over KOH pellets, and 
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distilled before being stirred under an atmosphere of nitrogen prior to use. β-
galactosidase from Aspergillus oryzae (8 DEA units mg-1) was purchased as a lyophilised 
solid from Sigma-Aldrich and stored in a -20 °C freezer. Prior to use a stock solution of 
the enzyme was prepared using 50 mM Tris buffer (pH 9) and stored at 4 °C until 
immediate use. Alkaline phosphatase from bovine intestinal mucosa (≥10 DEA units 
mg-1) was purchased as a lyophilised solid from Sigma-Aldrich and stored in a -20 °C 
freezer. -Chymotrypsin from bovine pancreas (≥40 DEA units mg-1) as a lyophilised 
solid from Sigma Aldrich and stored in -20 °C freezer. Manganese dioxide was activated 
before use by stirring in concentrated nitric acid, before filtering, washing, and drying. All 
substrates and reagents were used as received from commercial suppliers or prepared 
according to published procedures, respectively, unless otherwise stated. All buffers 
were freshly prepared according to previously published methods and carefully adjusted 




5.2 Data and supporting information for “Ratiometric Electrochemical 
Detection of β-Galactosidase” 
5.2.1 General information:  
Proton and carbon nuclear magnetic resonance (NMR) spectra were recorded 
on an Agilent Technologies 500 MHz spectrometer (1H NMR at 500 MHz and 13C NMR 
at 126 MHz). Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to residual protium in the solvent (1H NMR: CHCl3 
at 7.26 ppm, CD2HOD at 3.31 ppm, and C6H6 at 7.16 ppm). Chemical shifts for carbons 
are reported in parts per million downfield from tetramethylsilane and are referenced to 
the carbon resonances of the solvent peak (13C NMR: CDCl3 at 77.0 ppm, MeOH at 49.1, 
and C6H6 at 128.14). NMR data are represented as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, t = triplet, q = quartet, m = multiplet), coupling constants (Hz). IR spectra were 
recorded on a Perkin-Elmer 1600 FT IR spectrophotometer, with absorbencies quoted 
as ν in cm-1. High resolution mass spectrometry was performed on a Bruker MaXis HD 
electrospray ionisation quadrupole time-of-flight (ESI-QTOF) mass spectrometer. 
Melting points were obtained on a OptiMelt MPA100 automated melting point system. 
Electrochemical analysis was performed on a Metrohm Autolab PGSTAT30 potentiostat. 
Analytical thin layer chromatography (TLC) were performed using aluminium-backed 
plates coated with Alugram® SIL G/UV254 purchased from Macherey-Nagel and 
visualised by UV light (254 nm) and/or Vanillin staining. Silica gel column 
chromatography was carried out using 60 Å, 200-400 mesh particle size silica gel 
purchased from Sigma-Aldrich.  
5.2.2 Materials:  
All reactions were carried out under an atmosphere of nitrogen, in oven-dried 
glassware unless otherwise stated. Dichloromethane, tetrahydrofuran (THF) and toluene 
were dried and degassed by passing through anhydrous alumina columns using an 
Innovative Technology Inc. PS-400-7 solvent purification system and stored under an 
atmosphere of argon prior to use. D-galactose pentaacetate was purchased from 
Carbosynth. All other chemicals were purchased from Sigma-Aldrich. All other chemicals 
were used as received. β-galactosidase was purchased as a lyophilised solid from Sigma 
Aldrich and stored in a -20 °C freezer. Prior to use a stock solution of the enzyme was 
prepared using 50 mM Tris buffer (pH 9) and stored at 4 °C until immediate use. 
5.2.3 Electrochemical analysis:  
Electrochemical analysis was performed by applying a 10 µL sample to screen-
printed electrochemical cell equipped with carbon working and counter electrodes and a 
silver (pseudo Ag/AgCl) reference electrode. The potential across the cell was powered 
by a Metrohm Autolab PGSTAT30 potentiostat controlled by a laptop running General 
Purpose Electrochemical System (GPES) software in differential pulse mode 
(modulation = 0.04 s, interval = 0.1 s, initial voltage = −400 mV, end voltage = 600 mV, 
step potential = 3 mV, modulation amplitude 49.95 mV). Post-scan, a baseline correction 
(moving average: peak width = 0.03) was performed. Peak integrals were obtained using 
the ‘peak search’ function and conversions calculated using the equation: 
𝐶𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 (%) =  
(∫ 3)
(∫ 3+ ∫ 1)
 ×  100 
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5.2.4 Compound Data 
 (Per-(O)-acetyl--D-galactopyranosyl)-4-oxybenzaldehyde 
 
β-D-galactopyranose pentaacetate (3.90 g, 10 mmol, 1 eq.) was suspended in HBr (45 
% in AcOH, 10 mL) and acetic acid (5 mL) was added. The reaction was stirred for 1 h 
after which DCM (20 mL) and ice (20 g) were added. The organic layer was separated 
and the aqueous later was extracted with DCM (2 × 30 mL). The combined organic layers 
were washed with water (3 × 30 mL), sat. NaHCO3 (aq.) (30 mL), brine (20 mL), then dried 
over MgSO4 and the solvent was removed in vacuo. Purification via silica gel column 
chromatography (DCM 19:1 MeOH (Rf = 0.69)) gave the brominated intermediate as a 
pale-yellow oil (3.65 g, 89%).  
A solution of the intermediate (3.65 g) in acetone (20 mL) was added dropwise to a 
solution of 4-hydroxybenzaldehyde (2.44 g, 20 mmol, 2 eq.) in NaOH (aq.) (1 M, 20 mL) 
and the reaction was stirred for 20 h, after which DCM (20 mL) and water (20 mL) were 
added. The organic layer was separated, and the aqueous layer extracted with DCM (2 
 20 mL). The combined organic layers were washed with NaOH (aq.) (2  30 mL), water 
(20 mL), brine (20 mL), then dried over MgSO4 and the solvent was removed in vacuo. 
Purification via silica gel column chromatography (DCM 19:1 MeOH (Rf = 0.41)) gave the 
title compound as a pale-yellow oil. Trituration with ethanol gave the title compound as 
a white crystalline solid. (2.28 g, 50% over two steps). 
Mp; 117–118 °C (lit.1 115–117 °C) 
IR (solid cm-1); vmax 2984 (Ar-H), 1743 (C=O), 1692 (C=O), 1600, 1584, 1508, 1368, 1208, 
1159, 1041. 
1H NMR (500 MHz, CDCl3); 9.93 (1H, s, 11-H), 7.90–7.74 (2H, m, 9-H), 7.13–7.05 (2H, 
m, 8-H), 5.52 (1H, dd, J 10.4, 7.9 Hz, 2-H), 5.47 (1H, dd, J 3.5, 1.1 Hz, 4-H), 5.17 (1H, 
d, J 7.9 Hz, 1-H), 5.13 (1H, dd, J 10.4, 3.5 Hz, 3-H), 4.23 (1H, dd, J 11.1, 7.0 Hz, 6b-H), 
4.16 (1H, dd, J 11.2, 6.0 Hz, 6a-H), 4.12 (1H, ddd, J 7.0, 6.1, 1.1 Hz, 5-H), 2.18 (3H, s, 
COCH3), 2.06 (6H, m, 2 x COCH3), 2.02 (3H, s, COCH3). 
13C NMR (126 MHz, CDCl3); 190.6 (C11), 170.3 (1 x COCH3), 170.1 (1 x COCH3), 170.0 
(1 x COCH3), 169.3 (1 x COCH3), 161.3 (C7), 131.8 (C10), 131.8 (C9), 116.7 (C8), 98.6 
(C1), 71.3 (C5), 70.7 (C3), 68.4 (C2), 66.7 (C4), 61.3 (C6), 20.7 (COCH3), 20.6 (COCH3), 
20.6 (COCH3), 20.5 (COCH3). 





[4-(hydroxymethyl)phenyl]-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (2.30 g, 5.59 
mmol, 1 eq.) was added to CHCl3 (100 mL) and i-PrOH (40 mL) and then cooled to 0 °C. 
Sodium borohydride (0.423 g, 11.2 mmol, 2 eq.) was then added in one portion and the 
reaction allowed to warm to room temperature and stirred for 5 h, after which citric acid 
(100 mL, 10% in water) was added. The organic layer was separated, and the aqueous 
layer extracted with CHCl3 (2  30 mL). The combined organic layers were washed with 
sat. NaHCO3 (aq.) (30 mL), water (30 mL), brine (30 mL) then dried over MgSO4 and the 
solvent was removed in vacuo. Purification via silica gel column chromatography (Pet. 
40–60°C 1:1 EtOAc (Rf = 0.27)) gave the title compound as a colourless oil (1.74 g, 69%). 
Trituration with EtOH gave the title compound as a white crystalline solid. 
Mp; 113–116 °C (lit.1 100–112 °C). 
IR (solid cm-1); vmax 3558 (OH), 2924 (Ar-H), 1732 (C=O), 1520, 1371, 1213, 1061. 
1H NMR (500 MHz, CDCl3); 7.33–7.29 (2H, m, 9-H), 7.02–6.98 (2H, m, 8-H), 5.49 (1 H, 
dd, J 10.5, 8.0 Hz, 2-H), 5.46 (1H, dd, J 3.4, 1.2 Hz, 4-H), 5.11 (1H, dd, J 10.5, 3.4 Hz, 
3-H), 5.03 (1H, d, J 8.0 Hz, 1-H), 4.65 (2H, d, J 5.8 Hz, 11-H), 4.23 (1H, dd, J 11.4, 7.0 
Hz, 6-Ha), 4.16 (1H, dd, J 11.4, 6.4 Hz, 6-Hb), 4.08–4.04 (1H, m, 5-H), 2.18 (3H, s, 
COCH3), 2.07 (3H, s, COCH3), 2.06 (3H, s, COCH3), 2.01 (3H, s, COCH3), 1.60 (1H, t, J 
5.9 Hz, 11-OH). 
13C NMR (126 MHz, CDCl3); 170.5 (COCH3), 170.4 (COCH3), 170.2 (COCH3), 169.5 
(COCH3), 156.5, 136.1, 128.5 (C9), 117.1 (C8), 99.8 (C1), 71.1 (C5), 70.9 (C3), 68.8 
(C2), 67.0 (C4), 64.7 (C11), 61.4 (C6), 20.8 (COCH3), 20.7 (2 x COCH3), 20.7 (COCH3). 
Data in accordance with literature precedent.1 
 Ferrocenoyl azide 
 
Ferrocene carboxylic acid (2.00 g, 8.69 mmol, 1 eq.) was suspended in anhydrous DCM 
(20 mL) under N2 and then cooled to 0 °C. Oxalyl chloride (1.49 mL, 17.33 mmol, 2 eq.) 
was then added dropwise followed by a drop of DMF. The reaction was allowed to warm 
to room temperature and stirred for 3 h, after which the solvent was removed in vacuo. 
The solid residue was taken up in anhydrous DCM (20 mL) and cooled to 0 °C. 
Tetrabutylammonium bromide (30 mg, 0.09 mmol, 0.01 eq.) was added followed by 
sodium azide (0.85 g, 13.07 mmol, 1.5 eq.) in water (4 mL) and the reaction was left to 
stir for 48 h after which the reaction was diluted with water (50 mL) and the layers 
separated. The aqueous layer was extracted with DCM (2 x 20 mL) and the combined 
organic layers were dried over MgSO4 and the solvent removed in vacuo. Purification via 
silica gel column chromatography (Pet. 40–60°C 1:1 DCM (Rf = 0.45)) gave the title 
compound as a red-orange crystalline solid (1.98 g, 89%). 
Mp: 85-89 °C (lit.2 84-86 °C) 
IR (solid cm-1); vmax 3108, 3079, 2148 (N3), 1670 (C=O), 1453, 1372, 1206, 1184, 1054. 
1H NMR (500 MHz, C6D6); 4.74 (2H, t, J 2.0 Hz, Ar-H), 4.02 (2H, t, J 2.0 Hz, Ar-H), 3.91 
(5H, s, Cp-H). 
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13C NMR (126 MHz, C6D6); 176.3 (CO), 128.4 (Ar-C), 72.7 (Ar-C), 70.8 (Ar-C), 70.4 (Cp-
C). 
Data in accordance with literature precedent.2 
 4-((2,3,4,6-tetraacetyl--D-galactopyranosyl)oxy)benzyl (ferrocenyl)carbamate 
 
Ferrocenoyl azide (225 mg, 1 mmol, 1 eq.) was suspended in anhydrous toluene (2 mL) 
under argon. A solution of (per-(O)-acetyl-β-D-galactopyranosyl)-4-oxybenzyl alcohol 
(454 mg, 1 mmol, 1 eq.) in anhydrous toluene (2 mL) was added and the reaction refluxed 
for 2 h, after which the reaction was allowed to cool to room temperature and then the 
solvent was removed in vacuo. Purification via silica gel column chromatography (Pet. 
40–60°C 2:1 EtOAc (Rf = 0.18)) gave the title compound as an orange oil (531 mg, 78%). 
IR (film cm-1); vmax 3343 (NH), 2957 (C-H), 1745 (C=O), 1547, 1511, 1368, 1210, 1050. 
1H NMR (500 MHz, CDCl3); 7.32 (2H, d, J 8.2 Hz, 9-H), 7.00 (2H, d, J 8.2 Hz, 8-H), 5.72 
(2H, s, 15-H), 5.48 (1H, dd, J 10.5, 7.9 Hz, 2-H), 5.45 (1H, d, J 3.4 Hz, 4-H), 5.17–5.05 
(3H, m, 3-H, 11-H), 5.03 (1H, d, J 7.9 Hz, 1-H), 4.71 (2H, s, 16-H), 4.36–4.11 (7H, m, 6-
H, 17-H), 4.09–4.01 (1H, m, 5-H), 2.18 (3H, s, COCH3), 2.05 (6H, s, 2  COCH3), 2.01 
(3H, s, COCH3). 
13C NMR (126 MHz, CDCl3); 170.3 (COCH3), 170.2 (COCH3), 170.1 (COCH3), 169.3 
(COCH3), 156.9 (C12), 131.2 (C10), 129.9 (C9), 117.0 (C8), 99.6 (C1), 71.1 (C5), 70.8 
(C3), 69.6 (C17), 68.6 (C2), 66.8 (C4), 66.4 (C11), 64.8 (C16), 61.3 (C6), 60.7 (C15), 
20.7 (COCH3), 20.7 (COCH3), 20.6 (COCH3), 20.6 (COCH3). 
HRMS (ESI); calc’d for C32H35FeNO12 [M]+ : m/z 681.150, found 681.157. 
 4-((-D-galactopyranosyl)oxy)benzyl (ferrocenyl)carbamate 
 
4-((2,3,4,6-tetraacetyl-β-D-galactopyranosyl)oxy)benzyl (ferrocenyl)carbamate (531 mg, 
0.78 mmol, 1 eq.) was suspended in MeOH (10 mL). Sodium methoxide (210 mg, 3.9 
mmol, 5 eq.) was added in one portion and the reaction was stirred for 20 min, after 
which the reaction mixture was filtered. The filtrate was concentrated to give the title 
compound as an orange oil. Trituration with DCM gave the title compound as an orange 
crystalline solid. (239 mg, 60 %).  
Mp: 140-145 °C 
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IR (solid cm-1); vmax 3285 (OH), 2996 (C-H), 1770 (C=O). 
1H NMR (500 MHz, CD3OD); 8.55 (1H, s, 13-H), 7.34 (2H, d, J 8.2 Hz, 9-H), 7.11 (2H, d, 
J 8.2 Hz, 8-H), 5.07 (2H, s, 11-H), 4.87 (1H, d, J 7.9 Hz, 1-H), 4.46 (2H, s, 15-H), 4.09 
(5H, s, 17-H), 3.92 (2H, s, 16-H), 3.90 (1H, dd, J 3.4, 1.0 Hz, 4-H), 3.79 (1H, dd, J 9.7, 
7.9 Hz, 2-H), 3.77–3.71 (2H, m, 6-H), 3.68 (1H, ddd, J 6.8, 5.3, 1.1 Hz, 5-H), 3.57 (1H, 
dd, J 9.7, 3.4 Hz, 3-H). 
13C NMR (126 MHz, CD3OD); 159.0 (C7), 156.2 (C12), 132.0 (C10), 130.5 (C9), 117.7 
(C8), 102.8 (C1), 97.5 (C14), 76.9 (C5), 74.8 (C3), 72.2 (C2), 70.2 (C4), 70.0 (C17), 67.2 
(C11), 65.1 (C16), 62.4 (C6), 61.5 (C15). 
HRMS (ESI); calc’d for C24H27FeNO8 [M]+ : m/z 513.109, found 513.114. 
 Aminoferrocene 
 
Synthesised according to a literature procedure.3 
Mp: 149-152 °C (lit.3 151-153 °C) 
1H NMR (500 MHz, CDCl3); 4.11 (5H, s, Cp-H), 4.01 (2H, s, Ar-H), 3.86 (2H, s, Ar-H), 
2.56 (2H, brs, NH). 
13C NMR (126 MHz, CDCl3); 68.9 (Cp-C), 63.4 (Ar-C), 58.7 (Ar-C). 
 Per-(O)-acetyl--D-galactopyranosyl)-2-oxybenzaldehyde 
 
β-D-galactopyranose pentaacetate (780 mg, 2 mmol, 1 eq.) was suspended in HBr (45 
% in AcOH, 2 mL) and acetic acid (1 mL) was added. The reaction was stirred for 2 h 
after which DCM (10 mL) and ice (10 g) were added. The organic layer was separated 
and the aqueous later was extracted with DCM (2 × 10 mL). The combined organic layers 
were washed with water (3 × 10 mL), sat. NaHCO3 (aq.) (10 mL), brine (10 mL), then dried 
over MgSO4 and the solvent was removed in vacuo. Purification via silica gel column 
chromatography (DCM 19:1 MeOH (Rf = 0.68)) gave the brominated intermediate as a 
pale-yellow oil. 
A solution of the intermediate in DCM (4 mL) was added dropwise to a solution of 2-
hydroxybenzaldehyde (0.17 mL, 1.6 mmol, 0.8 eq.) and tetra-n-butylammonium bromide 
(516 mg, 1.6 mmol, 0.8 eq.) in NaOH (1 m, 4 mL) and the reaction was refluxed for 20 
h, after which the reaction was cooled to room temperature. DCM (10 mL) and water (10 
mL) were added. The organic layer was separated, and the aqueous layer extracted with 
DCM (2  20 mL). The combined organic layers were washed with HCl (aq.) (1 M, 10 mL), 
water (10 mL), NaOH (aq.) (1 M, 10 mL), brine (20 mL), then dried over MgSO4 and the 
solvent was removed in vacuo. Purification via silica gel column chromatography (Pet. 
40-60 °C 2:1 EtOAc) gave the title compound as a colourless oil (325 mg, 26 %). 
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IR (film cm-1); vmax 2971 (C-H), 1741 (C=O), 1600, 1483, 1368, 1212, 1039.  
1H NMR (500 MHz, CDCl3); 10.36 (1H, s, 13-H), 7.86 (1H, dd, J 7.5, 1.8 Hz, 11-H), 7.56 
(1H, ddd, J 8.3, 7.5, 1.8 Hz, 9-H), 7.18 (1H, td, J 7.5, 1.0 Hz, 10-H), 7.12 (1H, dd, J 8.3, 
1.0 Hz, 8-H), 5.59 (1H, dd, J 10.5, 7.9 Hz, 2-H), 5.48 (1H, dd, J 3.4, 1.1 Hz, 4-H), 5.16–
5.12 (2H, m, 1-H, 3-H), 4.24 (1H, dd, J 11.2, 6.9 Hz, 6-Ha), 4.16 (1H, dd, J 11.2, 6.2 Hz, 
6-Hb), 4.13–4.08 (1H, m, 5-H), 2.20 (3H, s, COCH3), 2.06 (6H, s, 2  COCH3), 2.02 (3H, 
s, COCH3). 
13C NMR (126 MHz, CDCl3); 189.2 (C13), 170.3 (COCH3), 170.1 (COCH3), 170.0 
(COCH3), 169.3 (COCH3), 158.8 (C7), 135.6 (C9), 128.3 (C11), 126.2 (C12), 123.5 
(C10), 115.8 (C8), 99.5 (C1), 71.3 (C5), 70.6 (C3), 68.4 (C2), 66.7 (C4), 61.2 (C6), 20.6 
(COCH3), 20.6 (COCH3), 20.6 (COCH3), 20.5 (COCH3). 
 [2-(hydroxymethyl)phenyl]-2,3,4,6-tetra-O-acetyl--D-galactopyranoside 
 
[2-(hydroxymethyl)phenyl]-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (289 mg, 0.64 
mmol, 1 eq.) was suspended in i-PrOH (20 mL) and heated to 50 °C and then cooled to 
room temperature. Sodium borohydride (24 mg, 0.64 mmol, 1 eq.) was then added in 
one portion and the reaction and stirred for 3 h, after which the reaction mixture was 
poured onto ice/water (10 mL) and pH adjusted to 6.5. The reaction mixture was 
extracted with CHCl3 (3  10 mL) and the combined organic layers were washed with 
water (2  20 mL), brine (10 mL) then dried over MgSO4 and the solvent was removed 
in vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 1:1 EtOAc) 
gave the title compound as a colourless oil (92 mg, 21 %). 
1H NMR (500 MHz, CDCl3); 7.33 (1H, dd, J 7.4, 1.7 Hz. 11-H), 7.30–7.25 (1H, m, 9-H), 
7.08 (1H, td, J 7.4, 1.0 Hz, 10-H), 7.02 (1H, dd, J 8.2, 1.0 Hz, 8-H), 5.52 (1H, dd, J 10.5, 
7.9 Hz, 2-H), 5.47 (1H, dd, J 3.5, 1.1 Hz, 4-H), 5.14 (1H, dd, J 10.5, 3.5 Hz, 3-H), 5.08 
(1H, d, J 7.9 Hz, 1-H), 4.68–4.56 (2H, m, 13-H), 4.22 (1H, dd, J 11.4, 7.2 Hz, 6-Ha), 4.16 
(1H, dd, J 11.4, 6.0 Hz, 6-Hb), 4.07 (1H, ddd, J 7.2, 6.0, 1.1 Hz, 5-H), 2.20 (3H, s, 
COCH3), 2.11 (3H, s, COCH3), 2.05 (3H, s, COCH3), 2.02 (3H, s, COCH3). 
13C NMR (126 MHz, CDCl3); 170.3 (COCH3), 170.2 (COCH3), 170.0 (COCH3), 169.9 
(COCH3), 154.8 (C7), 131.1 (C12), 129.6 (C11), 129.1 (C8), 123.6 (C9), 115.2 (C10), 
99.8 (C1), 71.1 (C5), 70.6 (C3), 68.7 (C2), 66.8 (C4), 61.3 (C6), 61.2 (C13), 20.8 
(COCH3), 20.6 (COCH3), 20.6 (COCH3), 20.5 (COCH3). 
 2-((2,3,4,6-tetraacetyl--d-galactopyranosyl)oxy)benzyl (ferrocenyl)carbamate 13 
 
Ferrocenoyl azide (45 mg, 0.2 mmol, 1 eq.) was suspended in anhydrous toluene (0.5 
mL) under argon. A solution of (per-(O)-acetyl-β-D-galactopyranosyl-2-oxybenzyl alcohol 
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(92 mg, 0.2 mmol, 1 eq.) in anhydrous toluene (0.5 mL) was added and the reaction 
refluxed for 2 h, after which the reaction was allowed to cool to room temperature and 
then the solvent was removed in vacuo. Purification via silica gel column chromatography 
(Pet. 40–60 °C 2:1 EtOAc) gave the title compound as an orange oil (101 mg, 74%). 
IR (film cm-1); 3323, 2881, 1678, 1552, 1416. 
1H NMR (500 MHz, CDCl3); 7.37–7.31 (1H, m, 11-H), 7.31–7.26 (1H, m, 9-H), 7.12–7.06 
(2H, m, 8-H, 10-H), 5.63 (2H, brs, Cp-H), 5.53 (1H, dd, J 10.3, 7.7 Hz, 2-H), 5.46 (1H, s, 
4-H), 5.20 (1H, d, J 12.8 Hz, 3-H), 5.15–5.01 (5H, m, 1-H, 13-H, Cp-H), 4.41 (5H, s, Cp-
H), 4.25 (1H, dd, J 11.4, 6.7 Hz, 6-Ha), 4.16 (1H, dd, J 11.4, 5.9 Hz, 6-Hb), 4.06 (1H, m, 
5-H), 2.19 (3H, s, COCH3), 2.11 (3H, s, COCH3), 2.06 (3H, s, COCH3), 2.02 (3H, s, 
COCH3). 
13C NMR (126 MHz, CDCl3); 170.4 (COCH3), 170.2 (COCH3), 170.1 (COCH3), 169.5 
(COCH3), 154.6 (C7), 129.5–129.3 (m, C9, C11), 126.5 (C12), 123.5 (C8), 115.7 (C10), 
99.9 (C1), 71.1 (C5), 70.7 (C3), 68.6 (C2), 66.8 (C4), 61.4 (C6, C13), 20.8 (COCH3), 20.7 
(COCH3), 20.6 (COCH3), 20.6 (COCH3). 
HRMS (ESI); calc’d for C32H36FeNO12 [M+H]+: m/z 682.158, found 682.166. 
 2-((-D-galactopyranosyl)oxy)benzyl (ferrocenyl)carbamate 
 
2-((2,3,4,6-tetraacetyl-β-D-galactopyranosyl)oxy)benzyl (ferrocenyl)carbamate (87 mg, 
0.13 mmol, 1 eq.) was suspended in MeOH (1 mL). Sodium methoxide (3 mg, 0.64 mmol, 
5 eq.) was added in one portion and the reaction was stirred for 1 h, after which the 
reaction mixture was filtered. The filtrate was concentrated to give an orange oil. 
Purification via silica gel column chromatography (DCM 9:1 MeOH (Rf = 0.38)) gave the 
title compound as an orange solid (50 mg, 76%). 
Mp: 160-163 °C 
IR (solid cm-1); 3568, 3287, 2879, 1679, 1608, 1552, 1499. 
1H NMR (500 MHz, CD3OD); 7.38 (1H, d, J 7.5 Hz, 11-H), 7.31–7.23 (2H, m, 8-H, 9-H), 
7.04 (1H, t, J 7.5 Hz, 10-H), 5.35–5.25 (2H, m, 13-H), 4.87 (1H, d, J 7.8 Hz, 1-H), 4.48 
(2H, s, Cp-H), 4.10 (5H, s, Cp-H), 3.93 (2H, t, J 2.0 Hz, Cp-H), 3.91 (1H, dd, J 3.4, 1.0 
Hz, 4-H), 3.86 (1H, dd, J 9.7, 7.8 Hz, 2-H), 3.78 (2H, qd, J 11.4, 6.0 Hz, 6-H), 3.69 (1H, 
ddd, J 6.8, 5.2, 1.0 Hz, 5-H), 3.59 (1H, dd, J 9.7, 3.4 Hz, 3-H). 
13C NMR (126 MHz, CD3OD); 156.9 (C7), 130.4 (C9), 129.9 (C11), 127.8 (C12), 123.4 
(C10), 116.8 (C8), 103.7 (C1), 77.1 (C5), 74.9 (C3), 72.4 (C2), 70.2 (C4), 70.0 (Cp), 65.1 
(Cp-C), 62.8 (C13), 62.5 (C6), 61.6 (Cp-C). 
HRMS (ESI); calc’d for C24H27FeNO8 [M]+: m/z 513.109, found 513.112. 
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5.2.5 Method for the electrochemical detection of -galactosidase (optimised 
conditions) 
 
A 10 mM stock solution of substrate 1 (5 mg) was prepared in DMSO (1 mL). A 1 mM 
stock solution of substrate 1 (100 L) was prepared using 50 mM pH 7 tris buffer (900 
L). To 800 µL of buffer (50 mM pH 7 tris buffer) in a small screw top vial equipped with 
a small magnetic stirrer was added 100 µL of the stock solution of 1 then 100 µL buffered 
(50 mM pH 7 tris buffer) solution of β-galactosidase. Every 3 minutes for 60 minutes 
thereafter, a 10 µL sample was subjected to electrochemical analysis. 
5.2.6 References 
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5.3 Data and supporting information for “An Organophosphorus(III)-
Selective Chemodosimeter for the Ratiometric Electrochemical 
Detection of Phosphines”  
5.3.1 General information:  
Proton and carbon nuclear magnetic resonance (NMR) spectra were recorded 
on an Agilent Technologies 500 MHz spectrometer (1H NMR at 500 MHz and 13C NMR 
at 126 MHz). Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to residual protium in the solvent (1H NMR: CHCl3 
at 7.26 ppm, and C6H6 at 7.16 ppm). Chemical shifts for carbons are reported in parts 
per million downfield from tetramethylsilane and are referenced to the carbon 
resonances of the solvent peak (13C NMR: CDCl3 at 77.0 ppm, and C6H6 at 128.14). 
NMR data are represented as follows: chemical shift, integration, multiplicity (s = singlet, 
d = doublet, t = triplet, m = multiplet, brs = broad singlet), coupling constants (Hz). IR 
spectra were recorded on a Perkin-Elmer 1600 FT IR spectrophotometer, with 
absorbencies quoted as ν in cm-1. High resolution mass spectrometry was performed on 
a Bruker MaXis HD electrospray ionisation quadrupole time-of-flight (ESI-QTOF) mass 
spectrometer. Melting points were obtained on an OptiMelt MPA100 automated melting 
point system. Electrochemical analysis was performed on a Metrohm Autolab 
PGSTAT30 potentiostat or a PalmSens Emstat3 Blue potentiostat. Analytical thin layer 
chromatography (TLC) were performed using aluminium-backed plates coated with 
Alugram® SIL G/UV254 purchased from Macherey-Nagel and visualised by UV light 
(254 nm). Silica gel column chromatography was carried out using 60 Å, 200-400 mesh 
particle size silica gel purchased from Sigma-Aldrich.  
5.3.2 Materials:  
All reactions were carried out under an atmosphere of nitrogen, in oven-dried 
glassware unless otherwise stated. Dichloromethane (DCM), and toluene were dried and 
degassed by passing through anhydrous alumina columns using an Innovative 
Technology Inc. PS-400-7 solvent purification system and stored under an atmosphere 
of nitrogen prior to use. 4-aminobenzyl alcohol was purchased from Alfa Aesar. 
Ferrocene carboxaldehyde was purchased from Fluorochem. All other chemicals were 
purchased from Sigma-Aldrich. All chemicals were used as received. 
5.3.3 Desktop Electrochemical analysis:  
Electrochemical analysis was performed by applying a 20 µL sample to screen-
printed electrochemical cell equipped with carbon working and counter electrodes and a 
silver (pseudo Ag/AgCl) reference electrode. The potential across the cell was powered 
by a Metrohm Autolab PGSTAT30 potentiostat controlled by a laptop running General 
Purpose Electrochemical System (GPES) software in differential pulse mode 
(modulation = 0.04 s, interval = 0.1 s, initial voltage = −400 mV, end voltage = 600 mV, 
step potential = 3 mV, modulation amplitude 49.95 mV). Post-scan, a baseline correction 
(moving average: peak width = 0.03) was performed. Peak integrals were obtained using 
the ‘peak search’ function and conversions calculated using the equation: 
𝐶𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 (%) =  
(∫ 4)
(∫ 4+ ∫ 1)
 ×  100 
5.3.4 Handheld Electrochemical analysis: 
Electrochemical analysis was performed by applying a 20 µL sample to screen-
printed electrochemical cell equipped with carbon working and counter electrodes and a 
silver (pseudo Ag/AgCl) reference electrode. The potential across the cell was powered 
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by a PalmSens Emstat3 Blue potentiostat controlled by a tablet using PS Touch in 
differential pulse mode (equilibration time = 0 s, initial voltage = -800 mV, end voltage = 
200 mV, step potential = 3 mV, pulse potential = 49.95 mV, pulse time = 0.1 s, scan rate 
= 0.015 V s-1). Currents were obtained using ‘peak search’ function and finding the 
maximum current. The currents were calibrated using Fig. S4 to obtain concentrations, 
and conversions calculated using the equation: 𝐶𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 (%) =  
[4]
([4] + [1])
 ×  100. 
5.3.5 Reaction optimization 
Table S1 – Reaction Optimisation 
 




PPh3 Eq. Conversion 
(%)a 
1 DMF 1:1 R.T. 10 37 
2 DMSO 1:1 R.T. 10 16 
3 Acetone 1:1 R.T. 10 48 
4 MeCN 1:1 R.T. 10 79 
5 THF 1:1 R.T. 10 34 
6 1,4-dioxane 1:1 R.T. 10 78 
7 MeCN 3:1 R.T. 10 78 
8 MeCN 1:3 R.T. 10 33b 
9 MeCN 3:1 R.T. 5 43 
10 MeCN 3:1 30 5 64 
11 MeCN 3:1 40 5 79 
12 MeCN 3:1 50 5 88 
Reaction conditions: Substrate 1 (1 mM), triphenylphosphine (V eq.), solvent:water X:Y 
(1 mL), Z °C (a) conversion determined from DPV after 60 minutes. (b) heterogeneous 
solution prevented accurate sampling. 
5.3.6 Complex Sample Testing 
 
 Complex Sample Preparation 
A 1 M stock solution with reference to 2-phenylpyridine was prepared from the crude 




• Unpurified 2-phenylpyridine, catalyst Pd(PPh3)4. 
• Purified 2-phenylpyridine, catalyst Pd(PPh3)4. 
• Unpurified 2-phenylpyridine, catalyst Pd(dba)2. 
• Purified 2-phenylpyridine, catalyst Pd(dba)2. 




Figure S4 - Conversion of substrate 1 (1 mM) to aminoferrocene 4 after addition of 
complex sample in acetonitrile:water (3:1, 1 mL) at 50 °C after 60 minutes . Error bars 
represent the standard deviation where n = 3. (1) Unpurified 2-phenylpyridine, catalyst 
Pd(PPh3)4; (2) Purified 2-phenylpyridine, catalyst Pd(PPh3)4; (3) Unpurified 2-
phenylpyridine, catalyst Pd(dba)2; (4) Purified 2-phenylpyridine, catalyst Pd(dba)2. 








Figure S5 - 31P NMR for Stock Solution 1-4 in CDCl3. (1) Unpurified 2-phenylpyridine, 
catalyst Pd(PPh3)4; (2) Purified 2-phenylpyridine, catalyst Pd(PPh3)4; (3) Unpurified 2-
phenylpyridine, catalyst Pd(dba)2; (4) Purified 2-phenylpyridine, catalyst Pd(dba)2. 
5.3.7 Compound Data 
 
Scheme S1 – Synthetic route to substrate 1 
 4-azidobenzyl alcohol 
 
4-aminobenzyl alcohol (319 mg, 2.6 mmol, 1 eq.) was dissolved in HCl (5 m, 1.25 mL) 
and cooled to 0 °C. A solution of sodium nitrite (207 mg, 3 mmol, 1.15 eq.) in water (5 
mL) was added dropwise over 15 mins, after which sodium azide (520 mg, 8 mmol, 3.1 
eq.) was added in portion wise over 30 mins. The reaction was stirred for 22 h at room 
temperature, after which the reaction was poured into sat. NaHCO3 (aq.) (20 mL). The 
aqueous layer was extracted with EtOAc (3  10 mL), and the combined organic layers 
were washed with water (10 mL), brine (10 mL), then dried over MgSO4 and the solvent 
was removed in vacuo. Purification via silica gel column chromatography (EtOAc 1:3 
Et2O (Rf = 0.74)) gave the title compound as a yellow solid (329 mg, 85 %). 
Mp; 29-33 °C (lit.1 28.5 °C)  
IR (film cm-1); vmax 3658, 3321, 2981, 2884, 2411, 2255, 2100 (N3), 1608, 1581, 1506, 
1460, 1419, 1280, 1024, 1010. 
1H NMR (500 MHz, CDCl3); 8.25–8.17 (2 H, m, 2-H), 7.56–7.48 (2 H, m, 3-H), 4.83 (2 H, 
s, 5-H). 
13C NMR (126 MHz, CDCl3); 139.3 (C4), 137.6 (C1), 128.5 (C2), 119.1 (C3), 64.6 (C5). 
Data in accordance with literature precedent.1 
 Ferrocenoyl azide 
 
Ferrocene carboxylic acid (2.00 g, 8.69 mmol, 1 eq.) was suspended in anhydrous DCM 
(20 mL) under N2 and then cooled to 0 °C. Oxalyl chloride (1.49 mL, 17.33 mmol, 2 eq.) 
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was then added dropwise followed by a drop of DMF. The reaction was allowed to warm 
to room temperature and stirred for 3 h, after which the solvent was removed in vacuo. 
The solid residue was taken up in anhydrous DCM (20 mL) and cooled to 0 °C. 
Tetrabutylammonium bromide (30 mg, 0.09 mmol, 0.01 eq.) was added followed by 
sodium azide (0.85 g, 13.07 mmol, 1.5 eq.) in water (4 mL) and the reaction was left to 
stir for 48 h after which the reaction was diluted with water (50 mL) and the layers 
separated. The aqueous layer was extracted with DCM (2 x 20 mL) and the combined 
organic layers were dried over MgSO4 and the solvent removed in vacuo. Purification via 
silica gel column chromatography (Pet. 40–60°C 1:1 DCM (Rf = 0.45)) gave the title 
compound as a red-orange crystalline solid (1.98 g, 89%). 
Mp: 85-89 °C (lit.2 84-86 °C) 
IR (solid cm-1); vmax 3108, 3079, 2148 (N3), 1670 (C=O), 1453, 1372, 1206, 1184, 1054. 
1H NMR (500 MHz, C6D6); 4.74 (2H, t, J 2.0 Hz, Ar-H), 4.02 (2H, t, J 2.0 Hz, Ar-H), 3.91 
(5H, s, Cp-H). 
13C NMR (126 MHz, C6D6); 176.3 (CO), 128.4 (Ar-C), 72.7 (Ar-C), 70.8 (Ar-C), 70.4 (Cp-
C). 
Data in accordance with literature precedent.2 
 4-azidobenzyl (ferrocenyl)carbamate 
 
Ferrocenoyl azide (225 mg, 0.88 mmol, 1 eq.) was suspended in anhydrous toluene (2 
mL) under argon. A solution of 4-azidobenzyl alcohol (149 mg, 1 mmol, 1.4 eq.) in 
anhydrous toluene (2 mL) was added and the reaction was refluxed for 2 h, after which 
the reaction was allowed to cool to room temperature. The solvent was in vacuo and 
purification via silica column chromatography (Pet. 40-60 °C 9:1 EtOAc (Rf = 0.22)) to 
give the title compound as an orange oil (298 mg, 90 %). 
IR (solid cm-1); vmax 3223, 3094, 2411, 2256, 2112, 2074 (N3), 1702 (C=O), 1507. 
1H NMR (500 MHz, CDCl3); 7.35 (2 H, d, J 8.0, 2-H), 7.03 (2 H, d, J 8.0, 3-H), 5.49 (1 H, 
brs, Cp-H), 5.18–4.68 (3 H, m, 5-H, Cp-H), 4.41 (7 H, brs, Cp(5)-H, Cp-H). 
13C NMR (126 MHz, CDCl3); 140.2 (C4), 133.1 (C1), 130.0 (C2), 119.3 (C3), 69.5 (Cp(5)-
C), 66.4 (Cp-C), 64.8 (C5), 60.9 (Cp-C). 
HRMS (ESI); calc’d for C18H16FeN4NaO2 [M+Na]+ : m/z 399.052, found 399.058. 
 Aminoferrocene 3 
 
Synthesised according to a literature procedure.3 
Mp: 149-152 °C (lit.3 151-153 °C) 
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1H NMR (500 MHz, CDCl3); 4.11 (5H, s, Cp-H), 4.01 (2H, s, Ar-H), 3.86 (2H, s, Ar-H), 
2.56 (2H, brs, NH). 
13C NMR (126 MHz, CDCl3); 68.9 (Cp-C), 63.4 (Ar-C), 58.7 (Ar-C). 
 2-Phenylpyridine 
 
i) To an oven dried carousel tube equipped with magnetic stirrer was added 
tetrakis(triphenylphosphine) palladium (0.072 g, 0.063 mmol, 1 eq.), potassium 
carbonate (1.74 g, 12.6 mmol, 2 eq.), phenyl boronic acid (1.02 g, 8.4 mmol, 1.33 eq.), 
2-bromopyridine (0.61 mL, 6.3 mmol, 1 eq.) and ethanol (5 mL). The vessel was 
evacuated and refilled with argon three times. The reaction mixture was heated to 100 
°C and stirred for 16 h. The reaction mixture was allowed to cool to room temperature 
and NaOH (aq.) (1 M, 20 mL) was added. The aqueous layer was extracted with EtOAc (3 
× 20 mL), and the combined organic layers were washed with brine (20 mL), dried over 
MgSO4 and the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 99:1 EtOAc) to give the title compound as colourless oil 
(0.714 g, 73 %). 
ii) To an oven dried carousel tube equipped with magnetic stirrer was added 
bis(dibenzylideneacetone) palladium (5.7 mg, 0.0063 mmol, 1 eq.), potassium carbonate 
(174 mg, 1.3 mmol, 2 eq.), phenyl boronic acid (102 mg, 0.84 mmol, 1.33 eq.), 2-
bromopyridine (0.06 mL, 0.63 mmol, 1 eq.) and ethanol (0.5 mL). The vessel was 
evacuated and refilled with argon three times. The reaction mixture was heated to 100 
°C and stirred for 16 h. The reaction mixture was allowed to cool to room temperature 
and NaOH (aq.) (1 M, 10 mL) was added. The aqueous layer was extracted with EtOAc (3 
× 10 mL), and the combined organic layers were washed with brine (10 mL), dried over 
MgSO4 and the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 99:1 EtOAc) to give the title compound as colourless oil 
(69.7 mg, 71 %). 
IR (film cm-1); vmax 3062, 1586, 1579, 1563, 1467, 1448, 1424. 
1H NMR (500 MHz, CDCl3); 8.70 (1H, dt, J 4.8, 1.4 Hz, Ar-H), 8.03–7.97 (2H, m, Ar-H), 
7.73–7.68 (2H, m, Ar-H), 7.51–7.45 (2H, m, Ar-H), 7.43–7.39 (1H, m, Ar-H), 7.23–7.16 
(1H, m, Ar-H). 
13C NMR (126 MHz, CDCl3); 157.5 (Ar-C), 149.7 (Ar-C), 139.4 (Ar-C), 136.8 (Ar-C), 129.0 
(Ar-C), 128.8 (Ar-C), 127.0 (Ar-C), 122.1 (Ar-C), 120.6 (Ar-C). 
5.3.8 Method for the desktop electrochemical detection of 




A 10 mM stock solution of substrate 1 (4 mg) was prepared in acetonitrile (1 mL). A 10 
mM stock solution of organophosphorus(III) compound was prepared in acetonitrile (1 
mL). To 250 µL of water and 550 µL of acetonitrile in a small screw top vial equipped 
with a small magnetic stirrer was added 100 µL of the stock solution of 1 then 100 µL of 
stock solution of organophosphorus(III) compound. The vial was then placed in a 
DrySyn® block warmed to 50 °C and stirred. Every 3 minutes for 60 minutes thereafter, 
a 10 µL sample was diluted in 90 µL tris buffer (pH 9, 50 mM), shaken well, and a 20 µL 
sample was subjected to desktop electrochemical analysis. 
5.3.9 Method for the handheld electrochemical detection of 
organophosphorus(III) compounds (optimised conditions) 
 
A 50 mM stock solution of substrate 1 (19 mg) was prepared in acetonitrile (1 mL). A 50 
mM stock solution of organophosphorus(III) compound was prepared in acetonitrile (1 
mL). To 250 µL of water and 350 µL of acetonitrile in a small screw top vial equipped 
with a small magnetic stirrer was added 200 µL of the stock solution of 1 then 200 µL of 
stock solution of organophosphorus(III) compound. The vial was then placed in a 
DrySyn® block warmed to 50 °C and stirred. Every 3 minutes for 60 minutes thereafter, 
a 10 µL sample was diluted in 90 µL tris buffer (pH 9, 50 mM), shaken well, and a 20 µL 
sample was subjected to handheld electrochemical analysis. 
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5.4 Design and Synthesis of Pseudo-Enantiomeric Proligands for Stimuli 
Responsive Asymmetric Catalysis 
5.4.1 General Procedure for Proligand Release. 
To a medium screw-top vial equipped with a magnetic flea was added PL (2.5 µmol, 2 
mol %), and dissolved in i-PrOH (0.5 mL) and carbonate buffer (pH 9.2, 50 mM, 0.5 mL). 
Trigger was added, and the reaction was stirred at 1000 rpm at room temperature for 1 
h. A 100 µL sample was taken after 1h and diluted in MeOH (900 µL) and shaken, and 
subjected to ESI-MS. 
5.4.2 -galactosidase proligand 
 Synthetic route to PL1 
 
 4-((2,3,4,6-tetraacetyl-β-D-galactopyranosyl)oxy)benzyl (2-(4-
methylphenyl)sulfonamido) 1,2-diphenylethyl)carbamate 103 
  
4-(hydroxymethyl)phenyl]-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (114 mg, 0.25 
mmol, 1 eq.) was dissolved in anhydrous EtOAc (1 mL) under N2 and cooled to 0 °C. 
Phosgene (0.13 mL, 20 wt. % in toluene) was added dropwise and then stirred for 1 h. 
The reaction was concentrated, and the residue taken up in anhydrous THF (2 mL) under 
N2 and cooled to 0 °C. (N)-tosyl diphenylethylenediamine (92 mg, 0.25 mmol, 1 eq.) was 
added and the reaction allowed to warm to room temperature. The reaction was stirred 
for 16 h, then sat. NaHCO3 (aq.) (10 mL) was added, followed by EtOAc (10 mL). The 
organic layer was separated, and the aqueous layer was extracted with EtOAc (2  10 
mL). The combined organic layers were washed with water (10 mL), brine (10 mL), dried 
over MgSO4 and then the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 7:3 EtOAc) gave the title compound as a colourless oil 
(77 mg, 37%). 
IR (film cm-1); vmax 3291 (Ar-H), 1685 (C=O), 1511, 1226, 1152, 1071, 1029. 
1H NMR (500 MHz, CDCl3); 7.41 (2H, d, J 7.8 Hz, Ar-H), 7.33–7.28 (2H, m, Ar-H), 7.17–
7.09 (3H, m, Ar-H), 7.06–6.89 (9H, m, Ar-H), 6.75 (2H, d, J 7.5, Ar-H), 6.01 (1H, t, J 10.1 
Hz, NH), 5.73 (1H, d, J 7.9 Hz, NH), 5.51–5.44 (2H, m, 2-H, 4-H), 5.13–5.09 (1H, m, 3-
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H), 5.07–5.02 (3H, m, 1-H, CH2), 4.88 (1 H, t, J 8.7 Hz, CHNH), 4.55 (1H, t, J 8.7 Hz, 
CHNH), 4.24–4.13 (2H, m, 6-H), 4.06 (1H, t, J 6.6 Hz, 5-H), 2.28 (3H, s, CH3), 2.17 (3H, 
s, COCH3), 2.05 (3H, s, COCH3), 2.04 (3H, s, COCH3), 2.01 (3H, s, COCH3). 
13C NMR (126 MHz, CDCl3 170.4 (COCH3), 170.3 (COCH3), 170.2 (COCH3), 169.5 
(COCH3), 156.9 (CO), 156.5 (Ar-C), 142.8 (Ar-C), 138.3 (Ar-C), 137.7 (Ar-C), 137.5 (Ar-
C), 136.1 (Ar-C), 131.2 (Ar-C), 129.8 (Ar-C), 129.2 (Ar-C), 128.5 (Ar-C), 128.5 (Ar-C), 
128.1 (Ar-C), 127.9 (Ar-C), 127.5 (Ar-C), 127.5 (Ar-C), 127.4 (Ar-C), 126.9 (Ar-C), 117.0 
(Ar-C), 117.0 (Ar-C), 99.8 (C-H), 99.6 (C-H), 71.1 – 71.0 (m, C-H), 70.9 (C-H), 68.8 (C-
H), 68.7 (C-H), 67.0 (C-H), 66.7 (C-H), 64.6 (C-H), 63.3 (C-H), 61.4 (C-H), 60.5–60.3 (m, 
C-H), 21.4 (COCH3), 20.8 (COCH3), 20.7 (COCH3), 20.6 (COCH3), 14.2 (CH3). 
HRMS (ESI); calc’d for C43H46N2NaO14S [M+Na]+ : m/z 869.256 found 869.269. 




methylphenyl)sulfonamido) 1,2-diphenylethyl)carbamate (67 mg, 0.08 mmol, 1 eq.) was 
suspended in MeOH (1 mL). Sodium methoxide (22 mg, 0.4 mmol, 5 eq.) was added in 
one portion and the reaction was stirred for 30 min, after which the reaction mixture was 
filtered. The filtrate was concentrated to give the title compound as a white solid (48 mg, 
88 %).  
Mp; 150–153 °C 
IR (film cm-1); vmax 3310 (OH), 1687 (C=O), 1534 (C-O), 1153, 1078, 1036. 
1H NMR (500 MHz, CD3OD); 7.34 (2 H, d, J 8.0, Ar-H), 7.26 (2 H, dd, J 11.1, 7.8, Ar-H), 
7.11–7.01 (7 H, m, Ar-H), 6.99–6.91 (5 H, m, Ar-H), 6.86 (2 H, d, J 7.4, Ar-H), 5.01 (1 H, 
d, J 12.5, 1-H), 4.94–4.89 (2H, m, CHNH, 2-H), 4.53 (1 H, t, J 4.6, CHNH), 3.92 (1 H, d, 
J 3.3, 4-H), 3.84–3.73 (4 H, m, CH2, 6-H), 3.68 (1 H, t, J 5.9, 5-H), 3.60 (1 H, dd, J 9.8, 
3.3, 3-H), 2.24 (3 H, s, CH3). 
13C NMR (126 MHz, CD3OD); 169.00 (CO), 161.81 (Ar-C), 142.16 (Ar-C), 138.74 (Ar-C), 
128.95 (Ar-C), 128.67 (Ar-C), 127.98 (Ar-C), 127.67 (Ar-C), 127.45 (Ar-C), 127.31 (Ar-
C), 127.10 (Ar-C), 126.79 (Ar-C), 126.61 (Ar-C), 126.38 (Ar-C), 116.31 (Ar-C), 101.47 
(C1), 75.47 (C-H), 73.41 (C-H), 70.88 (C-H), 68.81 (C-H), 63.43 (C-H), 62.91 (C-H), 
60.98 (C-H), 48.48 (C-H), 19.95 (CH3). 
HRMS (ESI); calc’d for C35H38N2NaO10S [M+Na]+ : m/z 701.214, found 701.217. 
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5.4.3 Fluoride Proligand 
 Synthetic route to PL2 
 
 4-((tert-butyldimethylsilyl)oxy)benzaldehyde 105 
 
4-hydroxybenzaldehyde (3.66 g, 30 mmol, 1 eq.) and triethylamine (6.3 mL, 45 mmol, 
1.5 eq.) were suspended in anhydrous DCM (50 mL) under N2. A solution of tert-
butyldimethylsilyl chloride (6.76 g, 45 mmol, 1.5 eq.) in anhydrous DCM (50 mL) was 
added dropwise over 30 min. The reaction was stirred at room temperature for 2 h, after 
which the reaction was quenched with water (100 mL). The organic layer was separated, 
and the aqueous layer extracted with DCM (3 × 100 mL). The combined organic layers 
were washed with water (150 mL), brine (100 mL), then dried over MgSO4, and the 
solvent was removed in vacuo. Purification via silica gel column chromatography (Pet. 
40–60 °C 9:1 EtOAc) gave the title compound as a colourless oil (6.14 g, 87%). 
IR (film cm-1); νmax 2956, 2931, 2859, 1697 (C=O), 1596, 1507, 1271, 1257, 1155. 
1H NMR (300 MHz, CDCl3); 9.85 (s, 1 H, 5-H), 7.79–7.68 (m, 2 H, 2-H), 6.94–6.87 (m, 2 
H, 3-H), 0.96 (s, 9 H, 8-H), 0.22 (s, 6 H, 6-H). 
13C NMR (75 MHz, CDCl3); 190.7 (C5), 161.4 (C1), 131.8 (C3), 130.4 (C4), 120.4 (C2), 
25.5 (C8), 18.2 (C7), -4.4 (C6). 
Data in accordance with literature precedent.298 
  (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol 106 
 
4-((tert-butyldimethylsilyl)oxy)benzaldehyde (6.00 g, 25.4 mmol, 1 eq.) was suspended 
in MeOH (125 mL) and cooled to 0 °C. Sodium borohydride (0.96 g, 25.4 mmol, 1 eq.) 
was added portion wise. The reaction was stirred at room temperature for 30 min, after 
which the reaction was cooled to 0 °C. The reaction was quenched with HCl (aq.) (1 M) 
and extracted with DCM (3 × 100 mL). The combined the organic layer were washed 
with brine (100 mL), then dried over MgSO4, and the solvent was removed in vacuo. 
Purification via silica gel column chromatography (Pet. 40–60 °C 4:1 EtOAc (Rf = 0.37)) 
gave the title compound as colourless oil (5.54 g, 92%). 
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IR (film cm-1); vmax 3352 br (OH), 2956, 2950, 2858, 1610, 1510, 1253, 915. 
1H NMR (300 MHz, CDCl3); 7.23–7.20 (m, 2 H, 2-H), 6.84–6.80 (m, 2 H, 3-H), 4.58 (s, 2 
H, 5-H), 0.99 (s, 9 H, 8-H), 0.20 (s, 6 H, 6-H). 
13C NMR (75 MHz, CDCl3); 155.2 (C1), 133.7 (C4), 128.5 (C2), 120.1 (C3), 65.0 (C5), 
25.7 (C8), 18.2 (C7), -4.4 (C6). 




Phosgene (2.6 mL, 20 wt. % in toluene) was stirred under N2 and cooled to 0 °C. tert-
butyldimethylsilyloxy benzyl alcohol (119 mg, 0.5 mmol, 1 eq.) was dissolved in toluene 
(2.5 mL) and added dropwise and then stirred for 2 h. The reaction was concentrated, 
and the residue taken up in anhydrous THF (4 mL) under N2 and cooled to 0 °C. (N)-
tosyl diphenylethylenediamine (183 mg, 0.5 mmol, 1 eq.) was added and the reaction 
allowed to warm to room temperature. The reaction was stirred for 16 h, and then sat. 
NaHCO3 (aq.) (20 mL) was added, followed by EtOAc (20 mL). The organic layer was 
separated and the aqueous layer was extracted with EtOAc (2 × 20 mL). The combined 
organic layers were washed with water (20 mL), brine (10 mL), dried over MgSO4, and 
then the solvent was removed in vacuo. Purification via silica gel column chromatography 
(Pet. 40–60 °C 3:2 EtOAc) gave the title compound as a white solid (56 mg, 18%). 
Mp; 97-103 °C. 
IR (solid cm-1); vmax 3288, 2954, 2931, 2858, 1683 (C=O), 1511, 1251, 1155. 
1H NMR (500 MHz, CDCl3); 7.44 (d, J = 7.9 Hz, 2H, 23-H), 7.23 (d, J = 7.9 Hz, 2H, 6-H), 
7.17–7.12 (m, 3H, 14-H, 20-H), 7.06–6.95 (m, 5H, 13-H, 15-H, 24-H), 6.92 (dd, J = 7.0, 
2.9 Hz, 2H, 19-H), 6.82 (d, J = 7.9 Hz, 2H, 5-H), 6.76 (d, J = 7.0 Hz, 2H, 18-H), 5.89 (d, 
J = 7.3 Hz, 1H, 21-H), 5.46 (d, J = 7.9 Hz, 1H, 10-H), 5.04 (s, 2H, 8-H), 4.86 (dd, J = 9.6, 
7.9 Hz, 1H, 11-H), 4.57 (dd, J = 9.6, 7.3 Hz, 1H, 16-H), 2.30 (s, 3H, 26-H), 0.98 (s, 9H, 
1-H), 0.19 (s, 6H, 3-H). 
13C NMR (126 MHz, CDCl3); 157.3 (C9), 156.0 (C4), 143.0 (C25), 138.0 (C12), 137.7 
(C22), 137.6 (C17), 130.1 (C6), 129.4 (C24), 128.9 (C7), 128.7 (C19), 128.2 (C14), 128.2 
(C15), 127.7 (C18), 127.6 (C20), 127.5 (C13), 127.0 (C23), 120.3 (C5), 67.4 (C8), 63.6 
(C16), 60.5 (C11), 25.8 (C1), 21.5 (C26), 18.4 (C2), -4.3 (C3). 






Phosgene (2 mL, 15 % in toluene) was suspended in toluene (2.5 mL) under N2 and 
cooled to 0 °C. (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol  (262 mg, 1.1 mmol, 1.1 
eq.) was dissolved in toluene (2.5 mL) and added dropwise. The reaction was allowed to 
warm to room temperature and then stirred for 2 h. The reaction was concentrated, and 
the residue taken up in anhydrous THF (8 mL) under N2 and cooled to 0 °C. (R,R)-(N)-
tosyl diphenylethylenediamine (366 mg, 1 mmol, 1 eq.) and triethylamine (0.1 mL) were 
added and the reaction allowed to warm to room temperature. The reaction was stirred 
for 16 h, then sat. NaHCO3 (aq.) (20 mL) was added, followed by EtOAc (20 mL). The 
organic layer was separated, and the aqueous layer was extracted with EtOAc (2  20 
mL). The combined organic layers were washed with water (20 mL), brine (10 mL), dried 
over MgSO4 and then the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc (Rf = 0.07)) gave the title compound as a 
white solid (240 mg, 38 %). 
Mp; 97-103 °C. 
IR (solid, cm-1); νmax 3295, 2955, 2931, 2858, 1689 (C=O), 1511, 1251, 1156. 
1H NMR (500 MHz, CDCl3);  7.43 (d, J = 7.9 Hz, 2H, 23-H), 7.25–7.20 (m, 2H, 6-H), 7.17–
7.12 (m, 3H, 14-H, 20-H), 7.05–6.91 (m, 7H, 13-H, 15-H, 19-H, 24-H), 6.82 (d, J = 7.9 
Hz, 2H, 5-H), 6.77 (d, J = 7.6 Hz, 2H, 18-H), 6.16 (d, J = 7.6 Hz, 1H, 21-H), 5.69 (d, J = 
7.7 Hz, 1H, 10-H), 5.03 (s, 2H, 8-H), 4.93–4.87 (m, 1H, 11-H), 4.58 (dd, J = 9.6, 7.7 Hz, 
1H, 16-H), 2.28 (s, 3H, 26-H), 0.99 (s, 9H, 1-H), 0.20 (s, 6H, 3-H). 
13C NMR (126 MHz, CDCl3); 157.2 (C9), 155.9 (C4), 142.9 (C25), 138.3 (C12), 137.8 
(C22), 137.6 (C17), 130.0 (C6), 129.3 (C24), 128.9 (C7), 128.6 (C19), 128.2 (C14), 128.0 
(C15), 127.6 (C18), 127.6 (C20), 127.5 (C13), 127.0 (C23), 120.2 (C5), 67.4 (C8), 63.5 
(C16), 60.5 (C11), 25.8 (C1), 21.5 (C26), 18.3 (C2), -4.3 (C3). 






Phosgene (2 mL, 15 % in toluene) was suspended in toluene (2.5 mL) under N2 and 
cooled to 0 °C. (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol  (262 mg, 1.1 mmol, 1.1 
eq.) was dissolved in toluene (2.5 mL) and added dropwise. The reaction was allowed to 
warm to room temperature and then stirred for 2 h. The reaction was concentrated, and 
the residue taken up in anhydrous THF (8 mL) under N2 and cooled to 0 °C. (S,S)-(N)-
tosyl diphenylethylenediamine (366 mg, 1 mmol, 1 eq.) and triethylamine (0.1 mL) were 
added and the reaction allowed to warm to room temperature. The reaction was stirred 
for 16 h, then sat. NaHCO3 (aq.) (20 mL) was added, followed by EtOAc (20 mL). The 
organic layer was separated, and the aqueous layer was extracted with EtOAc (2  20 
mL). The combined organic layers were washed with water (20 mL), brine (10 mL), dried 
over MgSO4 and then the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc (Rf = 0.07)) gave the title compound as a 
white solid (260 mg, 41 %). 
Mp; 97-103 °C. 
IR (solid, cm-1); νmax 3296, 2931, 1687 (C=O), 1511, 1251, 1155. 
1H NMR (500 MHz, CDCl3);  7.43 (d, J = 7.9 Hz, 2H, 23-H), 7.25–7.20 (m, 2H, 6-H), 7.17–
7.12 (m, 3H, 14-H, 20-H), 7.05–6.91 (m, 7H, 13-H, 15-H, 19-H, 24-H), 6.82 (d, J = 7.9 
Hz, 2H, 5-H), 6.77 (d, J = 7.6 Hz, 2H, 18-H), 6.16 (d, J = 7.6 Hz, 1H, 21-H), 5.69 (d, J = 
7.7 Hz, 1H, 10-H), 5.03 (s, 2H, 8-H), 4.93–4.87 (m, 1H, 11-H), 4.58 (dd, J = 9.6, 7.7 Hz, 
1H, 16-H), 2.28 (s, 3H, 26-H), 0.99 (s, 9H, 1-H), 0.20 (s, 6H, 3-H). 
13C NMR (126 MHz, CDCl3); 157.2 (C9), 155.9 (C4), 142.9 (C25), 138.3 (C12), 137.8 
(C22), 137.6 (C17), 130.0 (C6), 129.3 (C24), 128.9 (C7), 128.6 (C19), 128.2 (C14), 128.0 
(C15), 127.6 (C18), 127.6 (C20), 127.5 (C13), 127.0 (C23), 120.2 (C5), 67.4 (C8), 63.5 
(C16), 60.5 (C11), 25.8 (C1), 21.5 (C26), 18.3 (C2), -4.3 (C3). 
HRMS (ESI); calc’d C35H42N2NaO5SSi [M+Na]+: m/z: 653.247, found: 653.247. 
5.4.4 Hydrogen Peroxide Proligand 
 Synthetic route to S-PL3 
 
 4-(Hydroxymethyl)phenylboronic acid pinacol ester 113 
 
4-hydroxymethylphenyl boronic acid (1.52 g, 10 mmol, 1 eq.) was suspended in 
anhydrous THF (10 mL) in a flame dried flask with stirrer bar under N2. Pinacol (1.77 g, 
15 mmol, 1.5 eq.) and sodium sulfate (1.00 g) were added and the reaction stirred for 17 
h at room temperature. After which the reaction was filtered, concentrated and the 
residue taken up in EtOAc (20 mL). The organic layer was washed with water (3 × 20 
mL), and the combined organic layers washed with brine (20 mL), then dried over 
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MgSO4, and the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 4:1 EtOAc) gave the title compound as a white solid 
(1.53 g, 65 %). 
Mp; 75-77 °C (lit.144 75-77 °C) 
1H NMR (500 MHz, CDCl3); 7.82–7.79 (m, 2H, 4-H), 7.39–7.33 (m, 2H, 5-H), 4.70 (s, 2H, 
7-H), 1.34 (s, 12H, 1-H). 
13C NMR (126 MHz, CDCl3); 144.0 (C6), 135.0 (C4), 126.0 (C5), 83.8 (C2), 65.2 (C7), 
24.8 (C1). 
11B NMR (160 MHz, CDCl3); 30.9. 




Phosgene (15 % in toluene, 2 mL) was suspended in toluene (2.5 mL) under N2 and 
cooled to 0 °C. 4-(Hydroxymethyl)phenylboronic acid pinacol ester (258 mg, 1.1 mmol, 
1.1 eq.) was dissolved in toluene (2.5 mL) and added dropwise. The reaction was allowed 
to warm to room temperature and then stirred for 2 h. The reaction was concentrated, 
and the residue taken up in anhydrous THF (8 mL) under N2 and cooled to 0 °C. (S,S)-
(N)-tosyl diphenylethylenediamine (366 mg, 1 mmol, 1 eq.) and triethylamine (0.1 mL) 
were added and the reaction allowed to warm to room temperature. The reaction was 
stirred for 16 h, then sat. NaHCO3 (aq.) (20 mL) was added, followed by EtOAc (20 mL). 
The organic layer was separated, and the aqueous layer was extracted with EtOAc (2  
20 mL). The combined organic layers were washed with water (20 mL), brine (10 mL), 
dried over MgSO4 and then the solvent was removed in vacuo. Purification via silica gel 
column chromatography (Pet. 40–60 °C 9:1 EtOAc) gave the title compound as a white 
solid (311 mg, 50%). 
Mp; 83-87 °C. 
IR (solid, cm-1); νmax 3290, 2979, 1689 (C=O), 1360, 1322, 1144, 1088. 
1H NMR (500 MHz, CDCl3);  7.80 (2 H, d, J 7.2, 4-H), 7.42 (2 H, d, J 7.4, 22-H), 7.35 (2 
H, d, J 7.2, 5-H), 7.18–7.10 (3 H, m, 12-H, 14-H), 7.05–6.91 (7 H, m, 13-H, 18-H, 19-H, 
23-H), 6.76 (2 H, d, J 7.6, 17-H), 6.14 (1 H, d, J 7.8, 20-H), 5.85 (1 H, d, J 8.0, 9-H), 5.12 
(2 H, s, 7-H), 4.91 (1 H, dd, J 9.5, 8.0, 10-H), 4.60 (1 H, dd, J 9.5, 7.8, 15-H), 2.27 (3 H, 
s, 25-H), 1.35 (12 H, s, 1-H). 
13C NMR (126 MHz, CDCl3); 157.0 (C8), 142.9 (C24), 139.3 (C6), 138.3 (C11), 137.8 
(C21), 137.6 (C16), 135.1 (C4), 129.3 (C23), 128.6 (C14), 128.2 (C12), 128.0 (C3, C13), 
127.6 (C17), 127.6 (C19), 127.5 (C18), 127.3 (C5), 127.0 (C22), 83.9 (C2), 75.2, 67.3 
(C7), 63.3 (C15), 60.5 (C10), 25.0 (C1), 21.5 (C25). 
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11B NMR (160 MHz, CDCl3); 32.4. 
HRMS (ESI); calc’d C35H39BN2O6S [M]+: m/z: 627.270, found: 627.272. 
5.4.5 Peroxynitrite Proligand 
 Synthetic route to S-PL4 
 
 4-formylphenyl 4-bromobutanoate 115 
 
4-hydroxybenzaldehyde (1.22 g, 10 mmol, 1 eq.) was suspended in anhydrous DCM 
(100 mL) and cooled to 0 °C under N2. N,N'-dicyclohexylcarbodiimide (2.27 g, 11 mmol, 
1.1 eq.) and dimethylaminopyridine (0.12 g, 1 mmol, 1 eq.) were added. 4-bromobutyric 
acid (1.84 g, 11 mmol, 1.1 eq.) was added and the reaction allowed to warm to room 
temperature. The reaction was stirred for 16 h, after which NaOH (aq.) (2 M, 50 mL) was 
added and the organic layer was separated. The aqueous layer was extracted with DCM 
(2 × 50 mL), and the combined organic layers were washed with brine (50 mL), then 
dried over MgSO4, and the solvent was removed in vacuo. Purification via silica gel 
column chromatography (Pet. 40–60 °C 4:1 EtOAc) to give the title compound as a 
colourless oil (1.90 g, 70%). 
IR (film cm-1); vmax 2981, 2861, 2557, 1748 (C=O), 1683 (C=O), 1601, 1418, 1385, 1285, 
1137, 1110. 
1H NMR (500 MHz, CDCl3); 9.97 (1 H, s, 1-H), 7.93–7.87 (2 H, m 3-H), 7.30–7.24 (2 H, 
m 4-H), 3.53 (2 H, t, J 6.4. 7-H), 2.80 (2 H, t, J 7.2, 9-H), 2.32–2.23 (2 H, m, 8-H). 
13C NMR (126 MHz, CDCl3); 190.9 (C1), 170.5 (C6), 155.2 (C5), 134.1 (C2), 131.2 (C4), 
122.3 (C3), 32.6 (C9), 32.4 (C7), 27.5 (C8). 
Data in accordance with literature precedent.299 
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 4-(hydroxymethyl)phenyl 4-bromobutanoate 116 
 
4-formylphenyl 4-bromobutanoate (1.35 g, 5 mmol, 1 eq.) was dissolved in THF (50 mL) 
and cooled to 0 °C. Sodium borohydride (0.28 g, 7.5 mmol, 1.5 eq.) was added portion 
wise and the reaction allowed to warm to room temperature. The reaction was stirred for 
16 h, after which the solvent was removed in vacuo. Sat. NH4Cl (aq.) (20 mL) was added 
and extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with 
water (20 mL), brine (20 mL), then dried over MgSO4, and the solvent was removed in 
vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 3:2 EtOAc) gave 
the title compound as an off-white oil (0.75 g, 55%). 
1H NMR (500 MHz, CDCl3); 7.36 (2 H, d, J 8.5, Ar-H), 7.06 (2 H, d, J 8.5, Ar-H), 4.65 (2 
H, s), 3.53 (2 H, t, J 6.4, CH2CO), 2.77 (2 H, t, J 7.2, CH2Br), 2.34–2.20 (2 H, m, 
CH2CH2Br). 
Decomposition in solution prevented further NMR analysis. 
 4-(((((1S,2S)-2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamoyl)oxy)methyl)phenyl 4-bromobutanoate 117 
 
Phosgene (15 % in toluene, 2 mL) was cooled to 0 °C under N2.   A solution of 4-
(hydroxymethyl)phenyl 4-bromobutanoate  (300 mg, 1.1 mmol, 1.1 eq.) in anhydrous 
THF (5 mL) was added dropwise and stirred at room temperature for 16 h. After which 
the reaction was concentrated, and the residue taken up in anhydrous THF (8 mL). (S,S)-
(N)-tosyl diphenylethylenediamine (366 mg, 1 mmol, 1 eq.) and triethylamine (0.2 mL) 
were added and the reaction stirred at room temperature for 24 h. The reaction was 
quenched with sat. NaHCO3 (aq.) (20 mL) and EtOAc (20 mL) was added. The aqueous 
layer was extracted with EtOAc (2 × 20 mL), and the combined organic layers were 
washed with water (10 mL), brine (10 mL), dried over MgSO4, then the solvent was 
removed in vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 3:2 
EtOAc) to give the title compound as white solid (510 mg, 77%). 
Mp; > 77 °C (Decomposition) 
IR (film cm-1); vmax 3291 (Ar C-H), 1754 (C=O), 1686 (C=O), 1534 (C-O), 1509, 1199, 
1153. 
1H NMR (500 MHz, CDCl3); 7.42 (2 H, d, J 7.9, 24-H), 7.36 (2 H, d, J 7.6, 7-H), 7.18–
7.12 (3 H, m, 15-H, 16-H), 7.10–7.04 (2 H, m, 6-H), 7.04–6.91 (7 H, m, 14-H, 20-H, 21-
H, 25-H), 6.79–6.74 (2 H, m, 19-H), 6.18 (1 H, d, J 8.1, 22-H), 5.84 (1 H, d, J 8.0, 11-H), 
5.15–5.04 (2 H, m, 9-H), 4.92 (1 H, dd, J 9.0, 8.0, 12-H), 4.58 (1 H, t, J 9.0, 8.1, 17-H), 
3.54 (2 H, t, J 6.4, 1-H), 2.77 (2 H, t, J 7.2, 3-H), 2.33–2.26 (5 H, m, 2-H, 27-H). 
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13C NMR (126 MHz, CDCl3); 171.1 (C4), 157.0 (C10), 150.5 (C5), 143.0 (C23), 138.3, 
137.7 (C26), 137.6 (C18), 134.0 (C8), 129.9 (C13), 129.4 (C14), 129.3 (C7), 128.6 (C20), 
128.2 (C15), 128.0 (C16), 127.6 (C21), 127.6 (C25), 127.5 (C19), 126.9 (C24), 121.7 
(C6), 66.7 (C9), 63.4 (C17), 60.5 (C12), 32.7 (C1), 32.6 (C3), 27.7 (C2), 21.5 (C27). 





diphenylethyl)carbamoyl)oxy)methyl)phenyl 4-bromobutanoate (464 mg, 0.7 mmol, 1 
eq.) was dissolved in THF (10 mL). Trimethylamine (33% in EtOH, 0.83 mL) was added 
and the reaction was refluxed for 45 h. After which the reaction was concentrated, and 
the crude residue triturated in EtOAc. The precipitate was isolated and washed with 
EtOAc to give the title compound as a white solid (140 mg, 28%). 
Mp; > 60 °C (Decomposition) 
1H NMR (500 MHz, DMSO-d6); 8.22 (1 H, d, J 9.8, NH), 7.85 (1 H, d, J 9.6, NH), 7.30 (2 
H, d, J 8.2, Ar-H), 7.23–6.93 (16 H, m, Ar-H), 5.00–4.83 (3 H, m, CHNH, CH2Ar), 4.66 (1 
H, t, J 8.4, CHNH), 3.45–3.40 (2 H, m, CH2NMe3) 3.12 (9 H, s, N(CH3)3), 3.08 (3 H, s, 
CH3), 2.69 (2 H, q, J 6.7, 5.9, CH2COO), 2.06 (2 H, t, J 8.1, CH2CH2CH2). 
13C NMR (126 MHz, DMSO-d6); 170.8 (C=O), 155.5 (HNC=O), 149.8 (Ar-C), 141.6 (Ar-
C), 140.0 (Ar-C), 139.0 (Ar-C), 138.4 (Ar-C), 134.7 (Ar-C), 128.8 (Ar-CH), 128.7 (Ar-CH), 
127.8 (Ar-CH), 127.5 (Ar-CH), 127.2 (Ar-CH), 127.1 (Ar-CH), 126.8 (Ar-CH), 126.6 (Ar-
CH), 126.0 (Ar-CH), 121.7 (Ar-CH), 64.7 (ArCH2), 64.0 (CH2NMe3), 62.1 (CHNH), 59.8 
(CHNH), 52.4–51.8 (m, N(CH3)3, CH3), 30.3 (CH2COO), 17.9 (CH2CH2CH2). 
IR (film cm-1); vmax 3310, 3031, 1751 (C=O), 1689 (C=O), 1537 (C-O), 1509, 1479, 1456, 
1255, 1201, 1152, 1089, 1039. 
HRMS (ESI); C36H42N3O6S calc’d [M]+: m/z: 644.279, found: 644.280. 
5.4.6 Nucleophilic Base Proligand 







(S,S)-(N)-tosyl diphenylethylenediamine (366 mg, 1 mmol, 1 eq.) was suspended in 
water (1.5 mL) and p-dioxane (1.5 mL). 9-Fluorenylmethoxycarbonyl chloride (310 mg, 
1.2 mmol, 1.2 eq.) was added and the reaction stirred at 60 °C for 18 h. After which the 
reaction was filtered and washed with water. Double recrystallisation of the precipitate 
from ethanol afforded the title compound as a white solid (133 mg, 23%). 
Mp; >120 °C (Decomposition) 
IR (film cm-1); vmax 3309, 3033, 1688 (C=O), 1528 (C-O), 1316, 1245, 1223, 1040. 
1H NMR (500 MHz, CDCl3); 7.76 (d, J = 7.4 Hz, 2H, 22-H), 7.60 (t, J = 5.2 Hz, 2H, 25-
H), 7.46 (d, J = 7.8 Hz, 2H,4-H), 7.39 (t, J = 7.4 Hz, 2H, 23-H), 7.35–7.28 (m, 2H, 24-H), 
7.16 (s, 3H, 14-H, 16-H), 7.10–6.93 (m, 7H, 3-H, 10-H, 11-H, 15-H), 6.77 (d, J = 7.4 Hz, 
2H, 9-H), 5.77 (d, J = 6.7 Hz, 1H, 6-H), 5.71 (d, J = 8.2 Hz, 1H, 17-H), 4.91 (t, J = 8.2 
Hz, 1H, 12-H), 4.58 (dd, J = 8.2, 6.7 Hz, 1H, 7-H), 4.46 (t, J = 8.6 Hz, 1H, 19-Ha), 4.40–
4.30 (m, 1H, 19-Hb), 4.29–4.18 (m, 1H, 20-H), 2.28 (s, 3H, 1-H). 
13C NMR (126 MHz, CDCl3); 144.0 (C21), 143.9 (C18), 143.2 (C2), 141.4 (C13), 141.4 
(C26), 138.1 (C5), 129.4 (C3), 128.7 (C15), 128.3 (C14), 128.1 (C11), 127.8 (C10), 127.8 
(C23), 127.5 (C16), 127.5 (C9), 127.3 (C8), 127.3 (C24), 127.1 (C4), 125.3 (C25), 120.1 
(C22), 67.5 (C19), 63.3 (C7), 60.5 (C12), 47.3 (C20), 21.5 (C1). 
HRMS (ESI); calc’d C36H32N2NaO4S [M+Na]+: m/z: 611.198, found: 611.198. 
5.4.7 Hydrazine Proligand 








Phthalic anhydride (74 mg, 0.5 mmol, 1 eq.) and (S,S)-(N)-tosyl diphenylethylenediamine 
(183 mg, 0.5 mmol, 1 eq.) were suspended in acetic acid (1 mL) and refluxed for 1 h. 
After which the reaction was poured into ice/water, then filtered to give the title compound 
as a white compound (90.1 mg, 36%). 
Mp; 239–245 °C 
IR (film cm-1); vmax 3262, 1709 (C=O), 1317, 1152. 
1H NMR (500 MHz, CDCl3); 7.76 (2 H, dd, J 5.4, 3.1, 19-H), 7.68 (2 H, dd, J 5.4, 3.1, 20-
H), 7.43 (2 H, d, J 8.0, 4-H), 7.36 (2 H, dd, J 7.7, 2.0,14-H), 7.16 – 7.12 (3 H, m, 15-H, 
16-H), 7.10 – 7.03 (5 H, m, 9-H, 10-H, 11-H), 6.95 (2 H, d, J 8.0, 3-H), 5.86 (1 H, d, J 
9.3, 6-H), 5.73 (1 H, d, J 9.3, 12-H), 5.66 (1 H, t, J 9.3, 7-H), 2.27 (3 H, s, 1-H).  
13C NMR (126 MHz, CDCl3); 168.6 (C17), 142.8 (C2), 138.3 (C8), 137.9 (C5), 135.5 
(C13), 134.2 (C20), 131.6 (C18), 129.3 (C3), 129.0 (C14), 128.6 (C10), 128.5 (C15), 
128.1 (C16), 127.8 (C11), 127.1 (C4), 127.0 (C9), 123.6 (C19), 59.4 (C12), 58.5 (C7), 
21.6 (C1).  
HRMS (ESI); calc’d C29H25N2O4S [M+H]+: m/z: 479.150, found: 479.153. 
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5.4.8 -Chymotrypsin Proligands 
 Synthetic route to S-PL7 
 
 Benzoyl-L-tyrosine 133 
 
L-tyrosine methyl ester hydrogen chloride (4.00 g, 17.3 mmol, 1 eq.) was dissolved in 
water (72 mL) and diethyl ether (60 mL). Sodium carbonate (5.50 g, 52 mmol, 3 eq.) and 
benzoyl chloride (2 mL, 17.3 mmol, 1 eq.) were added and the reaction stirred for 30 
min. After which the ether layer was separated and washed with brine (10 mL), dried 
over MgSO4, then the solvent was removed in vacuo. The intermediate was taken up in 
MeOH (70 mL), and sodium hydroxide (2.8 g, 70 mmol, 4 eq.) was added. The reaction 
was stirred at room temperature for 3 h, after which the reaction was acidified to pH 2-3 
with conc. HCl. EtOAc (100 mL) and water (100 mL) were added and the organic layer 
was separated. The aqueous layer was extracted with EtOAc (2 × 30 mL) and the 
combined organic layers washed with water (50 mL), brine (20 mL), then dried over 
MgSO4 and the solvent was removed in vacuo to give the title compound as a colourless 
oil (4.72 g, 95%). 
IR (film cm-1); vmax 3301 (OH), 1712 (C=O), 1535, 1513, 1238. 
1H NMR (500 MHz, DMSO); 12.66 (1 H, s, 9-H), 9.17 (1 H, s, 1-H), 8.61 (1 H, d, J 8.2, 
10-H), 7.80 (2 H, d, J 7.8, 13-H), 7.52 (1 H, t, J 7.8, 15-H), 7.45 (2 H, t, J 7.8), 7.10 (2 H, 
d, J 8.2, 4-H), 6.65 (2 H, d, J 8.2, 3-H), 4.53 (1 H, ddd, J 10.0, 8.2, 4.4, 7-H), 3.07 (1 H, 
dd, J 13.9, 4.5, 6-Ha), 2.95 (1 H, dd, J 13.9, 10.5, 6-Hb). 
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13C NMR (126 MHz, DMSO); 173.3 (C8), 166.3 (C11), 155.8 (C2), 134.0 (C12), 131.3 
(C15), 130.0 (C4), 128.2 (C14), 128.2 (C5), 127.3 (C13), 115.0 (C3), 54.6 (C7), 35.5 
(C6). 
Data in accordance with literature precedent.162 
 (S)-2-benzamido-3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propanoic acid 134 
 
Benzoyl-L-tyrosine (3.50 g, 12.2 mmol, 1 eq.) was dissolved in DMF (25 mL). tert-
Butyldimethylsilyl chloride (4.07 g, 27 mmol, 2.2 eq.) and imidazole (3.68 g, 54 mmol, 
4.4 eq.) were added and the reaction stirred at room temperature for 64 h. After which 
diethyl ether (100 mL) was added and the mixture washed with water (50 mL). The 
aqueous layer was extracted with diethyl ether (3 × 50 mL), and the combined organic 
layers washed with water (2 × 50 mL), sat. LiCl (aq.) (2 × 50 mL), brine (50 mL), dried over 
MgSO4, then the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 2:1 EtOAc) gave the title compound as an orange foam 
(2.32 g, 48%). 
IR (film cm-1); vmax 3337 (OH), 3284 (OH), 1709 (C=O), 1638 (C=O), 1535 (C-O), 1516 
(C-O), 1228, 1257, 1017. 
1H NMR (500 MHz, CDCl3); 9.86 (1 H, s, 11-H), 7.68 (2 H, d, J 7.5, 15-H), 7.50 (1 H, t, J 
7.5, 17-H), 7.40 (2 H, t, J 7.5, 16-H), 7.05 (2 H, d, J 8.0, 6-H), 6.76 (2 H, d, J 8.0, 5-H), 
6.70 – 6.61 (1 H, m, 12-H), 5.05 (1 H, t, J 5.6, 9-H), 3.31 (1 H, dd, J 14.2, 5.6, 8-Hb), 3.20 
(1 H, dd, J 14.2, 5.6, 8-Ha), 0.97 (9 H, s, 1-H), 0.17 (6 H, s, 3-H). 
13C NMR (126 MHz, CDCl3); 175.3 (C10), 167.8 (C13), 155.0 (C4), 133.6 (C14), 132.1 
(C15), 130.6 (C6), 128.8 (C16), 128.4 (C7), 127.2 (C15), 120.5 (C5), 53.8 (C9), 36.6 
(C8), 25.8 (C1), 18.3 (C2), -4.3 (C3). 




(S)-2-benzamido-3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propanoic acid (1.20 g, 3 
mmol, 1 eq.) was dissolved in DMF (5 mL). N,N′-Dicyclohexylcarbodiimide (680 mg, 3.3 
mmol, 1.1 eq.) followed by hydroxybenzotriazole (446 mg, 3.3 mmol, 1.1 eq.) were 
added. The benzyl alcohol solution was added to a solution of 4-aminobenzyl alcohol 
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(388 mg, 3.15 mmol, 1.05 eq.) and triethylamine (0.42 mL, 3 mmol, 1 eq.) in DMF (5 mL). 
The reaction was stirred at room temperature for 16 h 30, after which the reaction was 
filtered and washed with EtOAc (30 mL). The organic layer was washed with water (20 
mL), and the aqueous layer extracted with EtOAc (2 × 20 mL). The combined organic 
layers were washed with water (3 × 20 mL), sat. LiCl (aq.) (20 mL), brine (20 mL), dried 
over MgSO4, then the solvent was removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 4:1 EtOAc to Pet. 40–60 °C 1:1 EtOAc) to give the title 
compound as an orange foam (639 mg, 42%). 
IR (film cm-1); vmax 3272, 2931, 2858, 1635 (C=O), 1606 (C=O), 1537 (C-O), 1509, 1251. 
1H NMR (500 MHz, CDCl3); 8.59 (1 H, s, 17-H), 7.74 (1 H, d, J 6.9, 13-H), 7.50 (1 H, t, J 
7.5, 15-H), 7.40 (2 H, dd, J 7.5, 6.9, 14-H), 7.36 (2 H, d, J 8.5, 19-H), 7.24–7.18 (3 H, m, 
20-H, 10-H), 7.11 (2 H, d, J 8.4, 6-H), 6.72 (2 H, d, J 8.4, 5-H), 5.06 (1 H, q, J 7.4, 9-H), 
4.60 (2 H, s, 22-H), 3.22 (1 H, dd, J 13.8, 6.6, 8-Hb), 3.15 (1 H, dd, J 13.8, 7.7, 8-Ha), 
0.94 (9 H, s, 1-H), 0.13 (6 H, s, 3-H). 
13C NMR (126 MHz, CDCl3); 169.7 (C16), 167.8 (C11), 154.9 (C4), 137.2 (C21), 137.0 
(C18), 133.6 (C12), 132.1 (C15), 130.5 (C5), 129.2 (C7), 128.8 (C13), 127.8 (C20), 127.3 
(C14), 120.5 (C20), 120.4 (C6), 65.0 (C22), 55.9 (C9), 38.0 (C8), 25.8 (C1), 18.3 (C2), -
4.3 (C3). 




Phosgene (15 % in toluene, 1 mL) under N2 was cooled to 0 °C. (S)-N-(3-(4-((tert-
butyldimethylsilyl)oxy)phenyl)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-
yl)benzamide (253 mg, 0.5 mmol, 1 eq.) was dissolved in anhydrous EtOAc (2.5 mL) and 
added dropwise. The reaction was allowed to warm to room temperature and then stirred 
for 6 h. The reaction was concentrated, and the residue taken up in anhydrous DCM (4 
mL) under N2 and cooled to 0 °C. (N)-(S,S)-tosyl diphenylethylenediamine (183 mg, 0.5 
mmol, 1 eq.) and sodium carbonate (64 mg, 0.6 mmol, 1.2 eq.) were added and the 
reaction allowed to warm to room temperature. The reaction was stirred for 16 h, then 
sat. NaHCO3 (aq.) (20 mL) was added, followed by EtOAc (20 mL). The organic layer was 
separated, and the aqueous layer was extracted with EtOAc (2  20 mL). The combined 
organic layers were washed with water (20 mL), brine (10 mL), dried over MgSO4 and 
then the solvent was removed in vacuo. Purification via silica gel column chromatography 
(Pet. 40–60 °C 1:1 EtOAc) gave the intermediate compound as a colourless oil (115 mg, 





The intermediate (115 mg, 0.13 mol, 1 eq.) was suspended in THF (1 mL). 
Tetrabutylammonium fluoride (1 M in THF, 0.25 mL, 0.25 mol, 2 eq.) was added and the 
reaction was stirred at room temperature for 5 min. After which EtOAc (10 mL) and water 
(10 mL) were added. The organic layer was separated, and the aqueous layer extracted 
with EtOAc (2 × 10 mL). The combined organic layers were washed with brine (10 mL), 
dried over MgSO4, then the solvent was removed in vacuo. Purification via silica gel 
column chromatography (Pet. 40–60 °C 3:2 EtOAc) to give the title compound as a white 
solid (81 mg, 80%, 21% over two steps). 
Mp; >200 °C (Decomposition) 
IR (film cm-1); vmax 3300 (OH), 1628 (C=O), 1528 (C-O), 1512 (C-O), 1324, 1149, 1090. 
1H NMR (500 MHz, CDCl3); 8.61 (1 H, s, OH), 8.45 (1 H, s, NH), 7.82 (2 H, d, J 7.6, Ar-
H), 7.55 (1 H, d, J 7.8, NH), 7.51–7.44 (1 H, m, Ar-H), 7.40–7.30 (4 H, m, Ar-H), 7.20 (2 
H, d, J 9.6, Ar-H), 7.12 (4 H, d, J 6.5, Ar-H), 7.00 (5 H, m, Ar-H), 6.90 (4 H, d, J 7.3, Ar-
H), 6.79 (2 H, d, J 7.6, Ar-H), 6.76–6.71 (2 H, m, Ar-H), 6.71–6.63 (2 H, m, Ar-H), 6.31 
(1 H, m, NH), 5.19–5.07 (2 H, m, CH2), 5.03–4.93 (1 H, m, CH2CH), 4.84 (1 H, t, J 11.1, 
CHNH), 4.59 (1 H, t, J 9.0, CHNH), 3.22–3.07 (2 H, m, CH2CH), 2.23 (3 H, s, CH3). 
13C NMR (126 MHz, CDCl3); 142.1 (Ar-C), 132.0 (Ar-C), 130.5 (Ar-C), 129.9 (Ar-C), 129.2 
(Ar-C), 128.7 (Ar-C), 128.5 (Ar-C), 128.1 (Ar-C),128.0 (Ar-C), 127.5 (Ar-C), 127.4 (Ar-C), 
127.3 (Ar-C), 127.1 (Ar-C), 126.8 (Ar-C), 120.3 (Ar-C), 115.9 (Ar-C), 66.7, 63.4 (CHNH), 
60.4 (CHNH), 56.2 (CHCH2), 38.1 (CH2CH), 21.3 (CH3). 
HRMS (ESI); calc’d C45H42N4NaO7S [M+Na]+: m/z: 805.267, found: 805.266. 
 Synthetic route to S-PL8 
 
 Benzoyl-L-phenylalanine 138 
 
L-phenylalanine (1.65 g, 10 mmol, 1 eq.) was dissolved in NaOH (aq.) (2 M, 11 mL) and 
cooled to 0 °C. Benzoyl chloride (1.6 mL, 10 mmol, 1 eq.) was added dropwise, and the 
reaction allowed to warm to room temperature and stirred for 2 h. After which the pH was 
adjusted to 5-6 with conc. HCl. The precipitate was filtered and washed with water to 
give the title compound as a white solid (0.742 g, 28%). 
Mp; 138–142 °C (lit.300 137–138 °C) 
IR (film cm-1); vmax 3289, 1707 (C=O), 1635 (C=O), 1523, 1270, 1242. 
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1H NMR (500 MHz, DMSO-d6); 12.79 (1 H, s, 8-H), 8.72 (1 H, d, J 8.1, 9-H), 7.82 (2 H, 
d, J 7.3, 12-H), 7.51 (1 H, t, J 7.3, 14-H), 7.45 (2 H, t, J 7.3, 13-H), 7.34 (2 H, d, J 7.4, 3-
H), 7.27 (2 H, t, J 7.4, 2-H), 7.18 (1 H, t, J 7.4, 1-H), 4.66 (1 H, ddd, J 10.6, 8.1, 4.4, 6-
H), 3.22 (1 H, dd, J 13.8, 4.4, 5-Hb), 3.10 (1 H, dd, J 13.8, 10.6, 5-Ha). 
13C NMR (126 MHz, DMSO-d6); 173.2 (COOH), 166.4 (Ar-CO), 138.2 (Ar-C), 134.0 (Ar-
C), 131.4 (Ar-CH), 129.1 (Ar-CH), 128.3 (Ar-CH), 128.2 (Ar-CH), 127.4 (Ar-CH), 126.4 
(Ar-CH), 54.3 (CH), 36.3 (CH2). 




Benzoyl-L-phenylalanine (134 mg, 0.5 mmol, 1 eq.) was suspended in anhydrous DCM 
(5 mL) under N2. Hydroxybenzotriazole (74 mg, 0.55 mmol, 1.1 eq.) was added and the 
reaction stirred for 10 min. N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (105 mg) was added and stirred for 15 min. After which N,N-
diisopropylethylamine (0.26 mL, 1.5 mmol, 3 eq.) and (S,S)-(N)-tosyl 
diphenylethylenediamine (183 mg, 0.5 mmol, 1 eq.) were added and the reaction stirred 
for 16 h. After which sat. NaHCO3 (aq.) (10 mL) was added, and the organic layer 
separated. The aqueous layer was extracted with DCM (2 × 10 mL), and the combined 
organic layers were washed 1M HCl (aq.) (10 mL), sat. NaHCO3 (aq.) (10 mL), brine (10 
mL), then dried over MgSO4, and the solvent was removed in vacuo. Purification via 
silica column chromatography (Pet. 40–60 °C 1:1 EtOAc) to give the title compound as 
an off-white solid (50 mg, 16%). 
Mp; 200–203 °C. 
IR (film cm-1); vmax 3289, 3030, 2924, 1706 (C=O), 1635, 1523, 1242. 
1H NMR (500 MHz, DMSO-d6); 8.60 (1 H, d, J 9.1, NH), 8.43 (1 H, d, J 8.6, NH), 8.27 (1 
H, d, J 9.2, NH), 7.80 (2 H, d, J 7.6, Ar-H), 7.52 (1 H, t, J 7.3, Ar-H), 7.46 (2 H, t, J 7.5, 
Ar-H), 7.29–7.13 (7 H, m, Ar-H), 7.13–7.07 (3 H, m, Ar-H), 7.05–6.96 (6 H, m, Ar-H), 
6.93–6.87 (3 H, m, Ar-H), 5.11 (1 H, t, J 8.0, ArCHNH), 4.87–4.77 (1 H, m, CHNH), 4.69 
(1 H, t, J 8.0, ArCHNH), 2.95 (1 H, dd, J 13.7, 5.3, CHH), 2.86 (1 H, dd, J 13.7, 9.7, 
CHH), 2.23 (3 H, s, CH3). 
13C NMR (126 MHz, DMSO-d6); 170.6 (C=O), 165.9 (C=O), 141.6 (Ar-C), 139.5 (Ar-C), 
138.8 (Ar-C), 138.3 (Ar-C), 137.9 (Ar-C), 134.1 (Ar-C), 131.2 (Ar-CH), 129.1 (Ar-CH), 
128.8 (Ar-CH), 128.1 (Ar-CH), 128.0 (Ar-CH), 127.7 (Ar-CH), 127.5–127.3 (m, Ar-CH), 
127.0 (Ar-CH), 126.7 (Ar-CH), 126.5 (Ar-CH), 126.2 (Ar-CH), 126.0 (Ar-CH), 61.6 
(ArCHNH), 57.3 (ArCHNH), 54.6 (CHNH), 37.2 (CH2), 20.8 (CH3). 
HRMS (ESI); calc’d C37H35N3NaO4S [M+Na]+: m/z: 640.225, found: 640.223. 
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 Synthetic route to S-PL9 
 
 tert-Butyldimethylsilyl 3,5-bis((tert-butyldimethylsilyl)oxy)benzoate 148 
 
3,5-dihydroxybenzoic acid (3.02 g, 20 mmol, 1 eq.) and imidazole (4.77 g, 70 mmol, 3.5 
eq.) were suspended in DMF (50 mL) under N2. tert-Butyldimethylsilyl chloride (10.5 g, 
70 mmol, 3.5 eq.) was added and the reaction stirred at room temperature for 19 h. After 
which the reaction was diluted with DCM (150 mL) and washed with water (50 mL). The 
aqueous layer was extracted with DCM (2 × 50 mL), and the combined organic layers 
were washed with aq. sat. LiCl (aq.) (3 × 100 mL), brine (2 × 50 mL), then dried over 
MgSO4, and the solvent was removed in vacuo. Purification via silica gel column 
chromatography (DCM) gave the title compound as a colourless oil (6.27 g, 63%). 
IR (film cm-1); vmax 2957, 2931, 2887, 1697 (C=O), 1589, 1340, 1253, 1166. 
1H NMR (500 MHz, CDCl3); 7.14 (2 H, d, J 2.3, 6-H), 6.53 (1 H, t, J 2.3, 5-H), 1.02 (9 H, 
s, 11-H), 0.98 (18 H, s, 1-H), 0.37 (6 H, s, 9-H), 0.21 (12 H, s, 3-H). 
183 
 
13C NMR (126 MHz, CDCl3); 166.3 (C8), 156.7 (Ar-C), 133.3 (Ar-C), 117.2 (Ar-C), 115.1 
(Ar-C), 25.8 (C1), 25.7 (C11), 18.4 (C2), 17.9 (C10), -4.3 (C3), -4.7 (C9). 
Data in accordance with literature precedent.301 
 3,5-bis((tert-butyldimethylsilyl)oxy)benzoic acid 149 
 
tert-Butyldimethylsilyl 3,5-bis((tert-butyldimethylsilyl)oxy)benzoate (6.27 g, 12.6 mmol, 1 
eq.) was suspended in THF:water:acetic acid (5:1:4, 100 mL) and stirred for 20 h at room 
temperature. After which the solvent was removed in vacuo, and the crude residue taken 
up in DCM (50 mL). The organic layer was washed with water (50 mL), and the aqueous 
layer extracted with DCM (2 × 50 mL). The combined organic layers were washed with 
brine (50 mL), then dried over MgSO4, and the solvent was removed in vacuo. 
Purification via silica gel column chromatography (DCM) gave the title compound as a 
white solid (3.59 g, 75 %). 
Mp; 188–190 °C. 
IR (film cm-1); vmax 2929 (OH), 2857, 1687 (C=O), 1590 (C-O), 1330, 1167. 
1H NMR (500 MHz, CDCl3); 7.19 (2 H, d, J 2.3, 6-H), 6.57 (1 H, t, J 2.3, 5-H), 0.99 (18 
H, s, 1-H), 0.22 (12 H, s, 3-H). 
13C NMR (126 MHz, CDCl3); 171.3 (C8), 156.8 (C4), 131.0, 117.9, 115.2, 25.8 (C1), 18.4 
(C2), -4.3 (C3). 
Data in accordance with literature precedent.301 
 2,5-dioxopyrrolidin-1-yl 3,5-bis((tert-butyldimethylsilyl)oxy)benzoate 150 
 
3,5-bis((tert-butyldimethylsilyl)oxy)benzoic acid (1.29 g, 3.4 mmol, 1 eq.), N,N'-
dicyclohexylcarbodiimide (0.70 g, 3.4 mmol, 1 eq.), and N-hydroxysuccinimide (0.39 g, 
3.4 mmol, 1 eq.) were suspended in 1,4-dioxane (20 mL) under N2 and stirred at room 
temperature for 16 h. After which the reaction was filtered and the solvent removed in 
vacuo to give the title compound as a white solid (0.77 g, 47%). 
Mp; 93–95 °C. 




1H NMR (500 MHz, CDCl3); 7.20 (2 H, d, J 2.3, 6-H), 6.61 (1 H, t, J 2.3, 5-H), 0.98 (18 
H, s, 1-H), 0.21 (12 H, s, 3-H). 
13C NMR (126 MHz, CDCl3); 169.3 (C=O), 161.8 (C=O), 157.1 (Ar-C), 126.6 (Ar-C), 
118.9 (Ar-C), 115.5 (Ar-C), 25.8 (C1), 18.3 (C2), -4.3 (C3). 
HRMS (ESI); calc’d C23H38NO6Si2 [M+H]+: m/z: 480.220, found: 480.223. 
 2,5-dioxopyrrolidin-1-yl (tert-butoxycarbonyl)-L-phenylalaninate 152 
 
L-phenylalanine (3.30 g, 20 mmol, 1 eq.) was suspended in 1,4-dioxane (50 mL) and aq. 
NaOH (50 mL, 2 M) and cooled to 0 °C and stirred for 15 min. After which di-tert-butyl 
dicarbonate (5.46 g, 25 mmol, 1.25 eq.) and warmed to room temperature. The reaction 
was stirred for 3 h, after which the reaction was concentrated. The residue was acidified 
to pH ~2–3 and extracted with DCM (3 × 50 mL). The combined organic layers were 
washed with brine (50 mL), dried over MgSO4, and then the solvent was removed in 
vacuo to give (tert-butoxycarbonyl)-L-phenylalanine as a white solid. 
N-Boc-L-phenylalanine (5.30 g, 20 mmol, 1 eq.), and N-hydroxysuccinimide (2.30 g, 20 
mmol, 1 eq.) were suspended in dimethoxyethane (30 mL) under N2 and added dropwise 
to a stirring solution of N,N'-dicyclohexylcarbodiimide (4.12 g, 20 mmol, 1 eq.) in 
dimethoxyethane (30 mL). The reaction was stirred at room temperature for 30 min, after 
which the reaction was cooled in the freezer for 16 h. The reaction was filtered, and the 
filtrate concentrated. Recrystallisation (i-PrOH) gave the title compound as a white solid 
(5.20 g, 72%). 
Mp; 147–150 °C. 
IR (film cm-1); vmax 3384, 2979, 2935, 1733 (C=O), 1704 (C=O), 1518 (C-O), 1208, 1160, 
1064, 1045. 
1H NMR (500 MHz, CDCl3); 7.35–7.25 (5 H, m, Ar-H), 5.01–4.83 (1 H, m, CHNH), 4.65 
(1 H, d, J 26.2, NH), 3.31 (1 H, dd, J 14.2, 5.8, ArCHH), 3.18 (1 H, dd, J 14.2, 6.1, 
ArCHH), 2.84 (4 H, s, CH2CH2), 1.41 (9 H, s, C(CH3)3). 
13C NMR (126 MHz, CDCl3); 168.7 (C=O), 167.8 (C=O), 154.7 (Ar-C), 134.8 (Ar-C), 
129.8 (Ar-C), 128.8 (Ar-C), 127.5 (Ar-C), 80.6 (CMe3), 52.8 (CHNH), 38.3 (Ar-CH2), 28.3 
(CH3), 25.7 (CH2CH2). 






2,5-dioxopyrrolidin-1-yl (tert-butoxycarbonyl)-L-phenylalaninate (724 mg, 2 mmol, 2 eq.) 
was suspended in THF (15 mL) under N2. (S,S)-(N)-tosyl diphenylethylenediamine (366 
mg, 1 mmol, 1 eq.) in THF (5 mL) was added and the reaction was heated to 50 °C and 
stirred for 4 h. After which the solvent was removed in vacuo, and the residue taken up 
in EtOAc (20 mL). The organic layer was washed with water (10 mL), and the aqueous 
layer extracted with EtOAc (2 × 10 mL). The combined organic layers were washed with 
brine (10 mL), dried over MgSO4, and then the solvent was removed in vacuo. 
The intermediate was taken up in DCM:TFA (4:1, 5 mL) and stirred at room temperature 
for 1 h. After which the reaction was diluted with sat. NaHCO3 (aq.) (15 mL) and extracted 
with CHCl3 (3 × 10 mL). The combined organic layers were washed with brine (10 mL), 
dried over MgSO4 and the solvent was removed in vacuo to give the title compound as 
a white solid (342 mg, 67%). 
Mp; 184–186 °C. 
IR (film cm-1); vmax 3308, 3063, 3032, 2981, 2927, 1648 (C=O), 1514 (C-O), 1495, 1455, 
1322, 1154, 1089. 
1H NMR (500 MHz, CDCl3); 8.37 (1 H, d, J 8.4, 5-H), 7.45 (2 H, d, J 8.3, Ar-H), 7.28–
7.24 (2 H, m, Ar-H), 7.23–7.17 (7 H, m, Ar-H), 7.05–6.99 (5 H, m, Ar-H, 2-H), 6.98–6.94 
(2 H, m, Ar-H), 6.92–6.88 (2 H, m, Ar-H), 5.25 (1 H, dd, J 10.4, 8.4, 4-H), 4.65 (1 H, d, J 
10.4, 3-H), 3.80 (1 H, dd, J 9.7, 3.8, 6-H), 3.26 (1 H, dd, J 13.8, 3.8, 7-Ha), 2.64 (1 H, dd, 
J 13.8, 9.7, 7-Hb), 2.27 (3 H, s, 1-H). 
13C NMR (126 MHz, CDCl3); 176.1 (C=O), 142.7 (Ar-C), 138.5 (Ar-C), 138.4 (Ar-C), 138.2 
(Ar-C), 137.8 (Ar-C), 129.4 (Ar-C), 129.2 (Ar-C), 128.8 (Ar-C), 128.6 (Ar-C), 128.1 (Ar-
C), 127.9 (Ar-C), 127.7 (Ar-C), 127.7 (Ar-C), 127.5 (Ar-C), 126.9 (Ar-C), 126.8 (Ar-C), 
64.1 (C3), 58.9 (C4), 56.4 (C6), 40.6 (C7), 21.5 (C1). 







phenylpropanamide (342 mg, 0.67 mmol, 1 eq.) and 2,5-dioxopyrrolidin-1-yl 3,5-bis((tert-
butyldimethylsilyl)oxy)benzoate (450 mg, 0.94 mmol, 1.5 eq.) were suspended in THF 
(10 mL) and stirred at room temperature for 48 h. After which the solvent was removed 
in vacuo, and the crude residue taken in EtOAc (20 mL). The organic layer was washed 
with water (3 × 10 mL), brine (10 mL), then dried over MgSO4 and the solvent removed 
in vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 4:1 EtOAc) 
afforded the intermediate as a colourless oil (190 mg, 32%), confirmed via ESI-MS 
C49H64N3O6SSi2 calc’d [M+H]+: m/z: 878.404, found: 878.404. 
The intermediate (140 mg, 0.16 mmol, 1 eq.) was suspended in THF (1 mL). 
Tetrabutylammonium fluoride (1 M in THF, 0.64 mL, 0.64 mmol, 4 eq.) was added and 
the reaction was stirred at room temperature for 30 min. After which the solvent was 
removed in vacuo and the crude residue taken up in EtOAc (10 mL). The organic layer 
was washed with water (3 × 10 mL), sat. NH4Cl (aq.) (10 mL), brine (10 mL), then dried 
over MgSO4 and the solvent was removed in vacuo to give the title compound as a white 
amorphous solid (75 mg, 72%, 23% over the two steps). 
IR (film cm-1); vmax 3154 (OH), 2922, 1639 (C=O), 1598, 1539, 1454, 1280, 1152. 
1H NMR (500 MHz, DMSO-d6); 9.41 (2 H, s, 25-H), 8.49 (1 H, d, J 9.5, 6-H), 8.27 (2 H, 
m, 17-H, 20-H), 7.28 (6 H, m, 9-H, 29-H, 30-H), 7.24–7.15 (8 H, m, 3-H, 10-H, 11-H, 14-
H, 31-H), 7.09–7.04 (3 H, m, 15-H, 16-H), 7.00 (2 H, d, J 8.1, 4-H), 6.60 (2 H, d, J 2.2, 
23-H), 6.33 (1 H, t, J 2.2, 26-H), 5.20 (1 H, dd, J 9.5, 5.6, 7-H), 4.80 (1 H, dd, J 10.1, 5.6, 
12-H), 4.63–4.56 (1 H, m, 19-H), 2.82 (1 H, dd, J 13.9, 10.9, 27-Hb), 2.73 (1 H, dd, J 
13.9, 3.4, 27-Ha), 2.23 (3 H, s, 1-H). 
13C NMR (126 MHz, DMSO-d6); 171.0 (C18), 166.6 (C21), 158.1 (C24), 141.8 (C2), 
139.6 (C8), 139.1 (C13), 138.6 (C28), 138.3 (C5), 136.1 (C22), 129.0 (C4), 128.9 (C29), 
128.0 (C30), 127.8 (C31), 127.5 (C14), 127.1 (C10), 127.1 (C15), 126.8 (C16), 126.7 
(C9), 126.2 (C11), 126.0 (C3), 105.6 (C23), 105.2 (C26), 61.9 (C12), 57.5 (C7), 55.0 
(C19), 36.5 (C27), 20.8 (C1). 




5.4.9 Alkaline Phosphatase 
 Synthetic route to S-PL10 
 
 diallyl (4-(hydroxymethyl)phenyl) phosphate 157 
 
Phosphorus trichloride (8.7 mL, 100 mmol, 2 eq.) was added to anhydrous THF (75 mL) 
and cooled to 0 °C. A solution of allyl alcohol (13.6 mL, 200 mmol, 4 eq.) and anhydrous 
TEA (31 mL, 220 mmol, 4.4 eq.) in anhydrous THF (25 mL) was then added dropwise. 
The reaction mixture was then allowed to warm to room temperature and stirred for 1 h, 
after which the reaction was cooled to 0 °C. Water (50 mL) was then added slowly and 
the reaction mixture allowed to warm to room temperature, and stirred for 30 min. The 
organics were removed in vacuo, and the aqueous layer extracted with EtOAc (3 × 100 
mL). The combined organic layers were dried over Na2SO4, and the solvent removed in 
vacuo. The residue was then dissolved in anhydrous toluene (75 ml) and added dropwise 
to a stirring solution of N-Chlorosuccinimide (11.7 g, 87.5 mmol, 1.75 eq.) in anhydrous 
toluene (75 mL) under argon at 0 °C. The reaction mixture was allowed to warm to room 
temperature and stirred for 16 h, after which the reaction was filtered via gravity filtration. 
The filtrate was then concentrated in vacuo. The residue was then taken up in anhydrous 
THF (50 mL) and added slowly to a stirring solution of 4-hydroxybenzaldehyde (6.1 g, 50 
mmol, 1 eq.) and anhydrous TEA (10.5 mL, 75 mmol, 1.5 eq.) in anhydrous THF (50 mL) 
at 0 °C under N2. The reaction mixture was allowed to warm to room temperature and 
stirred for 2 h. After which the reaction was filtered, and the filtrate concentrated in vacuo, 
then taken up in EtOAc (50 mL). The organic layer was washed with sat. NaHCO3 (aq.) 
(50 mL) and the organic layer separated. The aqueous layer was extracted with EtOAc 
(2 × 50 mL). The combined organic layers were washed with water (3 × 50 mL), dried 
over Na2SO4, and then the solvent was removed in vacuo. The residue was then taken 
up in anhydrous THF (50 mL) and cooled to 0 °C before sodium borohydride (3.8 g, 100 
mmol, 2 eq.) was added portion-wise. The reaction mixture was allowed to warm to room 
temperature and stirred for 2 h. The reaction mixture was then cooled to 0 °C and 
quenched with sat. NaHCO3 (aq.) (50 mL). The reaction mixture was extracted with EtOAc 
(3 × 50 mL). The combined organic layers were washed with NaOH (aq.) (1 M, 2 × 50 mL), 
water (2 × 50 mL), dried over Na2SO4, and then the solvent was removed in vacuo. 
Purification via silica gel column chromatography (EtOAc 1:1 Pet. 40–60 °C (Rf = 0.20)) 
gave the title compound as a colourless liquid (2.63 g, 19%). 
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1H NMR (500 MHz, CDCl3); 7.30 (d, J 8.4, 2 H, 5-H), 7.19–7.14 (m, 2 H, 6-H), 5.97–5.87 
(m, 2 H, 2-H), 5.35 (dq, J 17.1, 1.4, 2 H, 1-Htrans), 5.25 (dq, J 10.4, 1.4, 2 H, 1-Hcis), 4.65–
4.58 (m, 6 H, 3-H, 8-H). 
13C NMR (126 MHz, CDCl3); 149.9 (d, J 7.1, C4), 138.2 (d, J 1.4, C7), 132.1 (d, J 7.1, 
C2), 128.4 (C6), 120.1 (d, J 4.8, C5), 118.8 (C1), 69.0 (d, J 5.7, C3), 64.5 (C8). 
31P NMR (202 MHz, CDCl3); -6.24. 
IR (solid, cm-1); νmax 3418 (OH), 2880, 1608, 1506, 1267, 1210, 1164, 1097, 1013. 




Phosgene (2 mL, 15% in toluene) was suspended in anhydrous THF (2 mL) under N2 
and cooled to 0 °C. A solution of diallyl (4-(hydroxymethyl)phenyl) phosphate (370 mg, 
1.3 mmol, 1.3 eq.) in anhydrous THF (3 mL) was added dropwise, and the reaction stirred 
at 0 °C for 3 h. After which the reaction was concentrated, and the residue was then 
taken up in anhydrous THF (8 mL). (S,S)-(N)-tosyl diphenylethylenediamine (366 mg, 1 
mmol, 1 eq.) and triethylamine (0.2 mL) were added, and the reaction was stirred at room 
temperature for 16 h. After which the solvent was removed in vacuo, and the residue 
was taken up in EtOAc (20 mL), then washed with HCl (aq.) (1 M, 20 mL). The organic 
layer was separated, and the aqueous layer extracted with EtOAc (2 × 10 mL). The 
combined organic layers were washed with brine (10 mL), dried over MgSO4, and then 
the solvent was removed in vacuo. Purification via silica gel column chromatography 
(Pet. 40–60 °C 1:1 EtOAc (Rf = 0.6) to give the title compound as an amorphous white 
solid (460 mg, 68%).  
1H NMR (500 MHz, CDCl3); 7.42 (d, J 7.9, 2 H, Ar-H), 7.32 (d, J 8.1, 2 H, Ar-H), 7.20 (d, 
J 8.1, 2 H, Ar-H), 7.17–7.13 (m, 3 H, Ar-H), 7.07–6.92 ( m, 8 H, Ar-H), 6.77 (d, J 7.5, 2 
H), 6.00 (d, J 8.2, 1 H, NH), 5.93 (ddt, J 16.7, 10.6, 5.6, 2 H, CH2CHCH2), 5.74 (d, J 8.2, 
1 H NH), 5.37 (dq, J 16.7, 1.4, 2 H, HCHtransCH), 5.26 (dq, J 10.6, 1.4, 2 H, HCHcisCH), 
5.07 (s, 2 H, ArCH2), 4.89 (t, J 8.4,1 H, CHNH), 4.67–4.60 (m, 4 H, CH2OP), 4.57 (t, J 
8.2, 1 H, CHNH), 2.28 (s, 3 H, CH3). 
13C NMR (126 MHz, CDCl3); 157.0 (CO), 150.6, 143.0 (Ar-C), 138.1 (Ar-C), 137.8 (Ar-
C), 137.6 (Ar-C), 133.2(Ar-C), 132.2 (d, J 6.8, Alkenyl-C), 129.8 (Ar-C), 129.3 (Ar-C), 
128.7 (Ar-C), 128.3 (Ar-C), 128.1 (Ar-C), 127.7 (Ar-C), 127.5 (Ar-C), 127.5 (Ar-C), 127.0 
(Ar-C), 120.3 (d, J 5.0, (Ar-C)), 118.9 (Alkenyl-C), 69.0 (d, J 5.7, CH2OP), 66.7 (CHNH), 
63.5 (CHNH), 60.5  (CH2), 21.5 (CH3). 
31P NMR (162 MHz, CDCl3); -6.32. 
IR (solid, cm-1); νmax 3233 (NH), 3064, 2981, 1693 (C=O), 1538 (C-O), 1508, 1328, 1263, 
1219, 1157, 1091, 1016. 
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HRMS (ESI); calc’d C35H37N2NaO8PS [M+Na]+: m/z: 699.191, found: 699.199. 
 sodium 4-(((((1S,2S)-2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamoyl)oxy)methyl)phenyl phosphate S-PL10 
 
4-((bis(allyloxy)phosphoryl)oxy)benzyl ((1S,2S)-2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamate (460 mg, 0.68 mmol, 1 eq.) was suspended in MeOH (70 mL) 
and cooled to 0 °C. Tetrakis(triphenylphosphine)palladium(0) (8 mg, 0.01 mmol,  0.01 
eq.) and sodium borohydride (51 mg, 1.36 mmol, 2 eq.) was added portion wise . The 
reaction was stirred at room temperature for 20 h, after which the reaction was filtered 
through Celite, and then the solvent was removed in vacuo. The residue was taken up 
in water (10 mL), and then NaOH (1 M, 1.4 mL, 2 eq.) was added. The reaction was 
stirred at room temperature for 1 h, after which the reaction was washed with EtOAc (2 
× 20 mL), and then the solvent was removed in vacuo. Purification via reversed-phase 
flash column chromatography on C18 silica gel (50 g, 20 m) (water 1:0 MeOH → water 
0:1 MeOH) to give the title compound as a white solid (252 mg, 58%).  
Mp; >170 °C (decomposition) 
1H NMR (500 MHz, D2O); 7.28 (d, J 8.0, 2 H, Ar-H), 7.15 (s, 2 H, Ar-H), 7.11–7.04 (m, 5 
H, Ar-H), 7.04–6.97 (m, 5 H, Ar-H), 6.95 (t, J 7.4, 2 H, Ar-H), 6.90–6.83 (m, 2 H, Ar-H), 
4.90–4.79 (m, 3 H, CH2, CHNH), 4.51 (d, J 8.5, 1 H, CHNH), 2.18 (s, 3 H, CH2). 
13C NMR (126 MHz, D2O); 153.8 (C=O), 144.3 (Ar-C), 135.7 (Ar-C), 129.6 (Ar-C), 128.9 
(Ar-C), 128.4 (Ar-C), 128.2 (Ar-C), 127.7 (Ar-C), 127.5 (Ar-C), 127.3 (Ar-C), 127.2 (Ar-
C), 126.4 (Ar-C), 120.4 (d, J 4.5, Ar-C), 66.9 (CHNH), 62.1 (CHNH), 48.8 (CH2), 20.5 
(CH3). 
31P NMR (202 MHz, D2O); 0.04. 
IR (solid, cm-1); νmax 3279, 1684 (C=O), 1612, 1510, 1455, 1240, 1152, 1091. 




5.5 Stimuli Responsive Asymmetric Catalysis 
5.5.1 General Procedures 
 General procedure for electrochemical analysis 
Electrochemical analysis was performed by applying a 20 µL sample to screen-
printed electrochemical cell equipped with carbon working and counter electrodes and a 
silver (pseudo Ag/AgCl) reference electrode. The potential across the cell was powered 
by a Metrohm Autolab PGSTAT30 potentiostat controlled by a laptop running General 
Purpose Electrochemical System (GPES) software in differential pulse mode 
(modulation = 0.04 s, interval = 0.1 s, initial voltage = −400 mV, end voltage = 600 mV, 
step potential = 3 mV, modulation amplitude 49.95 mV). Post-scan, a baseline correction 
(moving average: peak width = 0.03) was performed. Peak integrals were obtained using 
the ‘peak search’ function and the currents were calibrated using Fig. 4-8 to obtain 
concentrations, and conversions calculated using the equation 𝐶𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 (%) =
 
(∫ 188)
(∫ 188+ ∫ 183)
 ×  100. 
 General procedure A for the transfer hydrogenation of ketone to alcohols 
To a medium screw-top vial equipped with a magnetic flea was added 
dichloro(pentamethylcyclopentadienyl)iridium (III) dimer (4 mg, 0.005 mmol, 1 mol %), 
N-tosyl ethylenediamine (2 mg, 0.01 mmol, 2 mol %) and sodium formate (170 mg, 2.5 
mmol) and dissolved in water (0.5 mL) and heated to 80 °C. Ketone (0.5 mmol, 1 eq.) in 
ethanol (0.5 mL) was then added.  The reaction was stirred at 1000 rpm for 3 h. The 
reaction mixture was poured onto water (20 mL) and EtOAc (20 mL). The organic layers 
were extracted, and the aqueous layer was extracted further with EtOAc (2 × 20 mL). 
The combined organics were washed with water (20 mL), brine (20 mL) then dried over 
MgSO4 and concentrated under reduced pressure. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc) gave the titled compound. 
 General procedure B for the catalyst optimisation  
To a medium screw-top vial equipped with a magnetic flea was added metal 
catalyst (1 mol %), ligand (2 mol %) and sodium formate (170 mg, 2.5 mmol, 5 eq.) and 
dissolved in water (1 mL). Trifluoroacetyl ferrocene (141mg, 0.5 mmol, 1 eq.) in ethanol 
(1 mL) was then added.  The reaction was stirred at 1000 rpm for 2-16 h. The reaction 
mixture was poured onto water (20 mL) and EtOAc (20 mL). The organic layer was 
separated, and the aqueous layer extracted with EtOAc (2 × 20 mL). The combined 
organic layers were washed with water (20 mL), brine (20 mL), then dried over MgSO4 
and concentrated under reduced pressure. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc) afforded the title compound as an orange 
solid. Enantiomeric ratios were measured via HPLC. 
 General procedure C for the single pseudo-enantiomer system optimisation  
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymenel)ruthenium(II) dimer (1 mg, 1.25 mol, 1 mol %), sodium formate (42 mg, 625 
mol, 5 eq.), 4-((tert-butyldimethylsilyl)oxy)benzyl (2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamate PL2 (1.6 mg, 2.5 µmol, 2 mol %), and trifluoroacetyl ferrocene 
(35 mg, 125 mol, 1 eq.) were dissolved in solvent (0.5 mL) and buffer (0.5 mL). 
Tetrabutylammonium fluoride (1 M in THF, 25 µL, 25 µmol, 20 mol %) was added, and 
the reaction was stirred at 1000 rpm at room temperature for 16 h. A 5 µL sample was 
taken after 16h and diluted in MeOH 1:1 water (95 µL) and shaken. A 5 µl sample was 
diluted in tris buffer (pH 7, 50 mM, 95 L) and subjected to electrochemical analysis. 
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5.5.2 Catalytic systems 
 General procedure for Single Pseudo-enantiomeric Proligand System 
Trifluoroacetyl ferrocene 183 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (1 mg, 1.25 mol, 1 mol %), sodium formate (42 mg, 625 
mol, 5 eq.), PL (2.5 µmol, 2 mol %), and trifluoroacetyl ferrocene (35 mg, 125 mol, 1 
eq.) were dissolved in i-PrOH (0.5 mL) and carbonate buffer (pH 9.2, 50 mM, 0.5 mL). 
Tetrabutylammonium fluoride (1 M in THF, 25 µL, 25 µmol, 20 mol %), hydrogen peroxide 
(25 µL, 250 µmol, 200 mol%) or alkaline phosphatase (1 mg, 10 units mg-1) was added, 
and the reaction was stirred at 1000 rpm at room temperature for 16 h. A 5 µL sample 
was taken after 16h and diluted in MeOH 1:1 water (95 µL) and shaken. A 5 µl sample 
was diluted in tris buffer (pH 7, 50 mM, 95 L) and subjected to electrochemical analysis. 
The reaction mixture was poured onto water (10 mL) and EtOAc (10 mL). The organic 
layer was separated, and the aqueous layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were washed with water (10 mL), brine (10 mL), then dried over 
MgSO4 and concentrated under reduced pressure. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc) gave the title compound as an orange solid. 
Enantiomeric ratio determined by HPLC analysis (Chiracel OJ: hexane/i-PrOH = 100:0 
→ 95:5 ramp 35 min, 95/5 constant 5 min, 95:5 → 100:0 ramp 5 min, 0 → 0.8 mL/min, 
250 nm, 20 °C). Retention time: t1 = 29.4 min, t2 = 33.4 min. 
Acetophenone 192 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (3.1 mg, 5 mol, 2 mol %), sodium formate (85 mg, 1.25 
mmol, 5 eq.), PL (10 µmol, 4 mol %) and acetophenone (29 l, 250 mol, 1 eq.) were 
dissolved in i-PrOH (1 mL) and carbonate buffer (pH 9.2, 50 mM, 1 mL). 
Tetrabutylammonium fluoride (1 M in THF, 100 µL, 100 µmol, 40 mol %), hydrogen 
peroxide (100 µL, 1 mmol, 400 mol%) or alkaline phosphatase (4 mg, 10 units mg-1) was 
added and the reaction was stirred at 1000 rpm at 25 °C for 24 h. The reaction mixture 
was poured onto water (10 mL) and EtOAc (10 mL). The organic layer was separated, 
and the aqueous layer extracted with EtOAc (2 × 20 mL). The combined organic layers 
were washed with water (10 mL), brine (10 mL), then dried over MgSO4 and concentrated 
under reduced pressure. The crude residue was then analysed by 1H NMR to obtain 
conversions. Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 
EtOAc) gave the title compound as a colourless oil. Enantiomeric ratio determined by 
HPLC analysis (Chiracel OD: hexane/i-PrOH = 95:5 25 min, 0.5 mL/min, 254 nm, 20 °C). 
Retention time: t1 = 15.8 min, t2 = 19.9 min. 
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Sodium pyruvate 193 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (3.1 mg, 5 mol, 2 mol %), sodium formate (85 mg, 1.25 
mmol, 5 eq.), PL (10 µmol, 4 mol %) and sodium pyruvate (27.5 mg, 250 mol, 1 eq.) 
were dissolved in i-PrOH (1 mL) and carbonate buffer (pH 9.2, 50 mM, 1 mL). 
Tetrabutylammonium fluoride (1 M in THF, 100 µL, 100 µmol, 40 mol %), hydrogen 
peroxide (100 µL, 1 mmol, 400 mol%) or alkaline phosphatase (4 mg, 10 units mg-1) was 
added and the reaction was stirred at 1000 rpm at 25 °C for 24 h. The reaction mixture 
was poured onto water (10 mL) and EtOAc (10 mL). The aqueous layer was separated, 
and the organic layer extracted with water (2 × 10 mL). The combined aqueous layers 
were concentrated under reduced pressure, and the crude residue analysed by 1H NMR 
to obtain conversions. The residue was dissolved in DMF (0.5 mL) and cooled to 0 °C. 
Benzyl bromide (0.06 mL, 0.5 mmol, 1 eq.) was added dropwise. The reaction was 
allowed to warm to room temperature and stirred for 18 h, after which Et2O (10 mL) was 
added. Sat. LiCl (aq.) (10 mL) was added and the organic layer separated. The aqueous 
layer was extracted with Et2O (3 × 10 mL) and the combined organic layers were washed 
with sat. NaHCO3 (aq.) (10 mL), brine (10 mL), then dried over MgSO4 and the solvent was 
removed in vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 
EtOAc) afforded the title compound as a colourless oil. Enantiomeric ratio determined by 
HPLC analysis (Chiracel OB-H: hexane/i-PrOH = 95:5 40 min, 0.5 mL/min, 254 nm, 20 
°C). Retention time: t1 = 29.0 min, t2 = 30.1 min. 
 Dual Pseudo-enantiomeric Proligand System R-PL2 and S-PL3 
Trifluoroacetyl ferrocene 183 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (1 mg, 1.25 mol, 1 mol %), sodium formate (42 mg, 625 
mol, 5 eq.), 4-((tert-butyldimethylsilyl)oxy)benzyl (2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamate R-PL2 (1.6 mg, 2.5 µmol, 2 mol %), 4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)benzyl (2-((4-methylphenyl)sulfonamido)-S,S-1,2-
diphenylethyl)carbamate S-PL3 (1.6 mg, 2.5 µmol, 2 mol %), and trifluoroacetyl 
ferrocene (35 mg, 125 mol, 1 eq.) were dissolved in i-PrOH (0.5 mL) and carbonate 
buffer (pH 9.2, 50 mM, 0.5 mL). Tetrabutylammonium fluoride (1 m in THF, 25 µL, 25 
µmol, 20 mol %) or hydrogen peroxide (25 µL, 250 µmol, 200 mol%) was added, and the 
reaction was stirred at 1000 rpm at room temperature for 16 h. A 5 µL sample was taken 
after 16h and diluted in MeOH 1:1 water (95 µL) and shaken. A 5 µl sample was diluted 
in tris buffer (pH 7, 50 mM, 95 L) and subjected to electrochemical analysis. The 
reaction mixture was poured onto water (10 mL) and EtOAc (10 mL). The organic layer 
was separated, and the aqueous layer extracted with EtOAc (2 × 20 mL). The combined 
organic layers were washed with water (10 mL), brine (10 mL), then dried over MgSO4 
193 
 
and concentrated under reduced pressure. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc) gave the title compound as an orange solid. 
Enantiomeric ratio determined by HPLC analysis (Chiracel OJ: hexane/i-PrOH = 100:0 
→ 95:5 ramp 35 min, 95/5 constant 5 min, 95:5 → 100:0 ramp 5 min, 0.8 mL/min, 250 
nm). Retention time: t1 = 29.4 min, t2 = 33.4 min. 
Sodium pyruvate 193 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (3.1 mg, 5 mol, 2 mol %), sodium formate (85 mg, 1.25 
mmol, 5 eq.), 4-((tert-butyldimethylsilyl)oxy)benzyl (2-((4-methylphenyl)sulfonamido)-
R,R-1,2-diphenylethyl)carbamate R-PL2 (6.3 mg, 10 µmol, 4 mol 4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)benzyl (2-((4-methylphenyl)sulfonamido)-S,S-1,2-
diphenylethyl)carbamate S-PL3 (6.4 mg, 2.5 µmol, 2 mol %) and sodium pyruvate (27.5 
mg, 250 mol, 1 eq.) were dissolved in i-PrOH (1 mL) and carbonate buffer (pH 9.2, 50 
mM, 1 mL). Tetrabutylammonium fluoride (1 M in THF, 100 µL, 100 µmol, 40 mol %) or 
hydrogen peroxide (100 µL, 1 mmol, 400 mol%) was added and the reaction was stirred 
at 1000 rpm at 25 °C for 24 h. The reaction mixture was poured onto water (10 mL) and 
EtOAc (10 mL). The aqueous layer was separated, and the organic layer extracted with 
water (2 × 10 mL). The combined aqueous layers were concentrated under reduced 
pressure, and the crude residue analysed by 1H NMR to obtain conversions. The residue 
was dissolved in DMF (0.5 mL) and cooled to 0 °C. Benzyl bromide (0.06 mL, 0.5 mmol, 
1 eq.) was added dropwise. The reaction was allowed to warm to room temperature and 
stirred for 18 h, after which Et2O (10 mL) was added. Sat. LiCl (aq.) (10 mL) was added 
and the organic layer separated. The aqueous layer was extracted with Et2O (3 × 10 mL) 
and the combined organic layers were washed with sat. NaHCO3 (aq.) (10 mL), brine (10 
mL), then dried over MgSO4 and the solvent was removed in vacuo. Purification via silica 
gel column chromatography (Pet. 40–60 °C 9:1 EtOAc) afforded the title compound as a 
colourless oil. Enantiomeric ratio determined by HPLC analysis (Chiracel OB-H: 
hexane/i-PrOH = 95:5 40 min, 0.5 mL/min, 254 nm, 20 °C). Retention time: t1 = 29.0 min, 
t2 = 30.1 min. 
 Dual Pseudo-enantiomeric Proligand System R-PL2 and S-PL10 
Trifluoroacetyl ferrocene 183 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (1 mg, 1.25 mol, 1 mol %), sodium formate (42 mg, 625 
mol, 5 eq.), 4-((tert-butyldimethylsilyl)oxy)benzyl (2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamate R-PL2 (1.6 mg, 2.5 µmol, 2 mol %), sodium 4-(((((1S,2S)-2-((4-
methylphenyl)sulfonamido)-1,2-diphenylethyl)carbamoyl)oxy)methyl)phenyl phosphate 
S-PL10 (1.6 mg, 2.5 µmol, 2 mol %), and trifluoroacetyl ferrocene (35 mg, 125 mol, 1 
eq.) were dissolved in i-PrOH (0.5 mL) and carbonate buffer (pH 9.2, 50 mM, 0.5 mL). 
194 
 
Tetrabutylammonium fluoride (1 m in THF, 25 µL, 25 µmol, 20 mol %) or alkaline 
phosphatase (1 mg, 10 units mg-1) was added, and the reaction was stirred at 1000 rpm 
at room temperature for 16 h. A 5 µL sample was taken after 16h and diluted in MeOH 
1:1 water (95 µL) and shaken. A 5 µl sample was diluted in tris buffer (pH 7, 50 mM, 95 
L) and subjected to electrochemical analysis. The reaction mixture was poured onto 
water (10 mL) and EtOAc (10 mL). The organic layer was separated, and the aqueous 
layer extracted with EtOAc (2 × 20 mL). The combined organic layers were washed with 
water (10 mL), brine (10 mL), then dried over MgSO4 and concentrated under reduced 
pressure. Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 EtOAc) 
gave the title compound as an orange solid. Enantiomeric ratio determined by HPLC 
analysis (Chiracel OJ: hexane/i-PrOH = 100:0 → 95:5 ramp 35 min, 95/5 constant 5 min, 




To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (3.1 mg, 5 mol, 2 mol %), sodium formate (85 mg, 1.25 
mmol, 5 eq.), 4-((tert-butyldimethylsilyl)oxy)benzyl (2-((4-methylphenyl)sulfonamido)-
R,R-1,2-diphenylethyl)carbamate R-PL2 (6.3 mg, 10 µmol, 4 mol %), sodium 4-
(((((1S,2S)-2-((4-methylphenyl)sulfonamido)-1,2-
diphenylethyl)carbamoyl)oxy)methyl)phenyl phosphate S-PL10 (6.4 mg, 2.5 µmol, 2 mol 
%) and acetophenone (29 l, 250 mol, 1 eq.) were dissolved in i-PrOH (1 mL) and 
carbonate buffer (pH 9.2, 50 mM, 1 mL). Tetrabutylammonium fluoride (1 M in THF, 100 
µL, 100 µmol, 40 mol %) or alkaline phosphatase ALP (4 mg, 10 units mg-1) was added 
and the reaction was stirred at 1000 rpm at 25 °C for 24 h. The reaction mixture was 
poured onto water (10 mL) and EtOAc (10 mL). The organic layer was separated, and 
the aqueous layer extracted with EtOAc (2 × 20 mL). The combined organic layers were 
washed with water (10 mL), brine (10 mL), then dried over MgSO4 and concentrated 
under reduced pressure. The crude residue was then analysed by 1H NMR to obtain 
conversions. Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 
EtOAc) gave the title compound as a colourless oil. Enantiomeric ratio determined by 
HPLC analysis (Chiracel OD: hexane/i-PrOH = 95:5 25 min, 0.5 mL/min, 254 nm, 20 °C). 
Retention time: t1 = 15.8 min, t2 = 19.9 min. 
Sodium pyruvate 193 
 
To a medium screw-top vial equipped with a magnetic flea was added dichloro(p-
cymene)ruthenium(II) dimer (3.1 mg, 5 mol, 2 mol %), sodium formate (85 mg, 1.25 
mmol, 5 eq.), 4-((tert-butyldimethylsilyl)oxy)benzyl (2-((4-methylphenyl)sulfonamido)-




diphenylethyl)carbamoyl)oxy)methyl)phenyl phosphate S-PL10 (6.4 mg, 2.5 µmol, 2 mol 
%) and sodium pyruvate (27.5 mg, 250 mol, 1 eq.) were dissolved in i-PrOH (1 mL) and 
carbonate buffer (pH 9.2, 50 mM, 1 mL). Tetrabutylammonium fluoride (1 M in THF, 100 
µL, 100 µmol, 40 mol %) or alkaline phosphatase ALP (4 mg, 10 units mg-1) was added 
and the reaction was stirred at 1000 rpm at 25 °C for 24 h. The reaction mixture was 
poured onto water (10 mL) and EtOAc (10 mL). The aqueous layer was separated, and 
the organic layer extracted with water (2 × 10 mL). The combined aqueous layers were 
concentrated under reduced pressure, and the crude residue analysed by 1H NMR to 
obtain conversions. The residue was dissolved in DMF (0.5 mL) and cooled to 0 °C. 
Benzyl bromide (0.06 mL, 0.5 mmol, 1 eq.) was added dropwise. The reaction was 
allowed to warm to room temperature and stirred for 18 h, after which Et2O (10 mL) was 
added. Sat. LiCl (aq.) (10 mL) was added and the organic layer separated. The aqueous 
layer was extracted with Et2O (3 × 10 mL) and the combined organic layers were washed 
with sat. NaHCO3 (aq.) (10 mL), brine (10 mL), then dried over MgSO4 and the solvent was 
removed in vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 
EtOAc) afforded the title compound as a colourless oil. Enantiomeric ratio determined by 
HPLC analysis (Chiracel OB-H: hexane/i-PrOH = 95:5 40 min, 0.5 mL/min, 254 nm, 20 
°C). Retention time: t1 = 29.0 min, t2 = 30.1 min. 
5.5.3 Compound Data 
 Acetyl ferrocene 176 
 
Acyl chloride (0.78 mL, 11 mmol, 1.1 eq.) and aluminium trichloride (1.47 g, 11 mmol, 
1.1 eq.) were suspended in dry DCM (25 mL) under N2. Ferrocene (1.87 g, 10.06 mmol, 
1 eq.) was then added portion wise and the reaction stirred for 16 h, after which water 
(25 mL) was then added and the organics separated. The aqueous layer was extracted 
with DCM (2  25 mL) and he combined organic layers were dried over MgSO4 and the 
solvent removed in vacuo. Purification via silica gel column chromatography (acetone 
1:5 Pet. 40–60 °C) gave the title compound as a red crystalline solid (1.87 g, 82 %). 
Mp; 80–83 °C (lit.303 79–81 °C) 
IR (solid, cm-1); vmax 3070 (CH), 1651 (C=O). 
1H NMR (500 MHz, CDCl3); 4.77 (2 H, t, J 1.9, 5-H), 4.50 (2 H, t, J 1.9, 4-H), 4.20 (5 H, 
s, 6-H), 2.39 (3 H, s, 1-H). 
13C NMR (126 MHz, CDCl3); 202.1 (C2), 79.3 (C3), 72.3 (C4), 69.9 (C6), 69.6 (C5), 
27.4 (C1). 
Data in accordance with literature precedent.303 




Ferrocene carboxaldehyde (2.14 g, 10 mmol, 1 eq.) was added to acetone (40 mL) and 
cooled to 0 °C. Potassium hydroxide (20 mL, 2 M) was then added and the reaction was 
stirred for 2 h after which the reaction mixture was poured into cold water. The red 
precipitate was filtered and then air-dried. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc (Rf = 0.25)) gave the title compound as a red 
crystalline solid (2.06 g, 81 %). 
Mp; 85–87 °C (lit.304 78–80 °C)  
IR (solid, cm-1); vmax 2166, 2030, 1662 (C=O), 1638, 1613, 1395, 1358, 1274. 
1H NMR (500 MHz, C6D6) 7.31 (1 H, d, J 16.0, HC=CH), 6.35 (1 H, d, J 16.0, HC=CH), 
4.15 (2 H, t, J 1.8, Ar-H), 4.07–4.05 (2 H, m, Ar-H), 3.87 (5 H, s, Cp-H), 1.97 (3 H, s, 
CH3). 
13C NMR (126 MHz, C6D6); 196.5 (CO), 144.5 (HC=CH), 126.0 (HC=CH), 80.2 (Ar-CCH, 
72.0 (Ar-CH), 70.8 (Cp-CH), 69.8 (Ar-CH), 28.2 (CH3). 
Data in accordance with literature precedent.304 
 4-ferrocenyl-butan-2-ol 180 
 
2-acetylvinylferrocene (127 mg, 0.5 mol, 1 eq.) was reacted according to the general 
procedure A to give the titled compound as a yellow oil (88 mg, 69 %). 
1H NMR (500 MHz, CDCl3); 4.13–4.11 (5H, m, Cp-H), 4.10–4.09 (2H, m, Ar-H), 4.08–
4.05 (2H, m, Ar-H), 3.87 –3.78 (1H, m, CHOH), 2.50–2.33 (2H, m, Fc-CH2), 1.72–1.61 
(2H, m, CH2), 1.22 (3H, d, J 6.2 Hz, CH3).  
13C NMR (126 MHz, CDCl3); 68.7, 68.0, 67.4, 40.6, 25.9, 23.8. 
 4-Ferrocenyl-butan-2-one 181 
 
2-acetylvinylferrocene (127 mg, 0.5 mol, 1 eq.) was reacted according to the general 
procedure A to give the titled compound as a red oil (11 mg, 9 %). 
1H NMR (500 MHz, CDCl3); 4.11 (5H, s, Cp-H), 4.05 (4H, s, Ar-H), 2.68–2.58 (4H, m, 
CH2CH2), 2.15 (3H, s, CH3). 
13C NMR (126 MHz, CDCl3); 208.5, 68.8, 68.2, 67.6, 45.4, 30.3, 23.9. 




1-ferrocenyl-2,2,2-trifluoroethanol (1.02 g, 3.59 mmol, 1 eq.) was added to toluene (40 
mL). Activated manganese dioxide (3.13 g, 36 mmol, 10 eq.) was added in one portion 
and the reaction was stirred at 60 °C for 24 h. The reaction mixture was filtered, and the 
precipitate was washed with EtOAc (20 mL) and water (50 mL). The filtrate and washings 
were combined, and the organic layer separated. The aqueous layer was extracted with 
EtOAc (2  20 mL) and the combined organic layers washed with brine (10 mL), then 
dried over MgSO4 and the solvent removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc (Rf = 0.69)) gave the title compound as a red 
liquid (1.05 g, 94 %). 
IR (film, cm-1); vmax 3112 (CH), 2160 (CH), 1682 (CO). 
1H NMR (500 MHz, CDCl3); 4.99–4.97 (2 H, m, Ar-H), 4.78–4.73 (2 H, m, Ar-H), 4.30 (5 
H, s, Cp-H). 
13C NMR (126 MHz, CDCl3); 117.9 (Ar-C), 115.6 (Ar-C), 70.9 (m, CF3). 
19F NMR (470 MHz, CDCl3); -72.09 (CF3). 
HRMS (ESI); calc’d C12H11F3FeO2 [M+H2O]+: m/z: 300.010, found: 300.010. 
 (N)-methoxyferrocenylformamide 187 
 
Ferrocene carboxylic acid (1.15 g, 5 mmol, 1 eq.) and DMF (0.037 g, 0.5 mmol, 0.1 eq.) 
were suspended in DCM (25 mL) and cooled to 0 °C. Oxalyl chloride (0.51 mL, 6 mmol, 
1.2 eq.) was added dropwise and the reaction was allowed to warm to room temperature 
and stirred for 3 h, after which the solvent was removed under reduced pressure. N,O-
dimethylhydroxylamine hydrogen chloride (0.49 g, 5 mmol, 1 eq.) and 
diisopropylethylamine (1.74 mL, 10 mmol, 2 eq.) were added to DCM (15 mL) and cooled 
to 0 °C. The crude product was taken up in DCM (10 mL) and then added dropwise. The 
temperature was maintained at 0 °C and the reaction stirred for 2 h 30, after which the 
reaction mixture was poured into sat. NaHCO3 (aq.) (25 mL). The organic layer was 
separated, and the aqueous layer extracted with EtOAc (2  20 mL). The combined 
organics were dried over MgSO4 and the solvent removed in vacuo. Purification via silica 
gel column chromatography (Pet 40–60 °C 9:1 EtOAc (Rf = 0.06)) gave the title 
compound as an orange oil (1.20 g, 88 %)   
IR (film, cm-1); vmax 3090, 2967, 2935, 2160, 2022, 1735, 1620 (C=O), 1459, 1381. 
1H NMR (500 MHz, CDCl3); 4.91–4.90 (2 H, m, Ar-H), 4.39–4.37 (2 H, m, Ar-H), 4.21 (5 
H, s, Cp-H), 3.74 (3 H, s, NOCH3), 3.31 (3 H, s, NCH3). 
13C NMR: (126 MHz, CDCl3) 71.3 (Ar-C), 70.8 (Ar-C), 69.8 (Cp), 61.3 (NOCH3), 33.7 
(NCH3). 
Data in accordance with literature precedent.305 
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 1-ferrocenyl-2,2,2-trifluoroethanol 188 
 
Ferrocene carboxaldehyde (1.0 g, 4.67 mmol, 1 eq.) and caesium fluoride (0.14 g, 0.93 
mmol, 0.2 eq.) were suspended in dry THF (50 mL) under N2 and cooled to 0 °C. TMSCF3 
(0.83 mL, 5.60 mmol, 1.2 eq.) was then added dropwise and stirred for 30 min. The 
solvent was removed under reduced pressure and the crude product was passed 
through a silica plug (DCM 95:5 MeOH). The crude product was taken up in dry THF (25 
mL) under N2 and cooled to 0 °C. TBAF (5.6 mL, 1 M in THF, 1.2 eq.) was then added 
dropwise, and the reaction was stirred for 1 h after which water (15 mL) and Et2O (10 
mL) were added. The organic layer was separated, and the aqueous layer extracted with 
Et2O (3  30 mL). The combined organic layers were washed with brine (10 mL), then 
dried over MgSO4, and the solvent removed in vacuo. Purification via silica gel column 
chromatography (Pet. 40–60 °C 9:1 EtOAc (Rf = 0.46)) gave the title compound as an 
orange crystalline solid (1.27 g, 97 %). 
Mp: 79-82 °C (lit.306 73–74 °C)  
IR (solid, cm-1); vmax 3458, 3101, 2922, 2103, 1655 (C=O), 1410. 
1H NMR (500 MHz, CDCl3) 4.65 (1 H, qd, J 6.5, 4.7, CHCF3), 4.40 (1 H, dd, J 1.4, 0.8, 
Ar-H), 4.33 (1 H, dd, J 2.4, 1.4, Ar-H), 4.28 (2 H, ddd, J 2.4, 1.4, 0.8, Ar-H), 4.26 (5 H, s, 
Cp-H), 2.46 (1 H, d, J 4.7, OH). 
13C NMR (126 MHz, CDCl3); 69.1 (CH), 69.0 (Ar-C), 68.9 (Cp), 66.1 (Ar-C). 
19F NMR (470 MHz, CDCl3); -78.12 (d, J 6.5, CHCF3). 
Data in accordance with literature precedent.306 
 1-phenylethanol 201 
 
Acetophenone (0.06 mL, 0.5 mmol, 1 eq.) was reacted according to general procedure 
A to give the title compound as a pale-yellow oil (87 mg, 99%). 
IR (film, cm-1); vmax 3350 (OH), 3063, 3028, 2973, 2927, 2874, 2160, 2031, 1602, 1450, 
1368, 1283. 
1H NMR (500 MHz, CDCl3); 7.40–7.33 (m, 4 H, Ar-H), 7.30–7.25 (m, 1 H, Ar-H), 4.90 (q, 
J 6.5, 1 H, CH), 1.91 (s, 1 H, OH), 1.50 (d, J 6.5, 3 H, CH3). 
13C NMR (126 MHz, CDCl3); 145.9 (Ar-C), 128.6 (Ar-C), 127.6 (Ar-C), 125.5 (Ar-C), 70.5 
(CHOH), 25.3 (CH3). 
Data in accordance with literature precedent.307 
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 Benzyl 2-hydroxypropanoate 197 
 
Dichloro(p-cymene )ruthenium(II) dimer (6.1 mg, 0.01 mmol, 2 mol %), sodium formate 
(170 mg, 2.5 mmol, 5 eq.), (±)-(N)-p-Tosyl-1,2-diphenylethylenmediamine (3.7 mg, 0.01 
mmol, 4 mol %) and sodium pyruvate (55 mg, 0.5 mmol, 1 eq.) were dissolved in i-PrOH 
(2 mL) and carbonate buffer (pH 9.2, 50 mM, 2 mL). The reaction was stirred at room 
temperature for 24 h. The solvent was removed in vacuo to give sodium lactate. Sodium 
lactate was dissolved in DMF (0.5 mL) and cooled to 0 °C. Benzyl bromide (0.06 mL, 0.5 
mmol, 1 eq.) was added dropwise. The reaction was allowed to warm to room 
temperature and stirred for 18 h, after which Et2O (10 mL) was added. Sat. LiCl (aq.) (10 
mL) was added and the organic layer separated. The aqueous layer was extracted with 
Et2O (3 × 10 mL) and the combined organic layers were washed with sat. NaHCO3 (aq.) 
(10 mL), brine (10 mL), then dried over MgSO4 and the solvent was removed in vacuo. 
Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 EtOAc) afforded 
the title compound as a colourless oil (50.4 mg, 65 %). 
IR (film, cm-1); νmax 3413 (OH), 2981, 1733 (C=O), 1203, 1124. 
1H NMR (500 MHz, CDCl3); 7.41–7.32 (m, 5 H, Ar-H), 5.21 (s, 2 H, CH2), 4.35–4.29 (m, 
1 H, CHOH), 2.99 (d, J 5.2, 1 H, OH), 1.43 (d, J 6.9, 3 H, CH3). 
13C NMR (126 MHz, CDCl3); 175.6 (C=O), 135.3 (Ar-C), 128.7 (Ar-C), 128.6 (Ar-C), 128.3 
(Ar-C), 67.4 (CH), 66.9 (CH), 20.4 (CH3). 
Data in accordance with literature precedent.308 
 Benzyl (2-((4-methylphenyl)sulfonamido)-S,S-1,2-diphenylethyl)carbamate 
S-PL11 
  
Phosgene (15 % in toluene, 2 mL) was suspended in toluene (2.5 mL) under N2 and 
cooled to 0 °C. Benzyl alcohol (0.1 mL, 1 mmol, 1 eq.) was dissolved in toluene (2.5 mL) 
and added dropwise. The reaction was allowed to warm to room temperature and then 
stirred for 2 h. The reaction was concentrated, and the residue taken up in anhydrous 
THF (8 mL) under N2 and cooled to 0 °C. (N)-tosyl-(S,S)-diphenylethylenediamine (366 
mg, 1 mmol, 1 eq.) and triethylamine (0.1 mL) were added and the reaction allowed to 
warm to room temperature. The reaction was stirred for 16 h, then sat. NaHCO3 (aq.) (20 
mL) was added, followed by EtOAc (20 mL). The organic layer was separated, and the 
aqueous layer was extracted with EtOAc (2 × 20 mL). The combined organic layers were 
washed with water (20 mL), brine (10 mL), dried over MgSO4 and then the solvent was 
removed in vacuo. Purification via silica gel column chromatography (Pet. 40–60 °C 9:1 
EtOAc) gave the title compound as a white solid (204 mg, 41 %). 
Mp; >150 °C (decomposition) 
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IR (solid, cm-1); vmax 3369, 3306, 1687, 1528, 1321, 1248, 1153. 
1H NMR (500 MHz, CDCl3);  7.43 (2 H, d, J 7.9, Ar-H), 7.38–7.29 (5 H, m, Ar-H), 7.20–
7.10 (3 H, m, Ar-H), 7.07–6.93 (7 H, m, Ar-H), 6.76 (2 H, d, J 7.6, Ar-H), 6.09 (1 H, d, J 
7.6, NH), 5.72 (1 H, d, J 7.8, NH), 5.13 (1 H, d, J 12.3, Ph-CHH), 5.10 (1 H, d, J 12.3, 
Ph-CHH), 4.91 (1 H, dd, J 9.6, 7.6 CHNH), 4.58 (1 H, dd, J 9.6, 7.8, CHNH), 2.28 (3 H, 
s, CH3). 
13C NMR (126 MHz, CDCl3); 143.0 (Ar-C), 136.2 (Ar-C), 129.3 (Ar-C), 128.7 (Ar-C), 128.6 
(Ar-C), 128.2 (Ar-C), 127.6 (Ar-C), 127.6 (Ar-C), 127.5 (Ar-C), 127.0 (Ar-C), 67.5 (CH2), 
63.5 (CHNH), 60.5 (CHNH), 21.5 (CH3). 
5.5.4 HPLC Traces 
 1-ferrocenyl-2,2,2-trifluoroethanol 188 
  
Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 31.523 BB 1.0112 1.09E+04 165.53996 49.5455 
2 37.765 MM 1.6555 1.11E+04 111.47632 50.4545 
  
Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 27.674 BB 0.8147 2861.85571 5.17E+01 86.7267 




Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 28.455 BB 0.733 333.86502 6.44E+00 11.7724 
2 32.84 BB 0.6863 2.50E+03 53.73201 88.2276 
 
 1-phenylethanol 201 
  
Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 15.817 BB 0.93 6.00E+03 9.29E+01 49.9795 
2 19.899 BBA 1.1678 6.01E+03 7.53E+01 50.0205 
  
Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 16.018 MM 0.7364 5.95E+01 1.35E+00 3.8272 




Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 16.971 BB 0.7413 8.55E+02 1.61E+01 95.3969 
2 21.098 MM 0.9524 4.12E+01 7.22E-01 4.6031 
 
 Benzyl 2-hydroxypropanoate 197 
 
  
Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 27.679 BB 0.573 2.96E+02 7.94E+00 45.0091 
2 29.551 BB 0.619 3.62E+02 8.83E+00 54.9909 
  
Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 28.961 BB 0.4903 8.03E+01 2.49E+00 3.2428 




Peak RetTime Type Width Area Height Area 
# [min] 
 
[min] [mAU*s] [mAU] % 
---- ------- ---- ------- ---------- ---------- -------- 
1 28.966 BB 0.7274 1.03E+03 2.09E+01 94.6894 
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